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ABSTRACT 
The biomedical application of nanotechnology has come into the spotlight, with the promise 
of ‘personalised’ therapeutics that couple early diagnosis with targeted therapeutic activity.  
Due to the rapid growth of the biomedical applications of nanoparticles, along with the lack 
of understanding concerning their interactions with biomolecules, there is a pressing need for 
the development of standard methods directed at investigating the effect of introducing these 
unique particles into the human body.  The central aim of this research is to establish a 
platform directed at assessing the biological fate of pioneering therapeutic particulate agents, 
such as metallophthalocyanines (MPcs) and multi-walled carbon nanotubes (FMWCNTs).  In 
particular, we proposed, that Quartz Crystal Microbalance with Dissipation (QCM-D) 
technology may be employed to assess the composition of blood protein corona deposited on 
the therapeutic surface, and subsequently assess the biocompatibility of such particles.   
 
The proposed method of protein detection utilises the nanogram sensitivity of QCM-D 
technology to monitor highly specific antibody-antigen interactions. In particular those 
interactions which occur when probe antibodies are used to detect adsorbed blood proteins 
deposited on target particle-modified sensor surfaces.  Protein detection analysis was directed 
toward identification of surface bound human serum albumin, complement factor C3c, and 
human plasma fibrinogen. 
 
Preliminary analysis of generic biomedical surfaces indicated human serum albumin 
demonstrates a higher binding affinity towards positively charged surfaces (i.e. cysteamine 
self-assembled monolayer), followed by hydrophobic surfaces.  Detection of complement 
C3c, corresponded with literature, where lower levels were detected on negatively charged 
surfaces (i.e. mercapto undecanoic acid self-assembled monolayer), and higher levels of more 
hydrophobic surfaces (i.e. 11-amino undecane thiol self-assembled monolayer).  Human 
plasma fibrinogen was observed to favour hydrophilic over hydrophobic self-assembled 
monolayer surfaces, which was in accordance with literature. 
 
II 
 
Application of the proposed protein detection method for biocompatibility analysis of target 
therapeutic molecules, namely metallophthalocyanines and acid functionalised multi-walled 
carbon nanotubes, demonstrated a dependence on modified-surface film characteristics, such 
as surface charge and topography with regards to human serum albumin and human plasma 
fibrinogen analysis representing new insights into their potential biomolecular interactions  
The highest levels of detected human serum albumin and complement C3c were detected on 
the GePcSmix-modified surfaces. AlPcSmix-modified surfaces analysis suggested the highest 
levels of human plasma fibrinogen.  Two methods of acid functionalisation were employed, 
using both nitric and sulphuric acid, and pure nitric acid.  A general increase in detected 
human serum albumin, corresponding with an increase in functionalisation time, was 
observed.  Complement C3c detection suggested an increase in deposited complement C3c, 
with increasing functionalisation time, when assessing nitric acid functionalised multi-walled 
carbon nanotubes, and a decrease, with increasing functionalisation time, when assessing 
nitric and sulphuric acid functionalised multi-walled carbon nanotubes.  Analysis of human 
plasma fibrinogen was inconclusive, as were cytotoxicity experiments utilising MCF-7 cells 
in the presence of metallophthalocyanine complexes, raising simultaneously important 
considerations for their application and study. 
 
In the first such detailed examination of its kind it was concluded that the proposed method of 
protein detection, using QCM-D, allows for the rudimentary but rapid means of analysis of 
select protein corona deposited on particulate biomedical surfaces.   
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CHAPTER 1:  OVERALL INTRODUCTION 
1.1. Overview 
Medical treatments involving the introduction of foreign surfaces to human blood 
components, such as implantations and the systemic administration of therapeutic drugs, is 
required to undergo rigorous biocompatibility testing to determine the haematocompatibility 
of the product before considering commercialization [1].  The ultimate objective of any 
therapeutic is the rapid and accurate diagnosis and treatment of a disease or illness, resulting 
in minimal secondary side effects [2].  Research into the adsorption of blood proteins to 
therapeutic surfaces has been highlighted as an important factor in the field of 
biocompatibility and biomaterials.  The adsorbed protein corona substantially influences the 
biodistribution and clearance of the drug molecule in biological systems, which would in turn 
potentially disrupt the delivery to the target site for its intended application and reduce the 
drugs efficiency. In addition, the composition of the adsorbed protein coat may potentially 
trigger defence mechanisms, such as the coagulation and complement system cascades [3-5].  
In particular, once introduced to the circulatory system, biomedical surfaces instantaneously 
encounter blood plasma proteins, such as opsonins (i.e. complement factor proteins and 
human plasma fibrinogen), which when bound, may result in the rapid uptake of the particle 
by the mononuclear phagocyte system (MPS) [6-8].  Conversely, the binding of dysopsonins 
(human serum albumin) to the surface results in an extended circulation lifetime of the 
particle within the blood system [9].  Numerous efforts have been directed towards the 
preferential binding of ‘inactive’ serum proteins to the biomaterial surface, such as human 
serum albumin (HSA), within the biological system.  The design and development of such 
surfaces requires an in-depth understanding of adsorption that occurs at the biomaterial 
interface within the complex biological media, in terms of protein composition, and 
conformation [5].   
 
To date, methods aimed at identification of the adsorbed protein coat composition, deposited 
on particulate therapeutics, predominantly involve gel electrophoresis analysis.  In particular, 
two dimensional polyacrylamide gel electrophoresis (2D-PAGE), sodium dodecyl sulphate 
(SDS) PAGE, and Western blot analysis [10-17].  These particular techniques require extensive 
preparation of the sample, where centrifugation is utilised in the separation of the protein 
coated particle from non-adsorbed proteins in solution.  This separation step introduces the 
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possibility of false protein identification, as protein aggregates, and larger protein molecules, 
may be unexpectedly incorporated in the purified sample preparation.  In addition to the 
increase in possible experimental error, the above mentioned techniques require the active 
removal of the absorbed serum protein from the therapeutic surfaces, using solubilising 
agents.  This active removal of serum proteins restricts the identification analysis to total 
level of protein present, omitting analysis of protein surface exposure, which is an influential 
factor.  The detection and quantification of the adsorbed proteins is determined through 
comparative studies with control samples, therefore limiting the detection range [10-15]. 
 
Alternative methods utilised for the identification of adsorbed protein include, enzyme-liked 
immunosorbent assays (ELISA) and Surface Plasmon Resonance (SPR) [12, 14, 18].  Both the 
ELISA- and SPR-based methods require the immobilisation of the therapeutic to the relevant 
substrate.  The utilisation of SPR for protein detection and identification provides real-time 
analysis of the protein-substrate adsorption process, in comparison to the analysis of the end-
point product employed in ELISA studies.  Similarly, Quartz Crystal Microbalance with 
Dissipation (QCM-D) has been employed for the analysis of blood protein adsorption, 
identification, and quantification.  The latter method demonstrates reproducible, real-time 
measurements with the possibility of equal sensitivity, through optimisation, in comparison to 
ELISA methods, in a fraction of the time, consequently providing the ‘rapid’ aspect of the 
protocol to be designed [19, 20].  A comparison between SPR and QCM-D revealed no 
considerable differences, with respect to limit of detection, cost, sensitivity, etc.  QCM-D 
does, however, allow for the analysis of structural changes, namely due to protein-substrate, 
and protein-protein interactions, which are essential aspects to consider when assessing 
protein adsorption, and therefore biocompatibility [20-22].   
 
QCM-D technology has demonstrated application in a variety of fields, including, the 
development of biosensors, monitoring of biofouling and surface functionalisation, analysis 
of surfactants-based studies, and in particular, analysis of biomaterials and drug    
development [23-28].  According to Sellborn et al. (2002) [21], QCM-D may be utilised to assess 
the complement activating ability of model biomaterial surfaces, prepared on the QCM-D 
sensor crystal.  This was reported to be achieved through the monitoring and quantification of 
anti-human C3c binding to the target surfaces, following treatment with human serum [21].  It 
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was on this basis that the utilisation of QCM-D, in this thesis, was proposed for the 
identification of adsorbed serum proteins on target surfaces. In particular, through the 
monitoring and quantification of subsequent target antibody binding, namely antibodies 
directed against human serum albumin, complement factor C3, and human plasma fibrinogen.  
Furthermore, the proposed method was assessed in terms of its application for protein 
detection on surfaces modified with therapeutic agents (i.e. metallophthalocyanines) and 
nanomaterials (i.e. multi-walled carbon nanotubes), and therefore potentially providing 
insight into their biocompatibility.  To my knowledge, the utilisation of QCM-D for the 
identification and quantification of protein binding to therapeutic particle-modified sensor 
surfaces has not yet been assessed. 
 
1.2. Quartz Crystal Microbalance with Dissipation Technology 
Quartz Crystal Microbalance with Dissipation (QCM-D) technology stems from the classical 
QCM technique which is described as a surface sensitive piezoelectric based method for the 
monitoring and quantification of adsorbed mass [29, 30].    The QCM-D system demonstrates 
applications in the characterization of the formation of thin films, due to its nanogram 
sensitive mass measurements, provided by frequency (f) changes, and its insight into 
structural properties, provided by the dissipation (D) changes [30].   
 
1.2.1. QCM-D Principal 
QCM-D involves the administration of an alternating current applied to a thin, disc-shaped 
quartz crystal, sandwiched between a pair of metal electrode films (i.e. Au), to generate a 
fundamental, or overtone, resonance frequency [29, 30].  In response to the adsorption of mass 
onto the electrodes, a decrease in resonance f is observed which, in the case of the adsorption 
of a thin, rigid film with negligible internal friction, is proportional to the mass added [22].  
This relationship is demonstrated by the Sauerbrey equation: 
∆f = -∆m/nC         Eq. 1 
Where ‘f‘ is the resonance frequency of the oscillating crystal, ‘m’ is the adsorbed mass, ‘n’ is the overtone 
number (1, 3, 5, 6…), and ‘C’ is the mass sensitivity constant (17.7 ng.Hz-1.cm-2 for a 5 MHz quartz crystal) [31]. 
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With regards to the adsorption of thick, and/or, loosely-structured viscoelastic films, the 
Sauerbrey equation does not hold true and leads to the underestimation of the adsorbed    
mass [22].  The ‘failure’ of the Sauerbrey equation in accurately determining adsorbed mass is 
due to the behaviour of the adsorbed viscoelastic film and its dampening influence on the 
propagation of the shear acoustic wave [32].  An additional factor contributing to the 
underestimation of the Sauerbrey adsorbed mass is due to the Sauerbrey model omitting 
coupled water/solvent molecules on or in the film. Coupled water has been reported to result 
in mass-uptake between 1.5 and 4 times greater than that of the adsorbed film dry mass [32]. 
 
The monitoring of an additional parameter, namely, dissipation, D, in combination with the f 
response, aids in overcoming the short-comings of the Sauerbrey-based determination of 
adsorbed mass, and allows for the concomitant characterisation of structural variations [25].  
The D factor may be described as the dissipative energy loss of the oscillating crystal due to 
the internal friction of the adsorbed film [22, 29-30].   
 
Shifts in the f and D responses have been related, through derivations by Voinova et al. 
(1999) [34], to the film density, thickness, and viscoelastic parameters, namely, viscosity and 
shear modulus [33].  In the event of the film-surface system behaving in accordance with a 
spring and dashpot mechanical element analogy for the system, where the spring corresponds 
with the shear rigidity of the film, and the dashpot with the viscosity, Voigt-based modelling 
of the film parameters is achievable [33].  The Voigt-based viscoelastic film model utilises 
both the f and D shifts to express the oscillatory motion of the shear acoustic wave 
propagating through a single homogeneous adsorbed layer, under non-slip conditions, when 
the film is in contact with a semi-infinite Newtonian liquid [32].  The mathematical model 
represents the adsorbed viscoelastic film via employing four unknown parameters, namely; 
elastic shear modulus (μf), shear viscosity (ηf), film thickness (δf), and film density (ρf), by 
the use of f and D shifts of 2 or more harmonics.  The coupled water in or on the adsorbed 
film is taken into account when using this model [32, 34].  Shear modulus is described as the 
ratio of shear stress applied to a body to the shear strain produced, in particular, the tangential 
forces to angular deformation.  Viscosity is the measure of the resistance to flow presented by 
a fluid when subjected to shear stress [Internet Reference 1].  Figure 1.1 schematically illustrates the 
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viscoelastic film parameters, namely shear modulus (A) and viscosity (B), in terms of film 
deformation under shear stress. 
. 
Figure 1.1.  Schematic representation of film deformation under shear strain illustrating film 
viscosity (A), and shear modulus (B).  Adaption of q-sense ® [Internet Reference 1].  
 
The Voigt model has, however, set requirements of the film for the accurate prediction of the 
f and D response (at any overtone) to n viscoelastic layers, namely [Alternative Reference 1]; 
 Total coverage of the sensor surface, of each layer, must be achieved 
 The deposited films are required to be of uniform thickness and homogeneous in 
nature 
 The viscoelastic properties of the deposited films are required to comply with either 
the Voigt, or Maxwell, viscoelastic representations 
 The film is required to demonstrate overtone-independent viscoelastic properties 
 All layers are free of internal stress 
 The film is required to be in contact with a bulk Newtonian fluid 
  
1.3. Target Proteins 
An ideal biomedical therapeutic is one which demonstrates an extended serum half-life, 
therefore increasing target site delivery, one which is non-toxic to biological components, one 
which evades the immune system, and one which maintains its integrity while within the 
biological system [3, 17].  The blood proteins of interest for this research are proteins which 
have been reported to be influential in biocompatibility, namely; human serum albumin 
A                                                          B 
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(Figure 1.2), a dysopsonin involved in particle blood circulation, human complement C3c 
(Figure 1.3), an opsonin involved in surface induced complement activation via the 
alternative pathway, and human plasma fibrinogen (Figure 1.4) an opsonin involved in the 
coagulation cascade. 
 
1.3.1. Human Serum Albumin 
The globular protein, human serum albumin (HSA), is an abundant protein in human plasma 
(45mg/ml), which has been reported to demonstrate a high binding affinity towards 
negatively charged surfaces, as well as a greater affinity towards hydrophobic surfaces in 
comparison to hydrophilic surfaces [35, 36].  However, the protein retention time on the 
hydrophobic surface is reported to be shorter, in addition to demonstrating a greater surface 
coverage of the HSA molecules [36].  This increase in surface coverage is due to HSA 
exhibiting an isoelectric point (pI) value of 4.7, and therefore rendering it highly charged in 
physiological conditions, which subsequently results in the protein molecule demonstrating a 
decrease in stability with increase in pH shift from the pI value [36].  X-ray crystallographic 
analysis of the protein indicates equilateral triangular dimensions of 8 nm (sides) × 3 nm 
(depth) (Figure 1.2) [5].  Rasmol generated images were based on the relevant Protein Data 
Bank (PDB) files obtained from Research Collaboratory for Structural Bioinformatics 
(RCSB).   
 
Its relatively small size, and high serum concentration, results in HSA being a dominant 
protein identified on biomedical surfaces. Its presence on the surface greatly influences the 
circulation half-life of biomaterial, prolonging circulation and inhibiting phagocytosis [18].  In 
addition, it has been documented that the presence of a HSA coating on biomedical surfaces 
reduces negative side effects, such as coagulation and inflammation [37].   This feature of 
evading the immune, and the coagulation system, and subsequently increasing particle 
circulation time, is attributed to the adsorption of HSA on the biomedical surface, providing 
the surface with a hydrophilic nature, therefore reducing further blood protein binding [38].  
As a result of these qualities, albumin has been reported to be utilised as a drug carrier 
molecule [39].   
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Figure 1.2. Rasmol images of human serum albumin (PDB: 1E78).  A, indicates the chains of the 
protein; B, indicates the basic (blue) and acidic (red) moieties; and C, indicates the 
hydrophobic (yellow) and hydrophilic (magenta) moieties. 
 
1.3.2.  Human Complement C3c 
In the event of immune complement activation by therapeutic drugs and medical devices, not 
only alterations in the biodistribution and clearance of the drug are observed, but life-
threatening conditions may arise, such as hypersensitivity and anaphylaxis [9].  Numerous 
methods aimed at determining the immune complement activation potential of a novel 
surface have been reported.  Such as the detection of the C5a and C3a soluble complement 
components using radioimmunoassay and ELISA techniques, or detecting the presence of 
surface-bound complement factors such as C3 and C3b using methods such as surface 
plasmon resonance (SPR) and quartz crystal microbalance with dissipation (QCM-D) [9].  The 
detection of surface bound C3c has been reported as an arbitrary measure of bound 
complement factor C3, an indicator of surface induced complement activation [29].  
 
Each activation pathway of the complement system results in the cleavage, and therefore 
activation, of the 185 kDa complement component 3 (C3) into 9 kDa C3a and 180 kDa C3b 
peptide fragments via the action of the C3 convertase generated by each pathway [18, 40, 41].  
The resultant C3a fragment is released into the fluid medium, while C3b undergoes 
conformational change and is bound to the surface of the activating substance [40, 41].  
Examples of complement activating surfaces are surfaces which display nucleophiles, such as 
hydroxyl and amino groups, while non-activating surfaces display negatively charged groups, 
e.g. carboxyl group [40].  The presence of negatively charged groups results in the increase in 
the affinity of the C3b complement for the complement regulation protein, Factor H [40]. 
 
A                                                       B                                                       C 
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Figure 1.3. Rasmol images of complement factor C3c (PBD: 2A74). A, indicates the chains of the 
protein; B, indicates the basic (blue) and acidic (red) moieties; and C, indicates the 
hydrophobic (yellow) and hydrophilic (magenta) moieties. 
 
1.3.3. Human Plasma Fibrinogen 
Human plasma fibrinogen (HPF), a key protein in the coagulation cascade, and platelet 
adhesion and aggregation, is a highly elongated protein with a molecular weight of 340 kDa 
and dimensions of approximately 47 x 4.5 x 4.5 nm3, which is abundantly found in human 
plasma (3mg/ml) [5, 28, 42-44].  Structurally, HPF is composed of 6 polypeptides and 
demonstrates a pI of approximately 5.5, and therefore a net negative charge at physiological 
pH (Figure 1.4) [28, 44].  Functionally, HPF plays a role in blood coagulation, aggregation and 
adhesion processes of platelets, and is therefore an influential protein in biomaterial 
biocompatibility [42-44].  A high affinity towards hydrophobic surfaces has been reported, 
however, hydrophobic terminating self-assembled monolayers (SAMs) (e.g. CH3) have also 
been reported to deposit significantly lower amounts of fibrinogen in comparison to 
hydrophilic terminating SAMs (e.g. OH) [27].   
 
It has been postulated that the adsorption of fibrinogen to hydrophobic surfaces results in 
conformational change of the protein [45].  According to literature, Gessner et.al. (2002) [46], 
fibrinogen deposition on polymeric nanoparticles, demonstrating various surface charge 
densities, was the dominant protein when assessing human plasma deposition, along with 
immunoglobulin G (IgG) [46]. The D- and αC-domains of the protein are reported to be the 
surface active domains, where initial binding occurs through weak interactions with the      
αC-domain (Figure 1.4). It has been documented that HPF adsorbs in a concentration-
dependent manner, where, under low concentrations, rearrangement of the molecule may 
occur, to allow surface adsorption between both the αC- and D-domains.  This concentration 
A                                                       B                                                       C 
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dependent adsorption of the HPF molecules to surfaces attributes to the variability in the 
structure of the film [28].  
 
 
Figure 1.4.  Rasmol images of human plasma fibrinogen (PDB: 3GHF). A, indicates the chains of 
the protein; B, indicates the basic (blue) and acidic (red) moieties; and C, indicates the 
hydrophobic (yellow) and hydrophilic (magenta) moieties. 
 
1.4. Target Therapeutic Particles 
1.4.1. Metallophthalocyanines 
Photodynamic Therapy 
Photodynamic Therapy (PDT) is a promising treatment of malignant (cancer of the lungs, 
stomach, bladder, etc.) and non-malignant conditions (macular degeneration) [47, 48]. Selective 
cell death is induced in the presence of photosensitiser (PS), such as metallophthalocyanines 
(MPcs), visible light, and oxygen [47, 48].  The mechanism through which the PS molecules, 
such as MPcs, are activated, and subsequently induces cell death, is illustrated in Figure 1.5.   
 
 
Figure 1.5.  Modified Jablonski diagram illustrating the photosensitising process of MPc 
molecules.   
 
As Figure 1.5 displays, on absorption of visible light, the MPc molecule is excited to a short-
lived singlet state (MPc S0 → MPc S1), where through intersystem crossing (ISC), a 
A                                                       B                                                       C 
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radiationless relaxation process, excites the MPc triplet state (MPc T1).  It is this excited 
triplet state which undergoes either Type I or Type II mechanism reactions where it reacts 
with the surrounding environment.   
 
In the Type I mechanism, the triplet state energy of the MPc molecule is transferred to 
surrounding substrate molecules (Subst.) or ground state oxygen (3O2), resulting in the 
oxidation of the substrate (Subst.(ox)) through the production of superoxide radicals (
3O2˙
-), 
hydrogen peroxide, and hydroxyl radicals.  Type II mechanism involves the transfer of 
energy from the excited triplet state MPc to ground state oxygen, to generate cytotoxic 
excited singlet state oxygen (1O2) 
[47, 49-51].   Cell death results due to damage of the cellular 
membranes, organelle structures and genetic material from radicals and singlet state oxygen 
[50, 51].  Additionally to the direct cytotoxic action of PDT (outlined in Type I and II 
mechanisms in Figure 1.5), triggered release of complement proteins, inflammatory 
mediators, and growth factors occurs, as well as damage to the vasculature associated with 
the tumour [50]. 
 
Attributes required from a viable PS molecule include selective tumour localising ability, 
absorption of light in the red or near infra-red region of the spectrum, as greater tissue 
penetration is achieved at longer wavelengths, in addition to being non-toxic.  Through 
modification of the Pc molecule, such as ring substitution and strategic selection of central 
metals, MPcs may be designed to bear these desired traits [52].  The ease of substitution of the 
MPc aromatic rings, and incorporation of the metal centres, allows for the modulation of 
physicochemical properties to increase the activation wavelength, triplet state quantum yield, 
solubility, and triplet lifetimes [49, 53-55].  
 
Chemical and Structural Properties 
Metallophthalocyanines (MPcs) are aromatic metal complexes composed of N4 - ligands 
which resemble naturally occurring biological molecules, such as vitamin B12 
(cyanocobalamine) [56, 57].  Essentially, phthalocyanines adopt a planar conformation, 
however, distortion of the macrocycle geometry may occur when large central metal ions are 
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employed (e.g. lead), as well as through conformational stress experienced due to the 
presence of ring substituents [49].  Figure 1.6 schematically illustrates the MPc structure.   
 
 
Figure 1.6.  Schematic representation of a tetra-substituted metallophthalocyanine molecule.  
Metal centres and substituents present in scheme form the basis for research reported on 
in this chapter. 
 
Metallophthalocyanine Applications 
MPc compounds have been reported to catalyse an array of chemical reactions, both 
homogeneous and heterogeneous [56].  The distinct physical and chemical properties of MPc 
compounds allow them to be utilized in a variety of applications, such as sensors, 
electrocatalysts, and photosensitisers. [57]. Pertinent to the purposes of this research, MPc are 
utilized photosensitizers in the photodynamic treatment of cancer, such as skin, breast, 
oesophageal, and lung cancer [53, 58].  MPc molecules utilised in the latter contain               
non-transition metal ions (i.e. Al, and Ge) as the central metal, as they promote high triplet 
state quantum yields, as well as extended triplet lifetimes [49].   
 
Metallophthalocyanine Aggregation 
An additional requirement of the MPc molecule intended for use as a PS agent is the 
exhibition of a hydrophilic nature to aid particle solubility, as administration of the 
therapeutic is through intravenous injection [50].  Ring substitution of the macrocycle MPc, 
with sulphonic acid and carboxylic acid, has proved to be an effective modality in promoting 
MPc solubility [59].  However, water-soluble MPcs display a tendency to aggregate when in 
aqueous solution.  This aggregation of MPc molecules is the result of the formation of π-π 
interactions, which are permitted by the planar geometry of the macrocycle [60].  MPc 
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aggregation has a negative effect on the production of the singlet oxygen quantum yield as it 
results in the dissipation of the excited singlet state energy [49].  Aggregation has been 
reported for MPc molecules demonstrating a low degree of sulphonation, such as CuPcS2 and      
ZnPcS [60, 61].   
 
Surfactant dissociation of the MPc aggregates has been demonstrated, however, the use of 
such a method is not applicable in the current experimental procedure, as interference with 
MPc immobilisation to the SAM surface, and with blood protein binding may occur [49].   
Mechanical means of dispersion, namely, extended ultra-sonication of the MPc solutions, was 
therefore favoured.   
 
Currently, derivatives of sulphonated aluminum phthalocyanines have been utilized in the 
photodynamic treatment of cancer, while non-transition metal sulphonated phthalocyanines, 
Zn and Mg phthalocyanines, and thiol-derivatized MPc’s are under investigation [56].   The 
biocompatibility of MPc molecules was the subject of Chapter 3, and 5. 
 
1.4.2. Carbon Nanotubes 
Structurally, carbon nanotubes (CNTs) are hollow cylinders composed of hexagonal 
arrangements of carbon atoms that demonstrate significant electrical, electrochemical and 
mechanical characteristics [62].  Two forms of synthesised CNTs exist, namely, single-walled 
carbon nanotubes (SWCNTs), which consist of one single-walled tube, and multi-walled 
carbon nanotubes (MWCNTs), which consist of layers of carbon tubes (Figure 1.7) [63].   
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Figure 1.7.  Schematic representation of single-walled (I) and multi-walled (II) carbon 
nanotubes. 
 
Carbon Nanotube Application 
To date, the use of CNTs for the encapsulation of therapeutic drugs has been investigated, as 
well as their application in gene therapy, tissue engineering and as scaffolds for cellular 
growth [63-65].  Numerous studies have been conducted, aimed at assessing the 
biocompatibility of such materials, however, results obtained have generally been 
inconclusive and often contradictory [66-69].  Several in vitro studies report little, or no     
CNT-induced cytotoxicity [69, 70], while some indicate adverse effects, such as decrease in cell 
viability, activation of inflammatory responses [71], apoptosis [72], and oxidative stress [73].   
One of the key concerns, in terms of CNT nanotoxicity, is the presence of contaminants, 
generated through CNT synthesis, as well as the tendency of CNTs to aggregate [62, 68].   
 
Carbon Nanotube Functionalisation 
There are several proposed methods currently researched to address the aspects of CNT 
purity and aggregation, in particular, surface oxidation of nanotubes.  This can proceed via 
chemical oxidation, photo-oxidation, gas phase treatment, and exposure of CNTs to oxygen 
plasma [74]. Of particular interest is that of chemical oxidation, as it is a well established, 
simple and efficient means of functionalising CNT surfaces with oxygen containing      
groups [75].   
 
I                              II 
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In addition to increasing purity and decreasing aggregates, oxidation of CNTs adds further 
substituents, such as hydroxyls and carboxyl groups, which allows for further 
functionalisation of the CNT surface, as the substituents provide sites for covalent and      
non-covalent attachment of other particles to the sidewalls of the CNTs [63, 76].    
Functionalisation, through chemical oxidation, therefore provides a means to alter surface 
properties of the CNTs, towards improving biocompatibility [76]. 
 
The biocompatibility of CNTs, both non-functionalised and functionalised is of immediate 
research interest given their rapid incorporation into several technologies                            
(e.g. drug delivery) [64].  This was the subject of Chapter 4. 
 
1.5. Research Aims and Objectives 
The central aim of this research is to establish a platform directed at assessing the biological 
fate of pioneering therapeutic particulate agents, such as metallophthalocyanines (MPcs) and 
multi-walled carbon nanotubes (MWCNTs).  In particular, we proposed, in this thesis, that 
QCM-D technology may be utilised to assess the composition of blood protein coats 
deposited on the therapeutic surface, and subsequently assess the biocompatibility of such 
particles.  Figure 1.8 illustrates the main objectives addressed, in the relevant chapters, to 
asses QCM-D applicability in as a screening method for target particle biocompatibility. 
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Figure 1.8 Main objectives addressed for the analysis of QCM-D applicability in biocompatibility analysis of metallophthalocyanines and acid 
functionalised multi-walled carbon nanotubes.   
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CHAPTER 2:   
BIOMOLECULAR INTERACTIONS WITH METAL SURFACES AND MODIFIED 
GOLD SURFACES 
 
2.1. INTRODUCTION 
2.1.1. Preliminary Studies 
Prior to investigations assessing the composition of the blood protein films which coat the 
target therapeutics, namely acid functionalised multi-walled carbon nanotubes (FMWCNTs) 
and MPc molecules, preliminary studies were necessary to assess both the accuracy, and 
reproducibility of the proposed detection method, as well as establishing the uppermost levels 
of target protein detection, via the design of control experiments.  
 
2.1.2. QCM-D Sensor Surface Modification 
In order to examine the biocompatibility of a wide range of biomedical surfaces, techniques 
such as Surface Plasmon Resonance (SPR), Atomic Force Microscopy (AFM), ellipsometry, 
and recently, QCM-D, have been relied on the use of generic surface modification   
techniques [21, 27, 42, 77-81].  In particular, surface modification through the formation of self-
assembled monolayers (SAMs) has proven to be a highly reproducible and stable         
method [21, 27, 77, 82].   
 
The metal electrode surface (i.e. gold) of the quartz crystal sensor, utilised in QCM-D, 
exhibits favourable surface properties which facilitate simple electrode surface modifications.  
In addition to diversifying the range of the QCM-D sensor surface characteristics, with 
respect to surface charge, surface moieties, etc., these electrode modifications prove to be 
beneficial in the immobilization of target molecules via the introduction of required chemical 
properties on the surface, and therefore the construction of a desired interface [83].  
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2.1.2.1. Self-Assembled Monolayer Modification 
The use of a self-assembled monolayer (SAM) deposition is a simple and effective means of 
modifying an electrode as it provides reproducibility and stability.  This spontaneous 
organization of a single layer of SAM molecules is the result of the high affinity of the 
molecules terminal functional group for the target surface [56].  In the case of gold surface 
modification, n-alkyl thiols are reported to assemble in a monolayer fashion, where strong 
interactions between the thiol sulphur and the gold surface results in an approximately 30° 
near polar covalent interaction.  Studies reveal distinct differences in monolayer structure 
when assessing long- and short-chain alkyl thiols: more densely-packed, reproducible films 
are deposited when the chain length exceeds n = 9 [84-86].  The selection criteria for the SAM 
molecules is based on what is to be immobilized (i.e. target molecule) onto the Au substrates 
and to what it is being immobilized to (i.e. electrode surface), as well as the desired 
monolayer thickness.   
 
A wide range of thiolated molecules are available for gold surface modification.  Through 
monolayer coverage of surfaces, SAM surface modification provides for the study of the 
biocompatibility of a range of different exposed functional groups, of differing charges and 
differing physical properties.  It also provides a platform for the immobilisation of the 
different target molecules, and the study of the biocompatibility thereof (as described in 
Chapters 3 and 4, for MPc- and CNT- modified surfaces, respectively). 
 
For the purpose of this study protein adsorption to gold and silicon dioxide coated sensor 
surfaces, and both positively and negatively charged SAM interfaces formed on Au 
substrates, were assessed.  The utilisation of gold and silicon dioxide sensor surfaces 
(whereby protein interactions at the surface is examined directly) provides information on the 
interaction between the blood proteins and hydrophobic, and negatively charged hydrophilic 
solid surfaces, respectively.  Furthermore, utilisation of differently charged SAM surfaces 
allows the influence of surface charge on protein binding to be assessed.  Varying length      
n-alky thiols were utilised for the generation of positively charged surfaces, also permitting 
the examination of the influence of film density on biocompatibility with the target proteins.   
 
Cysteamine is frequently utilised for SAM surface modification yielding a positively charged 
surface with exposed NH3
+ groups, with a chain length of n = 2.  Likewise, 11-amino 
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undecane thiol exposes a NH3
+ charge, but has a longer chain length of n = 11[83].  Mercapto 
undecanoic acid yields a negatively charged surface with exposed COO- groups at 
physiological pH [87]. 
 
2.1.2.2. Antibody Modification 
The deposition of antibody molecules on the gold sensor surface (Figure 2.1; A), directed 
against the target proteins, and the subsequent blood protein adsorption, served as a means of 
assessing the uppermost level of probe antibody binding, due to the specificity of the 
antibody-antigen interaction.  In particular, anti-human albumin (AbHSA), human 
immunoglobulin G (IgG), and anti-human fibrinogen (AbHPF) were utilised in the surface 
modification of the gold sensor surface for the detection of adsorbed human serum albumin 
(HSA), complement factor C3c, and human plasma fibrinogen (HPF), respectively.  IgG was 
employed for complement C3c detection as it is reported to be an activator of the 
complement system, through classical pathway activation [88].  The adsorption of IgG 
molecules to gold surfaces has been well documented, as well as its applicability in the 
detection of surface induced complement activation studies utilising anti-human C3c probe 
molecules [21, 89].  Figure 2.1 schematically illustrates the target surfaces evaluated in this 
chapter. 
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Figure 2.1.  Schematic representation of (A) target surfaces probed for blood protein 
adsorption; (B) adsorbed target protein detection protocol monitored using 
QCM-D. I (B) illustrates the target surfaces, both modified and unmodified; II, the 
adsorption of blood proteins; and III, the detection of target proteins via antibody 
binding.  Antibodies utilised were directed against human serum albumin, 
complement factor C3c, and human plasma fibrinogen. 
 
 
2.1.3. Chapter Aims and Objectives 
The principle aims of this chapter were to assess the efficiency of QCM-D in examining 
protein adsorption on surfaces which demonstrate known characteristics, secondly to 
establish control experiments, and thirdly, to evaluate experimental reproducibility. 
 
 
 
Unmodified Sensor 
Surface
Protein Modified Sensor Surface
Unmodified and Protein 
Modified Sensor Surface
Blood Protein 
Adsorption
Target Anitbody Binding
A 
 
 
 
 
 
B 
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Objectives 
1. Fabricate target surfaces, with known characteristics, ex situ, for subsequent binding 
analysis 
a. SAM modification of the gold sensor surface, to generate positively charged 
(11-AUT and Cyst.), and negatively charged (MUA) surfaces 
2. Fabricate control surfaces for HSA, complement C3c and HPF protein analysis 
a. Target antibody adsorption (AbHSA, IgG, and AbHPF) to the gold sensor 
surface, monitored and quantified using QCM-D 
b. Fabrication of the HSA control surface on both new, and used gold sensor 
surfaces, to assess experimental reproducibility dependence on the quality of 
the gold sensor surface 
3. Monitor and quantify blood protein adsorption to the prepared modified, and 
unmodified surfaces, using QCM-D 
4. Monitor and quantify probe antibody binding to the previously prepared blood protein 
coated surfaces, using QCM-D 
 
 
2.2. INSTRUMENTATION AND METHODOLOGY 
2.2.1. Instrumentation 
Frequency and dissipation measurements were recorded in a Quartz Crystal Microbalance 
with Dissipation E-4 system (Q-Sense AB, Goteborg, Sweden), using QSoft Acquisition 
Software.  The QCM-D sensors used were AT-cut quartz crystals, 14 mm in diameter, 
sandwiched between 100 nm thick polycrystalline gold electrodes, with fundamental 
resonance frequency of 5 MHz (Q-Sense AB, Goteborg, Sweden).  Data analysis was 
performed using the QTools Analysing Software provided by Q-Sense.  Ultrasonication of 
samples, for the purpose of degassing, was carried out using an S10H Elmasonic sonicator.  
Ultraviolet/ozonation, UV.TC.EU.003 (Bioforce Nanosciences), was utilised in the 
preparation of the quartz sensor surfaces. 
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2.2.2. Reagents 
Protein adsorption analysis was performed in a 1 X PBS buffer solution, containing NaCl 
(Merck), KCl (Sigma), Na2HPO4 (Sigma), KH2PO4 (Merck), MgCl2 (Merck) and CaCl2 
(Merck), referred to as PBSMg/Ca.   For PBS buffer utilised in negative controls, referred to as 
PBS, both MgCl2 and CaCl2 supplements were omitted.  The pH of the buffer was adjusted, 
using 0.2 mM NaOH (Merck), to the physiological pH of 7.4.  PBS was utilised as the 
solvent in the preparation of 5% human serum solutions, obtained from 3 donors        
(Reagent A+; SANBS), and 5% human plasma solutions (Reagent A+; SANBS), as well as in 
2% dilutions of polyclonal rabbit anti-human C3c complement, anti- human albumin, and 
anti-human fibrinogen, supplied by DakoCytomation, according to Sellborn, A. et al.    
(2002) [21].  In the case of the negative control, for complement C3 detection, heat inactivated 
human serum (iHS) was utilised.  iHS was prepared via heat denaturation of the blood 
proteins for a period of 30 min at 75°C.  Prior to use, the buffers, as well as all the solutions 
prepared, were degassed via ultrasonication for a period of 10 min.   
 
Surface modifications were prepared utilising Human IgG, Plasma (Calbiochem),             
anti- human albumin (DakoCytomation), anti-human fibrinogen (DakoCytomation),           
11-amino undecane thiol, hydrochloride (Dojindo Laboratories), cysteaminium chloride 
(Merck), and 11-mercapto undecanoic acid (Merck), as per Figure 2.1. 
 
Sodium dodecyl sulphate (90%), for cleaning purposes, was purchased from BDH Laboratory 
Supplies. 
 
The above mentioned reagents were utilised throughout the experimental procedures outlined 
in chapters 3 to 5.  Additional reagents required for analyses described in the latter chapters 
are listed in the relevant instrumentation and methodology sections. 
 
2.2.3. Methodology 
2.2.3.1. Preparation of QCM-D System 
Prior to use, the gold coated, AT-cut, quartz crystal were thoroughly cleaned using an 
established protocol (Fogel, et al. (2007)) [57].  The crystal is initially ultrasonicated in an 
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aqueous 2% solution of sodium dodecyl sulphate (SDS) to remove any loosely-bound 
proteins, followed by a rinse step with 95% absolute ethanol and MilliQ water, and a             
5 min immersion in a 5:1:1 solution of MilliQ water, 30% hydrogen peroxide (Merck), and 
25% ammonia (Merck) heated to 75°C, for the removal of lipids, thiols and proteins. The 
crystal was then thoroughly rinsed with 95% absolute ethanol and MilliQ water before drying 
with nitrogen gas (99.9%; Afrox) and exposure to ultraviolet/ozonation for approximately 2 
min to remove organic contaminants. 
 
Cleaning of the QCM-D chamber and tubing occurred before, and after each measurement, 
via flushing the system with 2% SDS, followed by MilliQ water, for a period of 15 min, 
respectively.  The chamber was rinsed with absolute ethanol and MilliQ water, followed by 
99.9% nitrogen gas (Afrox) drying. 
 
2.2.3.2. Sensor Surface Modification 
2.2.3.2.1. Self-Assembled Monolayer 
The preparation of 11-amino undecane thiol (11-AUT), mercapto undecanoic acid (MUA), 
and cysteamine (Cyst.) SAMs was carried out to evaluate the surface induced human serum 
and plasma protein adsorption on homogenous carboxylic acid and amine terminating layers, 
in addition to aiding target particle immobilisation (Chapter 3 and 4). SAM surface 
modifications were achieved by immersing a newly cleaned crystal in either an ethanol 
solution of 11-amino undecane thiol, hydrochloride, or 11-mercapto undecanoic acid, or an 
aqueous solution of cysteaminium chloride, followed by incubation overnight at 4°C. Prior to 
addition of the SAM molecules, the ethanolic solvent, and aqueous solution were de-aerated 
via bubbling with nitrogen gas for a period of 10 min.  Following the overnight incubation, 
the SAM-modified gold sensor crystals were thoroughly rinsed with ethanol and MilliQ 
water, several times, and dried with nitrogen gas prior to mounting in the QCM-D flow 
chamber. 
 
2.2.3.2.2. Antibody Controls 
Adsorption of the relevant antibodies to the gold sensor surface was monitored using     
QCM-D.  For the positive detection of surface induced complement activation, i.e. 
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complement C3 adsorption, 0.01μg/ml of IgG in PBSMg/Ca was introduced to the crystal 
surface.  The negative control, for complement activation, involved the deposition of IgG, 
dispersed in PBS buffer at a concentration of 0.01μg/ml.  Anti-human albumin- and anti-
human fibrinogen-PBSMg/Ca solutions were introduced to the sensor surface in a 0.14 mg/ml 
dilution.  Theoretically determined IgG-monolayer mass was determined for two scenario’s, 
namely, edge-on and planar orientation, with the aid of X-ray chrystillographic determined 
dimensions, using the following formulae: 
 
Calculations 
Edge-On: HeightIgG × BreadthIgG =   Surface Area(SA) IgG (1)   Eq. 2 
Planar:  LengthIgG × BreadthIgG =   Surface Area (SA)IgG (2)   Eq. 3 
SAAu Crystal ÷ SAIgG =  Number of molecules on Au surfaceIgG   Eq. 4 
Number of moleculesIgG × Atomic Mass Unit =  Monolayer MassIgG  Eq. 5 
Monolayer MassIgG × 1/ SAAu Crystal =   Monolayer Mass per cm
-2
IgG  Eq. 6 
 
2.2.4. QCM-D Monitoring and Quantification 
The complement activation detection protocol for the analysis of macromolecular surface 
induced complement activation using QCM-D technology reported by Sellborn, et al. (2002) 
was followed, with modifications, for the detection of the surface bound proteins [21].  The 
procedure involved obtaining stable frequency and dissipation baselines in buffer solution, 
followed by the introduction of a 5% dilution of human serum/plasma in buffer, to allow 
serum protein binding to the quartz crystal surface, modified or unmodified.  Following a 
buffer rinse, an antibody specific for the target protein was introduced, in a 2% dilution with 
buffer.  This was followed by a buffer rinse.  PBSMg/Ca buffer solutions were used for all the 
complement activation analyses, with the exception of the negative control, where PBS buffer 
was utilised.  The flow rate and temperature parameters of the QCM-D system were set at 
100 µl.min-1 and 32.0°C, respectively.  Both the biomolecular interaction between the 
prepared surface and human serum proteins, as well as the interaction between the bound 
serum proteins and antibody was monitored, and quantified, using QCM-D technology.    
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2.3. RESULTS AND DISCUSSION 
Section 2.3.1. provides an introduction to data analysis techniques employed when assessing 
QCM-D responses. Section 2.3.2. details gold surface modification through antibody 
adsorption obtained using QCM-D technology.  Section 2.3.3. addresses the composition of 
the adsorbed blood protein coat generated on both the modified and unmodified surfaces, in 
particular, the detection of HSA, complement factor C3, and HPF, using probe antibodies 
binding, monitored using QCM-D. 
 
2.3.1. Introduction to QCM-D Data Analysis 
Quartz Crystal Microbalance with Dissipation (QCM-D) is a surface sensitive piezoelectric 
based method for the monitoring and quantification of adsorbed mass, in the nanogram scale.  
QCM-D technology simultaneously measures two parameters, namely, frequency (f), which 
is dependent on the oscillating adsorbed mass and the intrinsic properties of the film, and 
dissipation (D), which is dependent on the films viscoelastic properties [45, 90, 91].  Figure 2.2 
illustrates the f and D outputs, at overtones of 7, 9, and 11, produced from the adsorption of 
human serum (HS) to the 11-AUT SAM-modified gold sensor surface, and the subsequent 
anti-human C3c binding (AbC3c).  Crude analysis of the f and D responses recorded provides 
information on deposited film rigidity, film interface roughness, and subsequent structural 
changes of the deposited film due to the particle/protein adsorption [23, 30, 92]. 
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Figure 2.2.  QCM-D frequency (Blue) and dissipation (Red) shifts illustrating human serum 
adsorption to the 11-amino undecane thiol self-assembled monolayer-modified 
gold sensor surface (I) and subsequent anti-human C3c binding (II).  The frequency 
shifts represented are f/n, where n represents the overtone number. Introduction of 
PBSMg/Ca buffer, for the removal of non-specifically bound protein, is illustrated by the 
vertical arrows.  Separation of f, suggesting surface roughness, is indicated by the 
dashed circle. Overtones 7, 9 and 11 are illustrated. 
 
QCM-D Response Analysis 
An important film parameter, obtainable from frequency (Δf) and dissipation (ΔD) shifts 
generated from the deposition of a film, is that of (Δf/ΔD).  This parameter provides 
information on relative film rigidity: the higher the value of Δf/ΔD, the more rigid the film, 
while low values are indicative of the adsorption of a fairly viscoelastic film [36].  The Δf/ΔD 
value of a film may also serve as an indication of the validity of the Sauerbrey determined 
film thickness and adsorbed mass.  When this value is below 10 Hz/1E-6, there is no longer a 
linear relationship between the Δf and adsorbed mass (Δm), therefore resulting in the ‘failure’ 
of the Sauerbrey model [23].   
 
Structural properties of the film interface are indicated by the dependence of the Δf, and 
therefore Δm, on the overtone number.  An overtone-dependent mass shift suggests the 
deposition of a film which demonstrates a ‘rough’, or ‘fuzzy’ interface, while an overtone-
independent mass shift suggests a ‘sharp’ interface [30]. A rough film interface is visible as a 
 11  
   9  
   7  
  7  
  9  
11  
(I) Human Serum                 (II) Anti-Human C3c 
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separation of the (Δf/n) values, as observed in the HS adsorption to the gold sensor surface in 
Figure 2.2 (Phase I; dashed circle).  For the purpose of this study, the nature of the film 
interface is represented in terms of the average (Δf/n) percentage coefficient of variation     
(% CV), where a high % CV corresponds with a ‘rough’ interface, and vice versa.   
 
Analysis of structural changes due to the addition of molecules to the surface may be 
represented through plotting D versus f responses.  The latter method of analysis illustrates 
the time-independent structural changes of the film due to the addition of individual mass 
units [92].  Figure 2.3 illustrates the D versus f plot (overtone n = 7) generated from the 
adsorption of HS on an 11-AUT SAM-modified surface, and the subsequent AbC3c binding.  
This plot serves as an example for the interpretation of D vs. f plots.  D vs. f plots, in addition 
to providing information on film structural changes, schematically illustrate the time 
dependence of the adsorption process. This is observed in the separation of the data points: 
further separation is an indication of a higher rate of mass addition, and vice versa [30, 22].   
 
 
Figure 2.3.  Dissipation versus frequency plot of human serum adsorption, and the subsequent 
anti-human C3c binding, to the gold QCM-D sensor surface modified with an 11-
amino undecane thiol SAM.  The gradient of the plot is schematically illustrated by the 
solid lines.  Point of introduction of human serum, anti-human C3c, and PBSMg/Ca buffer 
are indicated by HS, Ab, and arrows, respectively.  Overtone 7 was utilised in the plot 
generating. 
 
According to literature, a single-phase adsorption mechanism is expected to generate a 
straight line when plotting D vs. f [22].  The adsorption of HS (Figure 2.3) generated a slightly 
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upwards sloping curve in the D7 vs. f7 plot, indicating that each protein molecule attaching 
results in a greater increase in D, and therefore film viscoelasticity, in comparison to the 
underlying adsorbed protein film.    In contrast, a downwards sloping D7 vs. f7 plot would be 
interpreted as an increase in film rigidity with the addition of new molecules, as there would 
be an increase in f without a linear increase in D. Nearing the end of the HS adsorption 
process (Figure 2.3), the gradient of the plot increased, suggesting a greater increase in film 
viscoelasticity [23].  This may be interpreted as the addition of loosely adsorbed proteins on 
the surface of the already deposited film.  Following the introduction of PBSMg/Ca, as a rinsing 
step, a large decrease in both D7 and f7 are observed, indicating the removal of a large portion 
of the loosely bound serum proteins.  The subsequent addition of AbC3c was observed as a 
downward sloping curve, suggesting an increase in film rigidity as each antibody molecules 
adsorbed.  Possible explanations for this occurrence are, firstly, the ‘filling-in’ of the 
depressions found at the serum protein interface, or secondly, that antibody binding results in 
conformational changes in the target protein which renders them more rigid.  Thirdly, 
antibody-antibody interactions may occur between the bound probe antibodies, which would 
subsequently increase the film rigidity [81].  
 
In the event of the ‘failure’ of the Sauerbrey model in determining adsorbed mass, 
viscoelastic modelling of the film is required, which provides additional information on film 
parameters in comparison to the Δf/ΔD and mass shift values.  QTools provides a 
mathematical model, developed by Voinova et al., 1999 [34], which is able to predict fn and Dn 
responses to n viscoelastic layers, under certain considerations [30, Alternative Reference 1].  In 
particular, the Voigt-based model takes into consideration both the viscoelastic nature of the 
film, and the influence of the bulk liquid.  The latter model defines films in terms of 
thickness, density,  and the viscoelastic properties, such as shear modulus, and viscosity [23]. 
 
Voigt-Based Modelling 
Viscoelastic modelling of QCM-D involves setting parameters, such as film thickness, 
viscosity, and shear modulus, to generate fitted responses for the extraction of viscoelastic 
parameters.  Initially, general parameter ranges are selected, which are later refined following 
fitting of the data as resultant viscoelastic parameters provide an indication of the accuracy of 
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the generated model.  Detailed below is an example of the modelling process utilised in this 
study, using the modelling of HS adsorption to an 11-AUT SAM (Table 2.1), as an example. 
 
In the following example, fitted data were generated from the QCM-D responses where the 
film parameters were limited to a particular range, namely film viscosity                          
(0.005 – 0.1 kg.ms-1), shear modulus (5000- 1E8 Pa), and thickness (1E-11 – 2E-8 m), to 
illustrate the effect of the various fitting options (Table 2.1; Table 2.2).  Fitting of the data 
may be carried out in both descending or ascending increments, and may be either forced to 
fit within the selected parameters, or just guided by the set parameters.  Table 2.1. illustrates 
the data plot of the original QCM-D responses (solid lines) and the fitted data obtained 
through Voigt modelling (symbols).  The purpose of this particular plot is to provide a visual 
indication of the accuracy of the Voigt-model.  An accurate model would be observed as the 
QCM-D responses and the fitted data overlapping, as observed for the descending fitted data, 
while devation of fitted data from the original data, as observed for the ascending fitted data, 
indicates failure of the model to accurately predict film parameters.  Accuracy of the model 
system is indicated by a low χ2 value.   
 
Further analysis on the accuracy of the Voigt prediction is through examination of both the 
film viscosity and shear modulus trends in comparison to the film thickness.  Prior 
knowledge of adsorption characteristics of the target molecule proves helpful in this aspect.  
For example, introduction of PBSMg/Ca functions to remove loosely bound protein, and is 
therefore expected to result in a decrease in the total film viscoelasticity.  The latter is 
predicted to be observed as an increase in both the film viscosity and shear modulus.  This is 
apparent when utilising the descending fit analysis technique, in the chosen example, 
however, the ascending fit generates viscosity values well below that of water, and 
concommitantly produces shear modulus values unrealistically low (Table 2.2).  Although 
these observations indicate the descending fit analysis as superior, that is not always the case.  
Alterations to set parameters may drastically change the output; it is therefore necessary to 
critically assess the accuracy of the generated model by varying the set parameter.   
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A comparison made between assessing two layers together or as individual layers (Table 2.1), 
revealed that analysis of each layer independently proved to be more accurate, as indicated by 
the lower χ2 value.  This means of analysis was therefore favoured for the current studies. 
 
Table: 2.1.  Voigt-determined film parameters following the adsorption of human serum to 11-
amino undecane thiol SAM, and the subsequent binding of anti-human C3c. 
Layer 
Fitted Parameters Voigt-Determined Parameter Values 
Parameters 
Min 
Estimation 
Max 
Estimation 
Descending Fit Ascending Fit 
Open Fit Force Fit Open Fit Force Fit 
1 
L1 visc (kg.ms-1) 0.0005 0.01 0.0047 0.0047 0.0006 0.0006 
L1 shear (Pa) 5000 1E8 9.3143E5 9.3143E5 4980 5124 
L1 thick (m) 1E-11 2E-8 1.3522E-8 1.3522E-8 1.4353E-11 1.4353E-11 
Total ChiSqr --- --- 54983 55013 3.9756E6 1.6486E5 
1 and 2 
L1 visc (kg.ms-1) 0.0005 0.01 0.0044 0.0044 0.0040 0.0050 
L1 shear (Pa) 5000 1E8 3.2046E5 8.2069E5 5000 5144.5 
L1 thick (m) 1E-11 2E-8 1.7192E-8 1.7192E-8 1.001E-11 1.0225E-11 
Total ChiSqr --- --- 4.6309E5 4.6353E5 1.245E7 5.398E5 
2 
L1 visc (kg.ms-1) 0.0005 0.01 0.0044 0.0044 0.0047 0.0047 
L1 shear (Pa) 5000 1E8 8.2046E5 8.2069E5 9.1031E5 9.1031E5 
L1 thick (m) 1E-11 2E-8 1.7192E-8 1.7191E-8 1.352E-8 1.352E-8 
Total ChiSqr --- --- 1.8874E5 1.8874E5 1.8871E5 1.8871E5 
 Overtones 7, 9 and 11 were utilised in the following studies 
 Film properties listed represent the final parameter value following protein addition 
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Table 2.2.  Assessing the effect of modelling parameters in the Voigt-determination of serum protein film parameters adsorbed to an 11-amino 
undecane thiol SAM-modified gold sensor surfaces.  
Plot 
Decending Fit Ascending Fit 
Open Fit Force Fit Open Fit Force Fit 
Data Plot 
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QCM-D Monitoring and Quantification of Adsorbed Mass 
As previously mentioned, the aim of these studies was to develop a rapid technique designed 
at identifying the composition of the blood protein coat that may deposit following 
intravenous administration of therapeutic agents.  Initial studies were thus directed toward 
protein identification on serum-coated planar surfaces, namely, gold, silicon dioxide, as well 
as SAM-modified gold, and antibody-modified surface controls, to identify relative target 
protein binding affinity trends.  Figure 2.4. schematically illustrates the protein adsorption 
that takes place at the sensor surface, with the corresponding QCM-D f and D responses, for 
the detection of IgG-induced complement activation.   
 
Figure 2.4.  Schematic representation of adsorbed target protein detection and the 
corresponding QCM-D response.  The detection of complement factor C3 on a 
human serum coated IgG-modified gold surface is illustrated.  The point of 
introduction of PBSMg/Ca buffer is indicated by vertical arrows.  Overtone 7 was 
utilised. 
 
As Figure 2.4 illustrates, the introduction of IgG, and the subsequent HS and AbC3c, resulted 
in a decrease in f, and an increase in D.  This decrease in f and increase in D correlates with 
an increase in adsorbed mass an increase in the film viscoelasticity, respectively.  The 
adsorption of IgG resulted in the deposition of a fairly rigid film, as observed by the low level 
of D increase and large decrease in f (i.e. high f/D). The adsorption of both HS and AbC3c 
resulted in the deposition of a fairly viscoelastic films, as indicated by the high shift in D, and 
low shift in f (i.e. low f/D).    
Time 
                 IgG                              HS                                  AbC3c 
Au 
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Following the initial buffer rinse, a minor increase in f and decrease in D indicates the 
removal of loosely bound IgG molecules from the surface.  The buffer rinse, following the 
addition of HS, resulted in the removal of non-specifically bound HS protein from the 
antibody-modified surface, rendering it less viscoelastic in nature, as observed by the large 
increase in f and decrease in D.  The introduction of the buffer rinse, following the deposition 
of the probe antibody, AbC3c, did not influence the antibody film, in terms of non-specifically 
bound protein removal, due to the high specificity of the antibody-antigen interactions. This 
level of AbC3c recorded serves as an indication of the level of bound complement C3 
molecules present in the HS film deposited on the IgG-modified surface.   
 
2.3.2. QCM-D Monitoring and Quantification of Surface Modification: Antibody 
Controls 
In order to assess the level of antibody attachment indicative of adsorption to a surface which 
promotes target protein binding, the binding of antibodies directed against the relevant 
serum/plasma proteins to the gold sensor surface were employed as controls.  AbHSA control 
experiments were performed in triplicate, on both new and previously utilised gold coated 
crystals.  The purpose of assessing protein binding to the two crystal types was to determine 
the effect of the chemical cleaning protocol employed on the gold surface, and therefore to 
assess an aspect of experimental reproducibility.   
 
Surface modification, via the deposition of SAMs was not monitored using QCM-D due to 
chemical restraints of the QCM-D system precluding the use of ethanol, the solvent utilised 
in SAM protein deposition (Section 2.2.3.2).  However, the generation of SAMs has been 
well documented in previous research, and is reported to be highly reproducible on gold 
surfaces [45].   
 
Information regarding antibody structure and target epitopes is limited for the specific AbHSA 
and AbHPF molecules used as probes in these studies.  However, immunoglobulin G (IgG) has 
been well characterised within literature [5, 89].  For the purpose of analysis, both the AbHSA 
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and AbHPF molecules were assumed to exhibit similar structural properties to that of the IgG 
molecule.   
 
IgG is a flexible, heterogenous (160 kDa) protein which, according to X-ray crystallographic 
data, adopts the ‘Y-model’ conformation, demonstrating dimensions of   14.2 × 8.5 × 3.8 nm 
(Figure 2.5) [5].  IgG-surface interactions have been reported to be both time-dependent and 
binding site dependent [89].  In addition, adsorption of IgG aggregates have been reported on 
surfaces, such as gold, as well as adsorption-induced denaturation of the IgG molecule [89].  
Due to the time-dependence of IgG adsorption and interaction with the substrate surface, 
antibody exposure to the gold sensor surface was limited to 30 min. 
 
 
Figure 2.5.  Rasmol generated illustration of human immunoglobulin G (PDB: 1IGY).  The x-,  
y-, and z-axis correspond to the lengths 14.2 nm, 8.5 nm, and 3.8 nm, respectively. The 
polyclonal antibody active sites are indicated by the asterisk.  
 
Theoretical Determination of IgG Monolayer 
For the purpose of antibody adsorption analysis, predicted mass shift of IgG monolayer 
deposition were theoretically determined utilising reported IgG dimensions.  These values 
served as a comparison for the Sauerbrey- and Voigt-determined mass shifts obtained 
experimentally.  Figure 2.6. schematically illustrates IgG monolayers adsorbed to gold,  
emphasising the potential variations in protein orientation expected.  Theoretical mass shifts 
for edge-on and planar orientated IgG monolayers were determined as 822.56 ng.cm-2 and 
492.38 ng.cm-2, respectively. 
 
Y 
X 
Side View Top View 
Z 
X 
* * 
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Figure 2.6.  Schematic illustration of the adsorbed IgG orientations within a monolayer 
deposited on gold. I-planar, II-edge-on, and III- mixed deposited orientation. 
 
QCM-D Response Analysis 
Crude analysis of the QCM-D response generated from the deposition of antibody molecules 
on the gold coated crystal surface suggested fairly rigid antibody films were adsorbed in all 
cases, as observed by the high Δf/ΔD values, which were greater than approximately 20 
(Table 2.3).  The latter also confirms the validity of the Sauerbrey determined film 
parameters.  Furthermore, the low percentage coefficient of variation of the average f shift, in 
all cases, indicated the nature of the film interfaces as being sharp/uniform. 
 
Table 2.3. QCM-D Frequency and Dissipation Shifts Following Gold Surface Modification with 
Anti-Human Serum Albumin, Human IgG, and Anti-Human Plasma Fibrinogen, for control 
experiments 
Molecule a 
f7 
D7 
f9 
D9 
f11 
D11 
Ave. f b 
Ave. f   
% CV  
Ave. D b 
AbHSA 
(new crystal) 
24.22 24.26 34.84 -41.44 ±1.40 3.38 1.54 ±0.33 
26.98 24.97 24.75 -36.19 ±0.44 1.22 1.42 ±0.05 
34.13 34.71 32.83 -44.90 ±0.20 0.45 1.33 ±0.04 
AbHSA 
(used crystal) 
37.47 30.72 34.20 -46.54 ±0.32 0.69 1.37 ±0.14 
32.73 31.83 30.38 -45.19 ±0.24 0.53 1.43 ±0.05 
19.44 19.25 19.51 -50.79 ±0.84 1.65 2.62 ±0.05 
AbIgG+ 34.78 39.07 34.10 -47.15 ±0.44 0.93 1.31 ±0.09 
AbIgG- 30.39 35.28 28.77 -50.61 ±0.62 1.23 1.62 ±0.16 
AbHPF 
 
32.56 33.11 33.58 -49.09 ±0.09 0.18 1.48 ±0.03 
a: Surface modification molecules utilised in the fabrication of the control surfaces 
b: Average values determined using responses obtained from overtones 7 -11 
 
 
Examination of the antibody adsorption process was facilitated by generating D7 versus f7 
plots (Figure 2.7).    In each case, adsorption phases were identified according to shifts in the 
gradient of the linear portions of the each slope.  The focus of this phase of research was to 
aid in the characterisation of the deposited film.  In particular, to identify monolayer, or 
multilayer surface coverage, and to assist in the determination of adsorbed antibody 
orientation.  In general, phase one indicates a uniform increase in both the f and D shifts, 
I                                                  II                                               III 
Au Au Au 
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whereas shifts to the slope gradient indicate changes in the film viscoelastic properties.  An 
increase in the gradient of the slope (i.e. decrease in f/D) is interpreted as an increase in film 
viscoelasticity, while a decrease in the gradient (i.e. increase in f/D) indicates and increase in 
film rigidity. As the first phase in each adsorption process being fairly uniform in behaviour 
between antibodies, focus was rather directed towards the shifts in gradient, and their 
corresponding interpretations. 
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Figure 2.7. Frequency versus dissipation plots of anti-human albumin (A), IgG (B), and anti-
human fibrinogen (C) adsorption to gold.  Symbols indicate D (y-axis) responses 
plotted relative to the f (x-axis) responses.  Solid lines schematically illustrate the 
gradient change, the first of which is indicated by 1. The scale for the D7 and f7 responses 
was maintained at 2E-6 and -60Hz, respectively, with the exception of AbHSA adsorption 
D7 response, indicated by the dashed line. Point of introduction of the PBSMg/Ca buffer 
rinse is indicated by the vertical arrows. Overtone 7 was utilised in generating the plots.  
 
Analysis of AbHSA adsorption, via D7 vs. f7 plots indicated fairly constant adsorption 
mechanisms for both the new and used gold sensor surfaces.  Figure 2.7 (A) illustrates a 
representative D7 vs. f7 plot of the AbHSA adsorption processes recorded.  Adsorption of the 
antibody to the gold substrate was observed as a three phase process, as indicated by the solid 
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lines in Figure 2.7.  The initial adsorption phase illustrated further separation of the ∆f/∆D 
data points, suggesting the initial rate of adsorption as being higher than the rate observed in 
phase two and three.  The second phase demonstrated a slight increase in the positive slope 
gradient of phase one, suggesting a greater increase in the D7 shifts, and therefore film 
viscoelasticity, with the subsequent addition of antibody molecules.  This increase in the 
viscoelasticity of the film may be interpreted as either protein denaturation or protein 
reorientation on the gold surface.  Phase three demonstrated a considerable increase in the 
slope gradient, and therefore D7 shifts, which corresponded with a minor increase in f7 shifts.  
This large increase in the slope gradient suggests the incoming antibody molecules are 
loosely bound to the previously deposited antibody surface, therefore contributing to the high 
viscoelastic nature of the adsorbed film.  
 
The introduction of the buffer rinse, indicated by the vertical arrows in Figure 2.7, resulted in 
a small decrease in both the f7 and D7 shifts, suggesting removal of the loosely bound 
proteins.  Furthermore, f7 shifts, and therefore adsorbed mass, resorted back to the 
approximate value recorded prior to the addition of the loosely bound proteins, in phase three.  
However, the same D7 value was not restored.  The f7 and D7 shifts observed during phase 
three of the adsorption process correspond with the initial deposition of a second layer of 
antibodies.  The adsorption of the multilayer to the previously adsorbed antibody layer arises 
from protein-protein interactions.  These interactions may produce conformation distortion of 
the underlying protein layer, therefore accounting for the large increase in film viscoelastic 
properties, observed during the addition of the loosely adsorbed molecules, and following 
their removal [89].   
 
D7 vs. f7 plots monitoring IgG adsorption (Figure 2.7; B) indicated both two and three phase 
processes in the absence (negative control) and presence of Mg2+ and Ca2+ ions (positive 
control), respectively.  Similarly, a three phase adsorption mechanism was observed for 
AbHPF-modification of the gold sensor surface (Figure 2.7; C). In the case of the three phase 
process, when assessing AbIgG+ and AbHPF adsorption, both phase two and three indicate 
slight increases in the slope gradient, suggesting an increase in the viscoelasticity of the film, 
potentially the result of protein denaturation or antibody reorientation.  The two phase 
process observed in the absence of the supplemented ions (negative control), indicates an 
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increase in the slope gradient, suggesting an increase in the viscoelastic nature of the film, 
similar to that observed in the presence of the Mg2+ and Ca2+ ions. Noteworthy change in the 
film properties were not apparent following the introduction of buffer rinse.   
It was concluded, from the D vs. f plot analysis (Figure 2.7), that deposited monolayer films 
remain following the buffer rinse, however, it is unknown whether these films are mono-
dispersed, or in fact, deposited aggregates.  This knowledge proved helpful when analysing 
the Sauerbrey and Voigt-determined film parameters, as it provided a basis on which to 
assess the recorded adsorbed film mass, in terms of it being a representation of a monolayer, 
or multilayer. 
 
Sauerbrey and Voigt-Based Analysis 
Table 2.4 summarises the Sauerbrey- and Voigt-determined film parameters of the surface 
modification, with target antibodies, for the control experiments. 
 
Table 2.4.  Sauerbrey and Voigt Modelled Analysis of Gold Surface Modification with Human 
IgG, Anti-Human Serum Albumin, and Anti-Human Plasma Fibrinogen, for control 
experiments 
Molecule a 
Sauerbrey Model Voigt Model 
ΔSauerbreym d 
Voigt m 
 
Film 
Thickness 
(nm) 
Mass  
(ng/cm2) b 
Ave. Mass 
(ng/cm2) 
Viscosity 
(kg/m.sec) c 
Shear 
Modulus 
(Pa) c 
Film 
Thickness 
(nm) 
 Mass  
(ng/cm2)  
Ave. Mass 
(ng/cm2) 
AbHSA 
(new 
crystal) 
6.74 
±0.23 
741.61 
±25.07 740.66 
±92.61 
(12.5% CV) 
 
6.26E-03 1.22E+06 8.33 832.55 
802.47 
±88.20 
(11.0% CV) 
0.89 
5.89 
±0.07 
647.58 
±7.85 
6.38E-03 1.79E+06 7.03 703.16 0.92 
7.57 
±0.05 
832.80 
±5.74 
8.06E-03 3.09E+06 8.72 871.70 0.96 
AbHSA 
(used 
crystal) 
7.30 
±0.03 
803.52 
±3.59 
840.36 
±59.47 
(7.1% CV) 
3.07E-03 3.57E+04 12.49 1249.45 
1239.26 
±108.02 
(8.7% CV) 
0.64 
7.35 
±0.04 
808.59 
±4.28 
2.77E-03 2.22E+04 13.42 1341.82 0.60 
6.07 
±5.26 
908.96 
±15.07 
4.85E-03 5.06E+05 11.27 1126.50 0.81 
AbIgG+ 
8.44 
±0.08 
843.67 
±7.80 
--- 7.56E-03 4.18E+06 8.65 865.13 --- 0.98 
AbIgG- 
9.06 
±0.12 
905.70 
±11.13 
--- 7.78E-03 1.87E+06 9.79 978.89 --- 0.93 
AbHPF 
 
8.78 
±0.02 
878.18 
±2.00 
--- 6.16E-03 4.32E+05 10.53 1052.54 --- 0.83 
a: Surface modification molecules utilised in the fabrication of the control surfaces 
b: Sauerbrey-determined adsorbed mass.  Standard deviation is obtained from 3 overtone responses. 
c:  Viscoelastic film parameters indicating film rigidity levels 
d: Indicates level of film hydration 
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Analysis of AbHSA adsorption to the gold surface revealed the deposition of films with 
Sauerbrey determined thickness ranging from 5.89 to 7.57 nm, on new crystals, and 6.07 to 
7.35 nm, on used crystals (Table 2.4).  According to the IgG dimensions, these thickness 
values correlate with the planar orientation of the antibody molecules, which is expected to 
demonstrate a film thickness of approximately 8.5 nm (Figure 2.6, I).  Although 
experimentally determined film thickness values were recorded to be below the predicted 
thickness of 8.5 nm, the planar orientation is still permissible, as IgG is reported to undergo 
conformational change once adsorbed to gold, therefore altering its dimensions [16].  
Similarly, the planar orientation was suggested by the Sauerbrey determined film thickness 
values for the IgG deposited film intended for the positive detection of adsorbed complement 
factor C3.  A film thickness greater than 8.5 nm, as seen for IgG adsorption of the 
complement factor C3 negative control (9.06 nm), and AbHPF (8.78 nm), may rule out the 
possibility of the deposition of a monolayer of planar orientated antibody molecules.    The 
latter film thickness values suggest the deposition of either edge-on orientated molecules, or 
both edge-on and planar orientated antibody molecules.   
 
The Voigt-determined film thickness values, on the other hand, indicate the deposition of 
notably thicker films in comparison to the Sauerbrey model, suggesting the formation of 
either multilayer films, or edge-on orientated monolayers, with the exception of IgG 
adsorption.  The analysis of adsorbed antibody orientation is an important parameter of the 
deposited film, as the degree of antibody active site exposure would demonstrate a great 
influence over the subsequent blood protein adsorption phase (Figure 2.6, II), in terms of 
mass bound and film viscoelastic parameters.  Film thickness alone is not sufficient to derive 
conclusions on the nature of the adsorbed film, due to the possibility of protein 
conformational change and/or denaturation.  It is necessary to make a comparison between 
theoretical and experimental adsorbed mass, together with viscoelastic parameters, namely, 
film viscosity and shear modulus (Table 2.4).   
 
Adsorption of AbHSA on new crystal surfaces resulted in the deposition of highly rigid films, 
as indicated by the high film viscosity and shear modulus, whose Voigt-determined mass was 
recorded to be somewhat greater than that determined through Sauerbrey analysis.  The 
Sauerbrey-determined adsorbed mass values suggest the possibility of films being composed 
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of mixed orientated molecules (741.61 ng.cm-2 and 647.58 ng.cm-2), and purely edge-on 
orientation (832.80 ng.cm-2), while edge-on orientated molecules (832.55 ng.cm-2 and 871.70 
ng.cm-2), and mixed orientated molecules (703.16 ng.cm-2) were suggested by the           
Voigt-based mass values (Figure 2.6).  AbHSA deposited films demonstrated high 
Sauerbreymass/Voigtmass values, suggesting a low portion of the adsorbed Voigt-mass is due to 
the entrapment of water molecules within the film [30].  The nature of the film interface, high 
film viscosity, high shear modulus, and low water content of the films leads one to conclude 
that densely-packed antibody films are deposited on the new gold surfaces, composed of both 
planar and edge-on orientated molecules.  
 
The adsorption of IgG on gold occurs at surface defects and impurities on the substrate [90].  
With regards to the new crystal surface, these surface defects and impurities are predicted to 
be at a minimum, therefore limiting the level of binding sites available for antibody 
adsorption [Internet Reference 1].  In this event, antibody molecules are reported to bind to the 
isolated binding sites, followed by deposition of antibody molecules adjacent to the already 
deposited antibodies [89].  For this reason, one may expect the deposition of densely-packed 
films on the new crystal surface, which correlates with experimental data. 
 
Contrary to this, adsorption of AbHSA on used crystals indicated the deposition of more 
viscoelastic films, suggested by the lower viscosity and shear modulus values.  These 
adsorbed films demonstrate considerably greater Voigt-mass (1126.50 ng.cm-2 – 1341.82 
ng.cm-2) in comparison to the Sauerbrey determined mass values (803.52 ng.cm-2 – 908.96 
ng.cm-2), and therefore low Sauerbreymass/Voigtmass values, indicating high levels of trapped 
water within the films.  Based on literature, if the degree of surface binding sites (i.e. defect 
sites on Au substrate) is high, as in the case of the used crystal surface, antibody aggregates 
are expected to adsorb, interacting with each other to extend across the surface until a 
smoother layer is generated [89].  The adsorption of such aggregates may explain the lower 
film viscosity and shear moduli observed for antibody binding on used crystal surface, as 
well as the high level of water present.  
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Reproducibility analysis, in terms of new versus used crystal surfaces, suggested a higher 
level of reproducibility for the modification of the used crystal surface (Table 2.4).  However, 
the reproducibility of antibody immobilisation step, may only be assessed by the final step in 
the protein detection protocol, namely, the probe antibody binding, as the orientation of the 
surface modification antibody molecules plays a crucial role in the control experiment design.  
However, it is important to note differences in the film parameters between the modified new 
and used crystal surfaces (Table 2.4). The occurrence of these deviations emphasises the 
influence of crystal quality on protein adsorption.   
 
Deposition of IgG molecules on the new gold sensor surface (Table 2.4), for the selective 
binding of complement factor C3c, was determined to result in the formation of highly rigid 
films, as indicated by the high viscosity and shear moduli, which demonstrate low level of 
water entrapment, indicated by the high Sauerbreymass/Voigtmass values.  Both the Sauerbrey 
and Voigt-determined adsorbed mass indicate the deposition of either edge-on orientated 
monolayers, or planar multilayers.  The D7 vs. f7 plot analysis indicated monolayer 
deposition, however, the analysis was inconclusive, in terms of the nature of the monolayer, 
whether it is composed of mono-dispersed antibody molecules, or aggregates. Irrespectively, 
the high film viscosity and shear moduli, together with the significantly low water content 
prediction, suggest the adsorption of densely-packed layers.  This high density of the film 
may lead to steric hindrance of the antibody molecule by surrounding antibody molecules, 
therefore one may predict, in the case of edge-on orientated molecules, an increase in both 
the film thickness.  The lower degree of entrapped water reported within the IgG film 
deposited for the positive detection of complement factor C3 may be explained by the 
composition of the solution buffer.  PBSMg/Ca contains both Mg
2+ and Ca2+ ions, included to 
aid in protein-protein interactions, in this case, antibody-antibody interactions, while these 
supplements are omitted in PBS [93]. 
 
Adsorption of AbHPF, on the other hand, resulted in the formation of a rigid film, 
demonstrating high viscosity and shear modulus, which contained higher levels of trapped 
water, in comparison to IgG.  Both the Sauerbrey and Voigt calculated adsorbed mass values 
for the adsorption of AbHPF suggested multilayer formation, as they were greater than the 
expected value for an edge-on monolayer, 822.56 ng.cm-2.  However, the high rigidity of the 
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film, and therefore high density, as previously discussed, leads one to consider a densely-
packed edge-on monolayer as a possible occurrence.  Figure 2.8. graphically displays the 
Sauerbrey and Voigt-determined adsorbed mass values observed when modifying the gold 
QCM-D sensor surface with the target antibodies described. 
 
The replicant studies indicate a variance of at least ± 50 ng.cm-2 between the surfaces for 
antibody adsorption.  These levels of variation are considered to indicate that reasonable, if 
not acceptable, reproducibility was achieved, in terms of total mass adsorbed. 
 
Figure 2.8.  Sauerbrey-(Blue) and Voigt-(Red) determined adsorbed antibody mass to the gold 
sensor surface.  Error bars indicate standard deviation where n = 3. 
 
The function of the antibody surface modification was to provide an indication of the level of 
probe antibody binding to a surface which primarily binds the target protein of interest.  In 
particular, analysis of the blood protein adsorption, and subsequent target antibody binding to 
the antibody films prepared was predicted to provide a positive control, to which the results 
of protein detection analysis on test surfaces may be compared.   
 
 
 
0
200
400
600
800
1000
1200
1400
1600
Im
m
o
b
ili
se
d
 A
n
ti
b
o
d
y 
M
as
s 
(n
g.
cm
-2
)
Anti-Human 
Albumin
IgG Anti-Human 
Firbinogen
new                        used                           +                               - +
43 
 
2.3.3. QCM-D Monitoring and Quantification of Biomolecular Interactions with the 
Surfaces: Modified and Unmodified 
Following surface modifications of the gold sensor surface using either SAM molecules or 
antibody molecules, target surfaces were introduced to either human blood plasma (HP) or 
human serum (HS).  Subsequently, target probe antibody (AbHSA, AbC3c, and AbHPF) binding 
was assessed for the detection of target proteins, namely HSA, complement C3c, and HPF. 
 
2.3.3.1. QCM-D Monitoring and Quantification of Blood Protein Adsorption to 
Unmodified and Modified Surfaces 
The adsorption of blood proteins to the target surfaces was assessed, using QCM-D, to 
provide information on characteristic blood protein adsorption behaviour, namely level of 
adsorbed protein on surfaces with known charge, and to provide a basis for the protein 
detection analysis.  HS is derived from HP through the removal of both the clotting factors, 
such as fibrinogen, and small molecules [94]. HS does not contain blood cells and clotting 
factors.  It was for this reason that human fibrinogen binding analysis was assessed utilising 
HP coated surfaces. 
 
Due to the complexity of proteins present in human blood samples, in-depth analysis of the 
binding process that occurs between the target surfaces and the serum/plasma was not 
explored other than antibody-antigen profiling of the surface.  Rather, analysis was focused 
on examining the reproducibility of the adsorption step, and the subsequent effect on protein 
detection reproducibility.  Analysis of the propagation of error from surface modification to 
blood protein binding and subsequently target protein detection, from a sensor perspective, 
provides an assessment of the robustness of the proposed protein detection method, and 
therefore its applicability as a biocompatibility screening technique.  Reproducibility analysis 
was limited to assessing HS adsorption on the unmodified and protein modified surfaces, and 
HP adsorption to the unmodified gold surface, due to the financial cost of performing these 
studies, in terms of the probe antibodies, and quartz crystal sensors.  
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QCM-D Response Analysis 
The key function of the preliminary analysis of the f and D shifts generated during the blood 
protein adsorption step, on unmodified and modified surfaces, was to assess the validity of 
the Sauerbrey model as a means of monitoring blood protein attachment (Table A.1).   Little 
deduction could be made concerning reproducibility from surface interface analysis            
(% Coefficient of Variation) and film rigidity (f/D) values due to the heterogenous nature of 
the blood samples.  Inter-phase shifts in film parameter, namely, film thickness, adsorbed 
mass, film viscosity and shear modulus, are represented for blood protein adsorption to the 
antibody modified surfaces, in comparison to the final film parameters being reported, as in 
the case of the bare and SAM modified surfaces.  This means of representation was selected 
to present the analysis of the blood protein deposition stages independently, rather than as an 
addition to the already deposited antibody layer. 
 
Sauerbrey and Voigt Analysis 
 Controls 
The attachment of blood proteins in HS on the AbHSA-modified surfaces was observed to be a 
highly variable process, when assessing either the new and used antibody-modified surfaces 
(Table 2.5.).  This high degree of variability is assumed to be the result of variations in the 
underlying antibody film, namely, antibody conformation, orientation, and packing density 
(Section 2.3.2.1; Table 2.4).  In general, HS adsorption to deposited antibody films adsorbed 
on new crystal surfaces, display lower levels of trapped water in comparison to the 
procedures where used crystals were employed.  The higher level of trapped water suggests 
conformational change of the target protein as a result of the antibody-protein interaction.  
Table 2.5 summarises the Sauerbrey- and Voigt-determined parameters of the blood protein 
films deposited on the modified and unmodified surfaces.   
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Table 2.5.  Sauerbrey and Voigt Modelled Analysis of Blood Protein Adsorption on Unmodified 
and Modified Surfaces 
Surface 
 
BP a 
Sauerbrey Model Voigt Model 
ΔSauerbreym d 
Voigt m 
 
 Mass  
(ng/cm2) b 
Ave. Mass 
(ng/cm2) 
Viscosity 
(kg/m.sec) c 
Shear 
Modulus 
(Pa) c 
 Mass  
(ng/cm2) 
Ave. Mass 
(ng/cm2) 
AbHSA 
 (new 
crystal) 
HS 
772.02 ±24.44 
610.46 ±158.78 
(26.00 %  CV) 
Decrease Decrease 801.43 
668.68 ±133.51 
(19.97 % CV) 
0.96 
454.61 ±11.53 Decrease Decrease 534.43 0.85 
604.75 ±16.84 Decrease Decrease 670.19 0.90 
AbHSA 
(used 
crystal) 
548.86 ±23.29 
563.26 ±144.10 
(25.58 % CV) 
Decrease Increase 1044.61 
1216.10 ±647.97 
(53.28 % CV) 
0.53 
426.90 ±6.41 Increase Increase 671.12 0.64 
714.02 ±25.49 Decrease Decrease 1932.56 0.37 
AbIgG 
HS 613.17 ±28.08 --- Decrease Decrease 645.12 --- 0.95 
iHS 281.34 ±17.65 --- Decrease Decrease 394.59 --- 0.71 
AbHPF 
 
HP 1045.25 ±22.32 --- Decrease Decrease 1575.16 --- 0.66 
Gold 
HS 
1157.41 ±20.66 
1212.35 47.56 
(3.92 % CV) 
Increase Increase 2106.18 
1510.19±303.93 
(20.13 % CV) 
0.55 
1258.70 ±112.81 Increase Increase 1388.52 0.91 
1191.46 ±17.62 Increase Increase 1423.20 0.84 
1192.18 ±27.50 Increase Increase 1305.11 0.91 
1192.06 ±27.96 Increase Increase 1305.90 0.91 
1282.28 ±25.73 Increase Increase 1532.22 0.84 
HP 
998.77 ±17.47 802.13 ±343.94 
(42.88  
% CV ) 
Increase Increase 1100.87 
914.86  ±367.82 
(40.21 % CV) 
0.91 
404.98 ±14.92 Increase Increase 491.19 0.82 
1002.63 ±40.41 Increase Increase 1152.53 0.87 
Silicon 
Dioxide 
HS 
1125.52 ±14.14 
1071.66 ±86.08 
(8.03 % CV) 
Increase Increase 1256.84 
1240.06 ±80.02 
(6.45 % CV) 
0.90 
1117.08 ±19.78 Increase Increase 1310.35 0.85 
972.39 ±17.01 Increase Increase 1152.98 0.84 
HP 935.54 ±21.11 --- Increase Increase 1128.98 --- 0.83 
11-AUT 
SAM 
HS 
977.35 ±25.20 
1012.21 ±124.06 
(12.26 % CV) 
Increase Increase 1147.53 
1242.27 ±103.39 
(8.32 % CV) 
0.85 
1149.97 ±27.78 Increase Increase 1352.55 0.85 
909.32 ±17.97 Increase Increase 1226.72 0.74 
HP 866.74 ±18.81 --- Increase Increase 1000.00 --- 0.87 
Cyst. SAM 
HS 
804.65 ±23.29 
781.18 ±45.23 
(5.79 % CV) 
Increase Increase 835.10 
946.88 ±142.92 
(15.09 % CV ) 
0.96 
729.04 ±5.05 Increase Increase 1107.91 0.66 
809.84 ±12.07 Increase Increase 897.64 0.90 
HP 1070.27 ±16.49 --- Increase Increase 1129.59 --- 0.95 
MUA SAM 
HS 
593.46 ±13.06 
666.36 ±65.74 
(9.87 % CV) 
Increase Increase 697.98 
786.99 ±77.19 
(9.81 % CV) 
0.85 
721.15 ±10.87 Increase Increase 835.54 0.86 
684.46 ±13.75 Increase Increase 827.44 0.83 
HP 892.12 ±25.09 --- Increase Increase 1175.28 --- 0.76 
a: Blood protein (BP)  sample adsorbed to the test surface 
b: Sauerbrey-determined adsorbed mass.  Standard deviation is obtained from 3 overtone responses. 
c:  Viscoelastic film parameters indicating film rigidity levels 
d: Indicates level of film hydration 
 
In terms of reproducibility, the process of HS binding to AbHSA modified surfaces exhibits 
similar coefficients of variation, for both new (26.00 %) and used (25.58%) modified 
crystals, when utilising the Sauerbrey model for mass detection (Table 2.5).  However, Voigt 
analysis suggested the adsorption of the serum coat on the new antibody-modified crystals 
(19.97 %) as being far more reproducible in comparison to the experiments assessing the 
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used crystal surfaces (53.28 %). Although low reproducibility was reported, this is not 
however an indication of the irreproducibility of the proposed method.   Adsorption of the 
final probe antibody, for the detection of target protein, is the crucial step.  Acceptable 
reproducibility, assumed as less than 10% variability, of the latter step, in the presence of 
irreproducible antibody surface modification and blood protein binding, would highlight the 
robust nature of the proposed methods, as the propagation of error would be eliminated. 
 
The adsorption of HS on the IgG coated gold surface generated a greater mass shift in 
comparison to the adsorption of heat inactivated human serum (iHS) (Table 2.5).  This 
occurrence is predicted, as well as the high level of trapped water within the iHS film, due to 
the denatured state of the heat inactivated blood sample, and the inactivation of C3c, resulting 
in lower mass binding.  HP adsorption to the AbHPF (fibrinogen control in Figure 2.9) coated 
surface resulted in the deposition of a fairly thick film, as observed by both the Sauerbrey and 
Voigt-determined parameters.   The low Sauerbreymass/Voigtmass value indicates a high level 
of hydration. 
 
 Unmodified Crystal Surfaces 
The adsorption of HS on the hydrophobic gold coated crystal surfaces was observed as the 
deposition of protein films which demonstrate varying degrees of hydration, as indicated by 
the Sauerbreymass/Voigtmass values (Table 2.5).  High reproducibility, in terms of the 
Sauerbrey determined adsorbed mass (3.92 % CV), was reported for HS adsorption on gold, 
however, the reproducibility decreases when assessing protein adsorption using the Voigt 
model (20.13 % CV).  The latter occurrence suggests varying degrees of protein denaturation 
occurred during the adsorption process, possibly due to the variations in the topography of 
the gold surface as a result of the chemical cleaning process.  In addition, low, comparable 
reproducibility was recorded for both the Sauerbrey and Voigt analysis of HP adsorption.  
The high variability in the adsorption process of HP may be the result of the composition of 
the blood sample, or variability in fibrinogen deposition, as it is a time-dependent process. 
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Acceptable reproducibility, where the coefficient of variation percentage is below 10 %, was 
reported for HS adsorption to the negatively charged SiO2 surface, with respect to both the 
Sauerbrey and Voigt determined adsorbed mass (Table 2.5).  An overall decrease in HS 
adsorption mass was recorded in comparison to that adsorbed to the gold surface.  This 
occurrence is predicted as HS proteins demonstrate a higher affinity towards hydrophobic 
surfaces over hydrophilic [95].   
 
SAM-Modified Surfaces 
Analysis of HS adsorption to the amine terminating SAM surfaces (Table 2.5), namely        
11-AUT SAM and Cyst. SAM surfaces, indicated higher mass adsorption occurred on the      
11-AUT SAM modified surfaces, suggesting the surface is more hydrophobic in nature, and 
therefore less protenated [95].  HS adsorption to the Cyst. SAM modified surfaces 
demonstrated higher Sauerbrey mass reproducibility in comparison to 11-AUT SAM 
surfaces, however, the Voigt-determined adsorbed mass suggested HS adsorption was more 
reproducible when assessing the 11-AUT SAM surfaces.  In addition, protein films deposited 
on the Cyst. SAM surfaces were reported to be less hydrated, suggesting a higher level of 
protein conformational change occurred.  Adsorption analysis of HS on the negatively 
charged MUA SAM-modified surfaces, reported lower levels of HS were deposited, and 
similar, acceptable reproducibility of the process was observed using both the Sauerbrey and 
Voigt-determined mass values. 
 
The levels of bound blood proteins recorded to adsorb to the test surfaces, both unmodified, 
and SAM modified, are predicted to be substantially greater than the blood protein levels 
deposited on the control surfaces (i.e. antibody-modified surfaces), due to the specificity of 
the antibody-antigen interactions. 
 
Overall Trends 
In general, HS protein exhibited a higher binding mass towards hydrophobic solid surfaces in 
comparison to hydrophilic surfaces, and hydrophobic SAM surfaces over hydrophilic SAM 
surfaces.  According to the both the Sauerbrey and Voigt-determined HP film parameters, HP 
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favours hydrophilic over hydrophobic surfaces.  Figure 2.9. summarised the adsorbed blood 
protein mass parameters and their adsorption reproducibility. 
 
Figure 2.9.  Sauerbrey (Blue) and Voigt (Red) determined adsorbed blood protein mass to 
unmodified, antibody-modified, and SAM modified surfaces.  iHS refers to the heat 
inactivated HS utilised for the negative C3c control.  Error bars indicate standard 
deviation where n =3, with the exception of gold HS binding where n = 6. 
 
2.3.3.2. QCM-D Monitoring and Quantification of Probe Antibody Adsorption to 
Unmodified and Modified Surfaces 
The detection of adsorbed target blood proteins was executed using the specificity of the 
antibody-antigen interaction.  The subsequent binding of probe antibodies, to the previously 
deposited blood protein coat, was monitored using QCM-D (Figure 2.1; B-III). 
 
When assessing the QCM-D responses obtained from AbHSA adsorption to the controls 
surfaces, the effect observed in terms of film interface properties were varying (Table A.2).  
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In cases where film interface roughness was reported to decrease, ‘filling-in of the 
depressions in the adsorbed HS layer was assumed to take place during the probe antibody 
adsorption process.  Contrary to this, possible explanations for the increase in surface 
roughness as a result of antibody deposition, include, the patterning of the probe antibody on 
the surface, and conformational change generated by the adsorbed target protein as a result of 
antibody binding.  In general, increases in film interface roughness, due to antibody binding, 
were recorded for the remainder of the surfaces, with the exception of the AbHPF, which 
demonstrated a decrease in the film interface roughness.   
 
Table 2.6 summarises the Sauerbrey and Voigt film parameters of the of the probe antibody 
films.  Of particular interest, is the adsorbed mass parameter, which serves as an indication of 
the level of exposed target protein present of the test surface.  
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Table 2.6.  Sauerbrey and Voigt Modelled Analysis of Probe Antibody Binding to Modified and 
Unmodified Surfaces 
Surface 
 
Probe a 
Sauerbrey Model Voigt Model 
ΔSauerbreyme 
Voigt m Δ Mass 
(ng/cm2) b 
Ave. Δ Mass 
(ng/cm2)  
ΔAbm c 
ΔBbm 
Δ Viscosity 
(kg/m.sec) d 
Δ Shear 
Modulus 
(Pa) d 
Δ  Mass 
(ng/cm2) 
Ave. Δ Mass 
(ng/cm2) 
ΔAbm c 
ΔBbm 
AbHSA 
(new 
crystal) 
AbHSA 
2612.84 ±101.38 2510.97 
±195.42 
(7.78% CV) 
3.38 Decrease Decrease 4916.09 3520.18 
±1289.50 
(36.63% CV) 
6.13 0.53 
2634.4 ±88.78 5.79 Increase Decrease 3270.96 6.12 0.81 
2285.66 ±46.88 3.78 Increase Increase 2373.48 3.54 0.96 
AbHSA 
Albumin 
(used 
crystal) 
2171.53 ±28.34 
2055.43 
±193.52 
( 9.42% CV) 
3.96 Increase Increase 2521.15 
2350.57 
±404.51 
(17.21% CV) 
2.41 0.86 
2162.72 ±39.27 5.07 Increase Increase 2641.84 3.94 0.82 
1832.03 ±30.77 2.57 Increase Increase 1888.71 0.98 0.97 
AbIgG 
 
AbC3c + 677.94 ±46.53 --- 1.11 Decrease Decrease 789.75 --- 1.22 0.86 
AbC3c - -19.07 ±6.96 --- -0.07 Increase Increase -81.03 --- -0.21 0.24 
AbHPF 
 
AbHPF 1796.9 ±1.09 --- 1.72 Increase Increase 1714.99 --- 1.09 1.05 
Gold 
AbHSA 
 
112.87 ±9.67 109.68 
±13.56 
(12.36% CV) 
0.10 Decrease Increase 356.49 241.73 
±104.39 
(43.18% CV) 
0.17 0.32 
94.81 ±64.21 0.08 Decrease Decrease 152.4 0.11 0.62 
121.36 ±12.39 0.10 Decrease Decrease 216.3 0.15 0.56 
AbC3c 
291.08 ±29.47 276.53 
±25.30 
(9.15% CV) 
0.24 Increase Increase 312.93 303.69 
±15.33 
(5.05% CV) 
0.24 0.93 
291.20 ±28.94 0.24 Increase Increase 312.15 0.24 0.93 
247.32 ±9.34 0.19 Increase Increase 285.99 0.19 0.86 
AbHPF 
1041.70 ±14.08 1016.38 
±181.31 
(17.84% CV) 
1.04 Increase Increase 1058.90 1033.00 
±178.07 
(17.24% CV) 
0.96 0.98 
1183.70 ±8.30 2.92 Increase Increase 1196.70 2.44 0.99 
823.74 ±42.64 0.82 Increase Increase 843.39 0.73 0.98 
Silicon 
Dioxide 
AbHSA 100.61 ±12.32 --- 0.09 Decrease Decrease 211.65 --- 0.17 0.48 
AbC3c 41.26 ±7.79 --- 0.04 Increase Increase 34.49 --- 0.03 1.20 
AbHPF 114.12 ±10.50 --- 0.12 Increase Increase 116.44 --- 0.10 0.98 
11-AUT 
SAM 
AbHSA 213.66 ±14.85 --- 0.22 Decrease Decrease 319.91 --- 0.28 0.67 
AbC3c 282.12 ±16.38 --- 0.25 Decrease Decrease 362.37 --- 0.27 0.78 
AbHPF 204.67 ±20.46 --- 0.24 Decrease Decrease 277.05 --- 0.28 0.74 
 
Cyst. 
SAM 
Ab(A) 313.68 ±22.74 --- 0.39 Decrease Decrease 365.23 --- 0.44 0.86 
AbC3c 47.24 ±3.15 --- 0.06 Decrease Decrease 212.82 --- 0.19 0.22 
AbHPF 1461.24 ±3.70 --- 1.37 Increase Increase 1424.73 --- 1.26 1.03 
MUA 
SAM 
AbHSA 76.10 ±16.93 --- 0.13 Decrease Decrease 198.68 --- 0.28 0.38 
AbC3c 18.42 ±1.05 --- 0.03 Decrease Increase 14.92 --- 0.02 1.23 
AbHPF 210.73 ±7.79 --- 0.24 Increase Decrease 290.73 --- 0.25 0.72 
a: Probe antibody for the detection of adsorbed HSA (AbHSA), complement factor C3 (AbC3c), and HPF(AbHPF) 
b: Sauerbrey-determined adsorbed mass.  Standard deviation is obtained from 3 overtone responses. 
c: Antibody probe mass as a proportion of total blood protein mass 
d:  Viscoelastic film parameters indicating film rigidity levels 
e: Indicates level of film hydration 
 
 
Sauerbrey and Voigt Analysis 
Controls Analysis 
On average, the adsorption of AbHSA on the control surfaces (resulted in large increases in 
film thickness (data not shown), deposited mass, film viscosity and shear modulus, and 
varying levels of film hydration (Table 2.6).  The occurrence of film thickness increases, 
greater than that predicted for an edge-on monolayer of antibody (Figure 2.5; 14.2 nm), 
suggests the possibility of antibody binding-induced conformational change of the target 
protein takes place.  Acceptable levels of reproducibility were reported for the Sauerbrey 
determined film mass parameters (new: 7.78 %; used: 9.42 %), while a decrease in 
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reproducibility was observed for the Voigt-based analysis (new: 36.63 %; used: 17.21 %).  
This decrease in reproducibility, as a result of taking into account trapped water, places 
emphasis on the target protein structural changes induced by antibody binding.   
 
A promising aspect concerning experimental reproducibility is the fact that the 
reproducibility of probe antibody detection is not dependent on the reproducibility of the 
blood protein adsorption step (Tables 2.4, 2.5, and 2.6).  This is observable in the case of the 
positive AbHSA control, where a used crystal surface was employed:  surface modification of 
the sensor surface with the target AbHSA antibody demonstrated 7.1 % CV, and 8.7 % CV. 
experimental reproducibility of the Sauerbrey- and Voigt-determined mass, respectively 
(Table 2.4).  The experimental reproducibility reported for the subsequent blood protein 
adsorption process, summarised in Table 2.5, indicated considerably lower reproducibility, of 
25.9 % CV (Sauerbrey), and 53.3 % CV (Voigt).  However, an increase in the reproducibility 
of the protein detection method was observed in the final, probe antibody step, where the 
Sauerbrey- and Voigt-determined mass demonstrated 9.4 % CV and 17.2 % CV, respectively 
(Table 2.6).  This lack of the propagation of error, from the initial, surface modification step, 
to the final, probe antibody binding step, highlights the robustness of the proposed protocol. 
 
According to the reproducibility analysis of the utilisation of new, and used, crystal sensor 
surfaces, the new crystal surface demonstrated more reproducible protein detection results, in 
terms of the Sauerbrey model, while the used crystal sensor surface demonstrate more 
reproducible Voigt model results (Table 2.6).  However, with respect to the aim of this 
particular control experiment, it is important of assess the reproducibility of the antibody 
modified surface in the selective adsorption of the target protein, namely HSA.  This may be 
assessed in terms of the total probe antibody mass as a proportion of the blood protein 
adsorbed mass (Table 2.6; Abm/BPm).  The Abm/BPm value indicates the selectivity of the test 
surface in binding the target protein, where the higher the value, the more selective the blood 
protein adsorption process.  On average, the utilisation of the new crystal sensor surface 
generated higher Abm/BPm values (Sauerbery: 4.3; Voigt: 5.3) in comparison to the results 
obtained using the used crystal surface (Sauerbery: 3.9; Voigt: 2.4), suggesting the new 
crystal surface was more effective in generating a positive control surface.  Reproducibility of 
the control experiments, in terms of the blood protein film, and probe antibody film           
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(i.e. Abm/BPm) indicated the new crystal demonstrated more reproducible results   
(Sauerbrey: 0.3 % CV; Voigt: 0.3 % CV, data not shown), in comparison to the used crystal 
surface (Sauerbrey: 0.3 % CV; Voigt: 0.6 % CV, data not shown).  It was therefore 
concluded, that the chemical cleaning process, and the utilisation of the crystal surfaces, 
negatively influence the reproducibility of experimental QCM-D procedures.  To my 
knowledge, this is the first documentation of QCM-D sensor crystal reproducibility analysis, 
in terms of the influence of chemical cleaning and reuse. 
 
Analysis of AbC3c + binding to the already deposited HS coated IgG film, for the positive 
detection of complement C3, indicated a decrease in the viscoelastic properties, with respect 
to viscosity and shear modulus (Table 2.6).  This increase in viscoelasticity was coupled with 
a slight increase in interface roughness, and increase in film hydration (Table 2.6; Table A.2).  
Furthermore, both the Sauerbrey and Voigt-determined film thickness values of the deposited 
film were recorded to be substantially lower than the predicted edge-on monolayer thickness 
of 14.5 nm, suggesting monolayer coverage of the HS surface was not achieved (Data not 
shown).  Taking these factors into consideration, antibody binding-induced target protein 
conformational change was considered to be unlikely.  In the case of HS protein adsorption to 
the IgG coated gold sensor surface, high levels of complement factor C3c are anticipated as 
IgG is a known activator of the complement system, and therefore high levels of probe   
AbC3c + are predicted to bind 
[21]. High levels of AbC3c +, in terms of total antibody mass, and 
Abm/BPm, were reported to bind to the IgG-modified surface, therefore correlating with the 
predicted results (Table 2.6). 
 
A negative mass response was reported for AbC3c – binding to the iHS coat adsorbed to the 
IgG-modified surface, generated for the negative control (Table 2.6).  This negative mass 
suggests the removal of adsorbed heat inactivated blood proteins from the IgG surface, by the 
AbC3c - molecules.  
 
AbHPF binding to the previously deposited HP coated AbHPF film resulted in the generation of 
a highly rigid film, whose Sauerbrey-determined mass value was an overestimation, and loss 
of trapped water was observed (Table 2.6).  This occurrence has been recorded in literature, 
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where it was attributed to antibody-antibody interactions which result in the ‘stiffening’ of 
the fibrinogen film.  The possibility of antibody-antibody interactions occurring of the 
fibrinogen-rich surface are greatly increased due to the fact that approximately 35 antibody 
molecules may potentially bind to one fibrinogen molecule [81].  High levels of HPF were 
predicted to adsorb to the adsorbed AbHPF-modified surface, due to the specificity of the 
antibody-antigen interaction.  High levels of probe AbHPF were therefore expected to bind to 
the HP coated AbHPF-modified surface.  The experimentally determined results concur with 
the theoretically predicted results (Table 2.6). 
 
Reproducibility Analysis:  Unmodified Gold Surface 
Adsorption of probe antibodies on blood protein coated gold surfaces resulted in a decrease in 
film viscosity, in comparison to the film HS film parameters (Table 2.5) when assessing 
HSA, while an increase in film viscosity was observed when assessing complement C3c and 
HPF (Table 2.6).  As previously discussed, AbHSA binding is predicted to result in 
conformational changes of the HSA molecule, while both AbC3c and AbHPF binding have little 
effect on the conformation of their respective target antigens. Both analysis of HSA and HPF 
adsorption on gold demonstrated low levels of reproducibility, however, acceptable levels 
were reported for complement C3 detection (Sauerbrey 9.2% CV; Voigt: 5.1 % CV).  These 
higher standard deviations observed for HSA and HPF may be attributed to by the number of 
antibody epitopes present on the target molecules, therefore emphasising the importance of 
protein conformation for detection purposes.  Both HSA and HPF proteins are reported to 
undergo some degree of conformational change when adsorbing to gold, therefore resulting 
in the exposure, or concealment of the target epitomes [81].   
 
AbHSA Binding Trends 
When assessing probe antibody binding, as a proportion of the blood protein bound 
(Abm/BPm), the Sauerbrey- and Voigt-determined adsorbed mass values indicated identical 
binding trends.  For simplicity, only the Voigt-based parameter will be referenced when 
discussing probe antibody binding.  Voigt-determined film parameters were predicted as a 
more accurate representation of the adsorbed protein films, as the mathematical model takes 
into account coupled water [34]. 
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The highest level of AbHSA (Abm/BPm) adsorbed on the unmodified and SAM-modified 
surfaces (Table 2.6) was observed on the Cyst. SAM surface (0.44), followed by the 11-AUT 
SAM surface (0.28), MUA SAM surface (0.28), unmodified SiO2 (0.17), unmodified gold         
(0.11-0.17).  Although HSA is reported to demonstrates a high binding affinity towards 
negatively charged surfaces, as well as hydrophobic surfaces, under physiological conditions, 
HSA carries a net negative charge, at physiological pH, as the molecule demonstrates an 
isoelectric point (pI) of approximately 4.7 [17, 95, 96].  The presence of this negative charge is 
predicted to influence the binding affinity of the target protein to the positively charged 
surfaces, via electrostatic interactions. This prediction corresponds with the experimentally 
determined occurrences, where higher levels of HSA were detected on the positively charged 
SAM surfaces (Cyst. and 11-AUT), in comparison to the negatively charges SAM (MUA).    
The similar HSA levels detected on the hydrophobic gold surface and the negatively charged 
SiO2 is in accordance with literature, as HSA is reported bind to both negatively charged and 
hydrophobic surfaces with a high affinity [35, 36].   
 
An alternative explanation for the deviation of the experimentally determined adsorbed HSA 
levels with literature reported binding affinity, may be the level of surface-induced 
conformational change of the protein.   High levels of HSA conformational change, upon 
adsorption to the test surfaces, may either increase or decrease the subsequent binding of the 
probe antibody, depending on the position of the antibody epitopes on the target protein 
following conformational change.  It has been reported that protein adsorption to both rigid, 
and hydrophobic surfaces, results in conformational changes of the protein on the          
surface [27,35]. 
 
A comparison between the level of AbHSA binding to the positive control surfaces (AbHSA-
modified gold), generated on both the new (3.51) and used (0.98) crystal surfaces, and the 
results obtained for the test surfaces, indicated substantially lower levels of HSA were 
deposited on the test surfaces, in comparison to the control surfaces.  
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AbC3c Binding Trends 
The levels of complement factor C3 (Table 2.6; Abm/BPm), via the detection of complement 
C3c, observed on the surfaces were: 11-AUT SAM (0.27) > gold surface (0.24 and 0.19) ≥ 
Cyst. SAM (0.19) > SiO2 (0.03) ≥ MUA SAM (0.02).  According to literature, complement 
activating surfaces display nucleophiles, such as hydroxyls and amino groups, while the 
presence of negatively charge groups, such as carboxyls, is reported on non-activating 
surfaces [9].   The experimentally determined binding trends observed for the complement 
factor C3 therefore correspond with literature findings, as higher levels of complement C3 
were reported on the positively charged SAMs (11-AUT and Cyst.) in comparison to the 
negatively charged SAM (MUA).  The 11-AUT SAM-modified surfaces were reported to 
demonstrate a more hydrophobic nature, determined via HS adsorption analysis, in 
comparison to the Cyst. SAM-modified surfaces.  This occurrence corresponds with a 
decrease in 11-AUT SAM surface protenation, therefore resulting in the generation of a 
surface composed of nucleophiles, which are complement activating [9].  Lower levels of 
adsorbed complement factor C3 were detected on the negatively charged surfaces silicon 
dioxide surface (Table 2.6).   The levels of AbC3c adsorption (Abm/BPm) on the test surfaces, 
fell within the range on the positive (1.22) and negative (-0.21) control surfaces.   
 
AbHPF Binding Trends 
The level of detected adsorbed HPF (Table 2.6; Abm/BPm) decreased as follows:  Cyst. SAM 
surface (12.6), 11-AUT SAM surface (0.28), MUA SAM surface (0.25), and unmodified 
SiO2 (0.10).  Varying levels of HPF were detected on the gold, hydrophobic surface, 
however, the levels were similar to that observed of the Cyst. SAM surface (0.73 to 2.44).  
HPF has been reported to demonstrate a high affinity towards hydrophobic surfaces, as well 
as favouring hydrophilic over hydrophobic SAM-modified surfaces [97, 98].  The 
experimentally determined HPF binding trend corresponded with literature, as the 
hydrophilic SAM-modified surfaces (Cyst.) demonstrated higher levels of HPF adsorbed to 
the surface, while the more hydrophobic SAM-modified surface (11-AUT) demonstrated a 
lower level of HPF.  However, similar levels of HPF were detected on the 11-AUT and the 
MUA SAM-modified surfaces.  The low level observed on the negatively charged SAM 
surface are predicted, as HPF demonstrates a pI of approximately 5.5, therefore rendering the 
molecule negatively charged at physiological pH [44].  A higher binding affinity towards the 
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hydrophobic gold surface was demonstrated in comparison to the unmodified negatively 
charged SiO2 surface.   
 
On average, the levels of HPF detected, via probe antibody binding, on the test surfaces did 
not exceed that observed on the control surface (1.09), with the exception of AbHPF binding 
on one unmodified gold surface (2.44), and the Cyst. SAM-modified surface (1.26).  These 
high levels of detected HPF highlight HPF adsorbed protein orientation as a potentially 
influential factor when detecting protein levels using probe AbHPF. 
 
2.4. CONCLUSIONS 
In conclusion, HSA detection, utilising the proposed method of probe antibody detection in 
conjunction with QCM-D technology, indicated high target protein levels on the positively 
charged Cyst. SAM-modified sensor surface, followed by 11-AUT SAM, MUA SAM, 
unmodified SiO2, and unmodified gold sensor surfaces (Table 2.6).  The levels of detected 
HSA on the test surfaces are supported by literature, therefore emphasising the accuracy of 
the proposed method of detection.  However, protein conformation change of the large, 
globular HSA, as a result of adsorption with the target surface, was suggested as a possible 
influential factor when detecting protein levels using probe antibody binding.  Assessment of 
the influence of conformational change may be carried out in studies where the target 
surfaces are incubated with pure HSA, instead of HS, followed by protein detection, using 
AbHSA.  The assessment of the HSA adsorption on the surface, using Sauerbrey- and Voigt-
determined film parameters, is expected to aid in identification of protein conformational 
change, via film hydration, and film viscoelasticity analysis.   
 
Detection of the complement system activation potential of the target surfaces, via 
complement C3 detection using AbC3c binding, indicated the following binding trend:         
11-AUT SAM > unmodified gold surface ≥ Cyst. SAM > unmodified SiO2 ≥ MUA SAM.  
The experimentally determined AbC3c, and therefore complement C3, binding trend 
corresponds with literature, as the nucleophiles bearing surface, 11-AUT, (i.e. complement 
activating) demonstrated higher levels of protein detection in comparison to that observed on 
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the carboxyl bearing surface, MUA SAM (i.e. non-activating) [9].    This correlation between 
the theoretical predictions and the experimentally determined results indicates the accuracy of 
the protein detection method.   
 
AbHPF probe antibody binding results indicated the following binding trend:   unmodified 
gold > Cyst. SAM surface> unmodified gold > 11-AUT SAM > MUA SAM > unmodified 
SiO2 (Table 2.6).  High levels of variability were observed for HPF binding to the 
hydrophobic gold. The orientation of adsorbed HPF was highlighted as an influential factor 
when detecting the levels of adsorbed protein using AbHPF antibody probes. 
 
With regards to experimental reproducibility, AbC3c detection of adsorbed complement C3 
proteins demonstrated the highest level of reproducibility (Sauerbrey: 9.15 % CV,         
Voigt: 5.05 % CV) in comparison to the detection of HSA and HPF (Table 2.6).  This high 
level of reproducibility may be attributed to by the small size of the target protein (i.e. 
complement C3c), and therefore lower predicted antibody : antigen (Ab:Ag) ratio [35].  The 
small size of the protein, and low Ab:Ag ratio, suggests the effects of conformational change 
of the target protein, on protein detection, would be minimum.  An additional factor to 
consider, is that the target protein, complement C3c, is tightly associated with other 
complement proteins on the target surface [35, 40, 41].  This tight association is predicted to limit 
the level of conformational change of the target C3c protein, therefore attributing to the 
reproducibility of the protein detection method.  
 
AbHSA detection of HSA demonstrated reasonably experimental reproducibility (12.36 % CV) 
when assessing the binding using the Sauerbrey model, however, the Voigt model indicated 
considerably low reproducibility (43.18 % CV).  This variability in reproducibility, between 
the two modelling systems, emphasises target protein conformational change as an influential 
factor.  The detection of HPF, using AbHPF probe antibody, indicated the lowest level of 
reproducibility (Sauerbrey: 17.84 % CV, Voigt: 17.24 % CV), which was proposed to be the 
result of adsorbed HPF orientation. 
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It is important to note the lack of error propagation from the surface modification, to the 
blood protein adsorption, and subsequent probe antibody binding steps (Table 2.4, 2.5, and 
2.6).  This is a favourable aspect when considering sensor design. 
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CHAPTER 3:   
BIOMOLECULAR INTERACTION WITH METALLOPHTHALOCYANINES 
 
3.1. INTRODUCTION 
3.1.1. Overview of MPcs 
To date, information regarding the interaction of MPc molecules with subcellular biological 
components, such as blood proteins, is limited, and chiefly directed towards the effect of 
protein adsorption on MPc dispersion and therapeutic effectiveness.  Investigations into the 
interaction of human and bovine serum albumin have, however, been conducted as serum 
albumin plays a significant role in the biodistribution of therapeutics through the circulatory 
system.  The dominating analytical method utilised in such studies were that of 
spectrophotometry and circular dichroism [64, 95, 99].  Although both methods of analysis 
provide useful information of protein interactions, they demonstrate a key limitation, namely, 
that proteins may only be assessed as independent molecules, rather than a component of a 
complex matrix, such as human blood.  The proposed method of utilising QCM-D 
technology, may provide a means of overcoming these limitations as biomolecular 
interactions between MPc molecules and human blood proteins, as a complex medium, were 
to be examined in terms of the protein coat composition when introduced to the circulatory 
system.   
 
3.1.2. Chapter Aims and Objectives 
The central aim this set of experimental procedures was to analyse the blood protein coat that 
adsorbs to MPc surfaces following introduction of human serum and human plasma, and 
subsequently assess the applicability of the proposed method of protein identification, using 
QCM-D, for analysis of particulate therapeutics. 
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Objectives 
1. Particle characterisation of prepared MPc molecules  
a. HPLC analysis of the degree of sulphonation of the MPc preparations 
b. Absorbance spectrophotometric analysis of the MPc preparations to assess 
particle aggregation 
2. Designing of strategies for the immobilisation of the MPc molecules to the QCM-D 
sensor surface using SAM-modification 
3. Monitoring and quantification of the sensor surface modification with the MPc 
molecules, using QCM-D 
4. Monitoring and quantification of human serum/plasma protein adsorption on the 
MPc-modified surfaces, using QCM-D 
5. Identification of surface bound serum/plasma proteins through QCM-D monitoring 
and quantification of the adsorption of antibodies directed against: 
a. Opsonins:  Complement component C3c and human plasma fibrinogen (HPF) 
b. Dysopsonin:  Human serum albumin (HSA) 
 
3.2. INSTRUMENTATION AND METHODOLOGY 
3.2.1. Instrumentation 
High Pressure Liquid Chromatography analysis of the MPc preparations was performed using 
Programmable Solvent Module 116 (Beckman System Gold); fitted with a C18 analytical 
column (Waters Symmetry; 3.9 × 260 mm), connected to UV detection unit (Beckman 
System Gold)  The mobile phase, 50:50 dilution of methanol to water, was degassed through 
a filtration process.  Absorbance spectral scans were performed using PowerWave X (Bio-
Tek Instruments, Inc.), for the analysis of MPc aggregation. 
 
3.2.2. Additional Reagents 
Sulphonated MPc samples in this study, containing a mixture of species with varying degrees 
of sulphonation, namely, sulphonated aluminum phthalocyanine mixture (AlPcSmix), 
sulphonated cobalt phthalocyanine mixture (CoPcSmix), sulphonated germainium 
phthalocyanine mixture (GePcSmix), sulphonated zinc phthalocyanine mixture (ZnPcSmix), 
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and the tetra-carboxylated cobalt phthalocyanine (CoTCPc), were provided by Prof. T. 
Nyokong of the Department of Chemistry, Rhodes University.  Tetra-sulphonated copper 
phthalocyanine (CuTSPc) was purchased from Sigma. 
 
3.2.3. Methodology 
3.2.3.1. Characterisation of Sulphonated Metallophthalocyanines 
3.2.3.1.1. Degree of Sulphonation Analysis via HPLC 
The HPLC analysis protocol was carried out, as explained by Ogunsipe and Nyokong (2005) 
[101], to determine the degree of MPc sulphonation.  0.1 mg/ml concentrations of each MPc 
mixture were prepared using the mobile phase, followed by an ultrasonication period of 15 
min [95].  The flow rate was set at 1 ml/min and injection volumes of 20 μl were analysed. 
CuTSPc, obtained from Sigma, provided an indication of the retention time expected for 
tetra-sulphonated species.   
 
3.2.3.1.2. Spectrophotometric Analysis of MPc Aggregation 
Absorbance spectrophotometric analysis of MPc dilutions prepared in PBSMg/Ca buffer and 
PBSMg/Ca buffer containing a 0.2% concentration of Triton X-100, a know surfactant, was 
carried out to assess MPc aggregation in the chosen buffer intended for QCM-D analysis.   
 
3.2.3.2. Surface Modification with MPcs 
The protocol for the immobilisation of the sulphonated MPc samples, to previously prepared 
11-AUT SAM surfaces, involved the suspension of 0.1 mg/ml MPc in PBSMg/Ca buffer       
(pH 7.4), followed by ultrasonication for a period of 15 min using ‘degas’ setting.  The 
QCM-D analysis of the immobilisation firstly involved obtaining stable f and D baselines 
using the PBSMg/Ca buffer, followed by the introduction of the suspended MPcSn sample, and 
subsequent PBSMg/Ca rinse.  Immobilisation of the tetra-carboxylated MPc sample, CoTCPc, 
was achieved through EDC/NHS facilitated binding.  0.1 mg/ml CoTCPc samples were 
prepared in MES buffer (pH 4.7), and ultrasonicated for a period of 15 min.  15 mM EDC 
and 15 mM NHS were then introduced, followed by a further sonication for 20 min, in the 
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dark.  QCM-D analysis of the immobilisation process involved introducing PBS Mg/Ca buffer, 
then MES buffer, MPc-EDC/NHS preparation, MES buffer, and a final rinse with PBSMg/Ca 
buffer. 
 
3.2.3.3. QCM-D Monitoring and Quantification 
Monitoring of protein binding, both blood protein and antibody binding, to the immobilised 
MPc samples was performed using a similar approach described in Chapter 2 Section 2.2.4.  
 
3.3. RESULTS AND DISCUSSION 
Section 3.3.1 reports on MPc characterisation, in terms of sulphonation and particle 
aggregation in PBSMg/Ca, while Section 3.3.2 examines the MPc immobilisation process in 
terms of theoretically determined parameters (3.3.2.1), and experimentally determined 
parameters, of the deposited MPc film.  Section 3.3.3 details protein adsorption to the 
deposited MPc film, both the blood protein adsorption (3.3.3.1), and antibody probe binding 
(3.3.3.2).  
 
3.3.1. Characterisation of Sulphonated MPcs 
3.3.1.1. Degree of Sulphonation Analysis via HPLC 
HPLC analysis of the sulphonated MPc samples was performed to evaluate the degree of 
sulphonation of the species present in the independently synthesised mixtures.  The response 
exhibited by CuTSPc provided a standard to which the HPLC retention times reported for the 
remainder of the MPc preparations could be compared, as CuTSPc sourced and purified to 
homogeneity by the commercial supplier.  Figure 3.1 illustrates examples of the HPLC 
retention times demonstrated by each MPc mixture.  No retention time peak was recorded for 
the CoTCPc sample.  Due to the negative charge carried by the analytical column, one 
assumes the initial peak recorded to be the more sulphonated species, followed by the second 
highest sulphonated species, and so on [101].   
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Figure 3.1.  HPLC trace for MPcs indicating the degree of sulphonation of the MPc species 
present in the MPc preparations.  The MPc preparations analysed were AlPcSmix, 
CoPcSmix, CuTSPc, GePcSmix and ZnPcSmix.  HPCL traces are illustrated for retention 
time 0 to 2.5 min.  Peak retention times are summarised in Table 3.1. 
 
As Figure 3.1 indicates, five peaks were recorded for AlPcSmix, two for GePcSmix and 
ZnPcSmix, and one for the CoPcSmix, and CuTSPc.  Table 3.1 summarises the average peak 
retention times recorded for the peaks observed in Figure 3.1, and the subsequent conclusions 
drawn from the study.  The single peak observed for the purchased CuTSPc was assumed to 
be indicative of a tetra-sulphonated species, therefore suggesting peaks possessing a retention 
time of 1.10 min arise from the presence of a tetra-sulphonated species in MPcmix.  A single 
dominant peak was recorded when examining CoPcSmix, demonstrated a similar retention 
time to that of CuTSPc.  It was therefore concluded that the CoPcSmix contained tetra-
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sulphonated species (Table 3.1).  Similarly, tetra-sulphonated species were assumed to be 
present in the AlPcSmix, GePcSmix, and ZnPcSmix samples,    (Figure 3.1 and Table 3.1).   
HPLC analysis of AlPcSmix indicated the presence of five variants of the sulphonated MPc, 
observed as five peaks (Figure 3.1).  The initial peak (A), demonstrated a retention time 
substantially less than that of the predicted tetra-sulphonated species.  This lower retention 
time suggests the presence of species which demonstrate a greater negative charge in 
comparison to that of the tetra-sulphonated species, and therefore a higher degree of 
sulphonation.  From the assumed tetra-sulphonated AlPc retention time, the responses 
obtained for the remainder of the peaks, namely, C, D, and E, were utilised as an indication of 
the retention times expected for tri-, di-, and mono- sulphonated species, respectively.  It was 
therefore concluded that GePcSmix, contained both tetra- and mono-sulphonated species.  The 
HPLC response for ZnPcSmix, indicated a broad band demonstrating a high retention time (F).  
The high retention time of the species suggests the presence of MPc aggregates, possibly 
consisting of low charged ZnPc molecules (i.e. mono-sulphonated).  According to literature, 
the degree of aggregation is dependent on the lipophilicity of the MPc molecules, therefore 
suggesting an increase in particle aggregation as the level of sulphonation decreases. [101].   
 
Table 3.1.  HPLC Analysis of the Degree of Metallophthalocyanine Sulphonation 
MPc 
Ave. Retention Time (min) 
Degree of Sulphonationa 
Peak A Peak B Peak C Peak D Peak E Peak F 
AlPcSmix 0.98 1.13 ± 0.01 1.29 1.38 ±0.02 1.68  Penta-; Tetra-; Tri-; Di-; Mono- 
CoPcSmix  1.11 ± 0.01     Tetra- 
CuTSPc  1.10 ±0.00     Tetra- 
GePcSmix   1.12 ±0.01   1.74 ±0.11  Tetra-;  Mono- 
ZnPcSmix  1.13 ±01.00    2.12 ±0.03 Tetra-; Aggregates 
a :   Determined by retention time 
Number of replicants was 3.  Uncertainty was standard deviation from the mean. 
In the case of standard deviation being omitted, peaks were not apparent in all three replicants 
 
 
In conclusion, HPLC analysis indicated; AlPcSmix contained penta-, tetra, tri-, di-, and mono-
sulphonated species; both CoPcSmix and CuTSPc contained tetra-sulphonated species;  
GePcSmix contained tetra- and mono-sulphonated species; and ZnPcSmix contained tetra-
sulphonated species and aggregates.  
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3.3.1.2. Spectrophotometric Analysis of MPc Aggregation 
Phthalocyanine absorption spectra are characterised by two absorption bands, namely, the 
Soret/B-band (~350 nm), and the Q-band (~680 nm) [95, 99].  According to literature, 
aggregation of Pc molecules may be evaluated through observing the Q-band. Splitting or 
broadening of the latter band has been reported to correspond with the presence of particle 
aggregates [49, 51, 95, 102].  Therefore, the focus of the spectrophotometric analysis of MPc 
aggregation was on the Q-band.   
 
Absorbance spectrophotometric analysis of the MPc preparations was performed to crudely 
assess particle aggregation in the chosen buffer utilised for MPc immobilisation analysis via 
QCM-D, namely, PBSMg/Ca (pH 7.4). Comparisons were made between the absorbance 
spectra (Q-band) of the MPc preparations in PBSMg/Ca buffer, with that of the spectra obtained 
where the surfactant, Triton X-100, was utilised as a dispersing agent (Figure 3.2).  Similar 
means of investigating MPc aggregation were reported by Ogunsipe and Nyokong (2005) 
[101]. 
 
Figure 3.2 illustrates the absorbance spectra obtained for the MPc preparations, both in 
PBSMg/Ca buffer, and when dispersed in PBSMg/Ca using 0.2% Triton X-100.  Q-band splitting 
was observed in all MPc preparations.  In the case of MPcs dispersed in PBSMg/Ca, the Q-band 
splitting may suggest one of two occurrences.  Firstly, that aggregated species are present, 
and/or secondly, the presence of species bearing varying degrees of sulphonation, which 
would therefore suggest individual Q-bands were observed, in comparison to Q-band   
splitting [95].  The addition of the surfactant, Triton X-100, was expected to result in 
monomerization of any MPc aggregates present in solution.  This was predicted to be 
observed as peak sharpening and and/or an increase in peak intensity [95].   
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Figure 3.2.  Absorbance spectrophotometric analysis of MPc aggregation.  Absorbance spectral 
scans of MPc preparations in PBSMg/Ca buffer (pH 7.4) and PBSMg/Ca                         
(0.2% Triton X-100). Dashed lines indicate the MPc monomer Q-band.   
Q-Band 
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Similar to the findings in literature, the addition of Triton X-100 resulted in an increase in 
peak intensity, when assessing AlPcSmix (Figure 3.2).  The latter implies monomerisation of 
the MPc aggregates. However, the factor responsible for the splitting of the Q-band was 
concluded to be the degree of sulphonation within the mixture rather than particle 
aggregation [95].  Spectrophotometic analysis of AlPcSmix (Figure 3.2) corresponds with 
HPLC analysis   (Table 3.1), which suggests the presence of mono-, di-, tri-, tetra-, and penta-
sulphonated MPc species, as MPc molecules demonstrating lower levels of sulphonation have 
been suggested to aggregate in aqueous solution [95, 101].  
 
The addition of Triton X-100 to both the CoPcSmix, CuTSPc and CoTCPc preparations 
resulted in a decrease in peak intensity.  According to literature, a decrease in Q-band 
intensity is indicative of photodegradation of the MPc molecule as a result of exposure to 
light [101].  The proposed photodegradation of CoTCPc, resulted in a decrease in absorbance 
levels, which generated the Q-band almost unidentifiable.  The presence of surfactant resulted 
in slight peak sharpening when assessing GePcSmix preparations, therefore suggesting that 
majority of the MPc species were in monomer form while in aqueous solution, with a small 
portion are present in aggregate form.  These results correspond with the HPLC analysis of 
the MPc preparation, which suggested high levels of tetra-sulphonated species and low levels 
of mono-sulphonated species.  The inclusion of Triton X-100 to the ZnPcSmix preparation 
resulted in a considerable change in peak intensities, suggesting a large portion of the MPc 
molecules are in aggregated form when in aqueous solution, as suggested by HPLC analysis 
indicating possible aggregation (Table 3.1).  
 
3.3.2. Surface Modification with MPcs 
According to literature, MPc molecules may adopt two conformations when immobilised to a 
target surface, namely, edge-on and/or planar conformations [49].  For the purpose of this 
research, immobilisation of both sulphonated and carboxylated MPcs were carried out using 
the amine terminating SAM, 11-AUT.  A positively charged SAM surface was utilised as it is 
predicted to promote MPc immobilisation through electrostatic interactions with the sulfonic 
acid groups present on sulphonated MPc molecules (Figure 1.6), and form a basis for 
covalent bonding with the carboxylic acid group of CoTCPc molecules.  11-AUT SAM 
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modification was favoured over Cyst. modification, due to the longer chain length, which has 
been reported to aid in the ordering of the self assembly process [84-86].  Figure 3.3 provides a 
schematic illustration of the anticipated orientations of MPc molecules immobilised on an  
11-AUT SAM. 
 
Figure 3.3.  Schematic representation of immobilised metallophthalocyanine orientation.  Planar 
and edge-on MPc conformations are illustrated by I and II, respectively. 
 
3.3.2.1. Theoretical Determination of Expected MPc Monolayer Mass 
When calculating the theoretical mass shifts expected during the immobilisation of MPc 
molecules on the 11-AUT SAM surface, four scenarios were considered where two aspects of 
the occurrence varied.  Firstly, the diameter of the MPc molecule was determined, where the 
ring substitutions were both included and excluded (Figure 3.4).  Secondly, the expected 
adsorbed mass was calculated for two conformations of the MPc molecule on the surface, 
namely side-on and planar conformation (Figure 3.3).  Possible distortion of the macrocylic 
geometry, due to the central metal, was omitted.   
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Calculations 
 MPc surface area was calculated, using the two scenarios illustrated in Figure 3.3, for 
the edge-on and planar conformations using the following formulae: 
Edge-On:  
Atomic radius MPc central metal × Molecular Diameter MPc = Surface Area MPc  Eq. 7 
Planar:   
π × (Molecular Radius MPc)
2 = Surface Area MPc     Eq. 8 
 The reciprocal of which indicates MPc occupancy on the sensor surface                  
(i.e. MPc molecules.cm-2) 
 From this, coverage of the MPc molecules was determined, followed by the number 
of mol’s of MPc per cm2, and finally the total mass per cm2 
 
 
Figure 3.4.  Rasmol determined MPc molecular diameter.  MPc diameters of 1.375 nm and 0.769 
nm were recorded for scenario I and II, respectively.  (PDB:  691745) 
 
The theoretical expected adsorbed mass for an MPc monolayer which adopts the edge-on and 
planar conformation, are summarised in Table 3.2.  These values were utilised in the 
assessment of MPc immobilisation, monitored using QCM-D. 
 
 
 
 
 
 
 
 
 
 
Scenario I                                Scenario II 
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Table 3.2. Theoretical MPc Immobilised Mass (ng.cm-2) for Edge-On and Planar Conformations 
Edge-On Conformation 
Substituents Tetra-SO4- Tri- SO4- Di- SO4- Mono- SO4- Tetra-COO- 
Scenario I II I II I II I II I II 
MPc 
Al 285.24 510.03 258.68 462.53 232.12 415.04 205.56 367.55 --- --- 
Co 322.42 576.49 --- --- --- --- --- --- 271.95 486.25 
Cu 344.73 616.39 --- --- --- --- --- --- --- --- 
Ge 359.66 643.09 --- --- --- --- 264.25 472.48 --- --- 
Zn 356.80 637.97 --- --- --- --- --- --- --- --- 
Planar Conformation 
Substituents Tetra-SO4- Tri- SO4- Di- SO4- Mono- SO4- Tetra-COO- 
Scenario I II I II I II I II I II 
MPc 
Al 96.14 307.38 87.19 278.76 78.24 250.13 69.29 221.51 --- --- 
Co 99.72 318.80 --- --- --- --- --- --- 84.11 268.90 
Cu 100.23 320.46 --- --- --- --- --- --- --- --- 
Ge 101.25 323.69 --- --- --- --- 74.39 237.82 --- --- 
Zn 100.44 321.11 --- --- --- --- --- --- --- --- 
Scenario I:  MPc dimensions including the ring substituents (Figure 3.4) 
Scenario II: MPc dimensions excluding ring substituents  
 
 
3.3.2.2. QCM-D Monitoring and Quantification of Surface Modification: MPcs 
The process for immobilisation of the MPc molecules to the 11-AUT SAM surface was 
monitored using QCM-D.  A brief examination of the f and D shifts, summarised in Table 
3.4, provided information on the rigidity of the immobilised MPc film.  For the purpose of 
assessing immobilised film properties, final frequency (f) and dissipation (D) values, after 
immobilisation, are reported, instead of changes in both Δf and ΔD.  This means of data 
depiction was favoured due to more realistic results being obtained from the Voigt-based 
modelling, in comparison to utilising the changes in shifts from initial (prior immobilisation) 
and final (post immobilisation) data. In all cases, immobilisation was recorded in 
quadruplicate (surfaces 0 – 3), with the exception of ZnPcSmix immobilisation, which was 
carried out to generate 9 replicates.   
 
QCM-D Response Analysis 
Table 3.3 summarises the f and D responses recorded for the immobilisation of the MPc 
molecules to the 11-AUT SAM surface.  f/D values higher than 10 Hz/1E-6 were recorded for 
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overtones 7 to 11 for the immobilisation procedures, suggesting fairly rigid MPc films were 
deposited, with the exception of AlPcSmix (2, 4), GePcSmix (0, 3) ZnPcSmix (1B, 1C, 2C, 3A, 
3B) and CoTCPc (1, 3) (Table 3.3). Rigidity may also serve as an indication of the validity of 
Sauerbrey determined film thickness and adsorbed mass (Chapter 2; Section 2.3.1).  One may 
therefore conclude, from the crude assessment of the raw data, the Sauerbrey determined 
adsorbed film thickness (δf) and mass are valid for all the immobilised surfaces, with the 
exception of the above listed films where the f/D values were below 10. 
 
Table 3.3.  QCM-D Frequency and Dissipation Shifts Following Metallophthalocyanine 
Immobilisation to 11-Amino Undecane Thiol Self-Assembled Monolayer 
Metallophthalocyanine 
f7 
D7 
f 9 
D9 
f 11 
D11 
Ave. 
F a 
Ave. f  
% CV 
Ave. 
D a 
AlPcSmix 
0 11.40 12.24 11.39 -17.24 ±0.94 5.45 1.48 ±0.10 
1 11.48 10.95 11.96 -26.91 ±1.10 4.09 2.35 ±0.18 
2 7.63 7.15 7.82 -22.79 ±0.65 2.85 3.03 ±0.20 
3 8.57 9.64 8.82 -20.58 ±0.61 2.96 2.29 ±0.16 
CoPcSmix 
0 203.52 194.15 55.55 -4.52 ±0.30 6.64 -0.03 ±0.05 
1 13.05 13.96 11.71 -10.70 ±0.23 2.15 0.83 ±0.07 
2 200.14 128.6 143.46 -5.27 ±0.09 1.71 -0.04 ±0.01 
3 227.00 78.50 78.33 -4.65 ±0.09 1.94 -0.05 ±0.02 
CuTSPc 
0 596.91 1462.66 228.11 -3.75 ±0.09 2.40 0.01 ±0.01 
1 80.01 61.53 345.82 -9.49 ±0.41 4.32 0.00 ±0.14 
2 34.54 33.11 22.17 -12.23 ±0.68 5.56 0.42 ±0.09 
3 40.75 38.00 34.00 -11.34 ±0.1 0.88 0.3 ±0.02 
GePcSmix 
0 
5.68 5.89 5.65 -10.77 ±0.67 6.22 1.88 ±0.12 
1 11.36 11.55 14.45 -9.57 ±0.60 6.27 0.78 ±0.14 
2 18.94 17.56 17.94 -7.58 ±0.43 5.67 0.42 ±0.02 
3 2.44 6.66 10.79 -9.05 ±1.45 16.02 1.87 ±1.34 
ZnPcSmix 
1A 22.83 17.71 18.90 -7.23 ±0.39 5.39 0.37 ±0.04 
1B 6.38 6.03 6.31 -18.96 ±0.95 5.01 3.04 ±0.17 
1C 7.64 7.59 7.13 -17.54 ±0.77 4.39 2.35 ±0.05 
2A 13.85 18.17 16.67 -7.27 ±0.15 2.06 0.45 ±0.06 
2B 14.23 16.44 19.6 -6.91 ±0.13 1.88 0.42 ±0.07 
2C 5.33 5.16 5.09 -27.25 ±1.86 6.83 5.25 ±0.24 
3A 5.55 5.40 3.51 -14.57 ±2.06 14.14 3.08 ±0.37 
3B 8.47 7.92 8.43 -6.54 ±0.3 4.59 0.79 ±0.04 
3C 33.06 20.78 25.24 -5.47 ±0.18 3.29 0.22 ±0.05 
CoTCPc 
0 16.42 25.68 59.60 -5.57 ±0.44 7.90 -0.21 ±0.1 
1 5.25 7.22 10.99 -15.62 ±1.97 12.61 2.14 ±0.57 
2 13.54 11.57 16.17 -14.16 ±0.51 3.60 1.04 ±0.14 
3 10.65 9.39 6.58 -13.59 ±1.60 11.77 1.56 ±0.23 
a: Average values determined using responses obtained from overtones 7 -11 
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An additional parameter which may provide information on the nature of film deposited is 
that of the average f percentage coefficient of variation (ave. f % CV) from a range of 
overtones.  In this case, overtones 7-11 were utilised as higher overtones generate more stable 
responses [Internet Reference 1].  High standard deviations are indicative of a rough film interface, 
while low standard deviations suggest a fairly uniform/sharp interface (Chapter 2;         
Section 2.3.1) [30].  The monitoring of MPc immobilisation, via QCM-D, to my knowledge, 
has not yet been reported in literature, and therefore the degree of variation in the percentage 
coefficient of variation has not yet been assessed.  There are therefore no absolute values 
which may be considered to be indicative of highly varied surface interfaces.  For the purpose 
of comparison, an ave. f % CV of below 10 % was considered to be an indication of a 
uniform/sharp interface. High ave. f % CV values were reported for the CoPcSmix (0), 
GePcSmix (3), ZnPcSmix (3A), and CoTCPc (1, 3) surfaces. This ‘rough’ interface is proposed 
to be the result of either the MPc molecules immobilising in mixed orientations, the 
patterning of the MPc molecules on the SAM surface, or the accumulation of MPc aggregates 
on the surface.   
 
Assessment of film formation process in terms of changes in film rigidity with the addition of 
MPc molecules was evaluated using D vs. f plots.  D vs. f plots (Figure 3.5) eliminates time 
as a parameter, and provides information on the changes in film structure, namely, the 
changes in dissipative energy per unit mass adsorbed (Chapter 2; Section 2.3.1).  Figure 3.7 
illustrates representative examples of the D vs. f plots of the MPc immobilisation processes. 
 
The immobilisation of AlPcSmix to the SAM surface was observed as a two phase process, 
according to the generated D7 vs. f7 plot (Figure 3.5).  The initial, more rapid phase, was 
followed by a phase with a more positive gradient, suggesting an increase in film 
viscoelasticity with the addition of in-coming MPc molecules, and therefore multilayer 
formation.  The point at which the gradient increases occurs at approximately                      
0.8 E-6/-8.0 Hz.  This f shift corresponds to approximately 140 ng.cm-2, when applying the 
Sauerbrey equation, which falls with in the range of theoretically determined planar 
monolayer mass (Table 3.2).  It was therefore concluded that AlPcSmix immobilisation results 
in the deposition of multilayers on the SAM surfaces.  Similarly, two phase immobilisation 
processes were recorded for CuTSPc, GePcSmix, and ZnPcSmix, suggesting multilayer 
73 
 
deposition (Figure 3.5).  However, in the case of CuTSPc immobilisation, the initial phase 
indicated highly rigid deposition of the MPc molecules to the surface, observed as an increase 
in f and minimal or no change in D, which demonstrated an approximate mass of 100 ng.cm-2 
(0.2 E-6/ -5.6 Hz), and therefore corresponding with the theoretical prediction of a planar 
monolayer (Table 3.2).  In addition, the buffer rinse step suggests the removal of the loosely 
bound MPc molecules adsorbed in phase two, rendering the final film as a monolayer, likely 
to be in the planar orientation, due to the high rigidity of the deposition (Figure 3.5). 
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Figure 3.5.  Representative dissipation versus frequency plot of the metallophthalocyanine 
immobilisation processes.  f (x-axis) and D (y-axis) shifts for overtone 7 were utilised.  
The solid lines indicate the gradient shifts of the mass addition.  The point of 
introducing the ‘rinse stage’ is highlighted using dashed circles.  Scale employed was -
30 Hz (f) and 4.5E-6 (D), unless stated. 
 
 
Similarly, rigid deposition of GePcSmix and ZnPcSmix sub-monolayer (0.1 E-6/ -3.0 Hz and 
0.3 E-6/ -4.0 Hz, respectively) were recorded, however, the buffer rinse did not indicate the 
removal of the loosely bound MPc molecules, suggesting the deposition of a multilayer.   
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Adsorption of CoPcSmix to SAM surface occurred in a three-phase process, observable by the 
three distinct slopes in the D7 vs. f7 plot (Figure 3.5).  The initial phase indicates low levels of 
adsorbed mass, which corresponded to high D shifts.  A distinct decrease in the slope 
gradient was observed in phase two.  This decrease suggests an increase in film viscosity as 
subsequent MPc molecules bound, suggesting the ‘filling in’ of the already deposited MPc 
film, deposited in phase one.   Phase three demonstrated an increase in the gradient of the 
slope in phase two, suggesting an increase in the film viscoelasticity as MPc molecules bind, 
and therefore the formation of a multilayer.  The point at which the gradient of the slope in 
phase two increase, to give rise to phase three, is approximately 0.4 E-6/ 3.0 Hz.  This 
increase indicates approximately 55 ng.cm-2 had adsorbed, using the Sauerbrey equation.  
According to the theoretically determined monolayer mass values (Table 3.2), this 
corresponded with the deposition of a planar orientated monolayer, or sub-monolayer.  A 
large decrease in the D shifts was recorded during the buffer rinse step, which corresponded 
with a small decrease in the f, and therefore mass, suggesting the removal of loosely 
associated MPc molecules (Figure 3.5),  The CoPcSmix film  was concluded to be a highly 
rigid film composed of a low mass, demonstrating a planar orientated monolayer, or sub-
monolayer.   
 
Examination of D versus f plot for the immobilisation of CoTCPc proved to be more 
challenging due to the utilisation of two different buffer solutions, namely PBSMg/Ca, and 
MES (Figure 3.5).  The primary focus was the introduction of MPc molecules, and not the 
effect of buffer alterations.  The portion of the plot that was of interest lies between the first 
and third dashed circles in Figure 3.5. The data points that lie between the first and second 
dashed circle represent the introduction of the MPc/MES and EDC/NHS solution, while the 
data points between the second and third circle represent the buffer rinse.  CoTCPc 
immobilisation to the SAM surface was observed as a two phase process.  The initial phase 
was observed as an increase in D with the addition of in coming MPc molecules (Figure 3.5).  
The second phase indicated a decrease in slope gradient, suggesting the ‘filling-in’ of the 
already deposited film.  This conclusion corresponds with the deposition of an edge-on film.   
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Sauerbrey and Voigt Based Analysis 
With the aid of Sauerbrey and Voigt-based modelling, film parameters such as thickness (δf), 
mass, viscosity (ηf) and shear modulus (μf) were determined for the immobilised MPc films 
(Table 3.4).  A comparison between the modelled film thickness (δf) and mass, with the 
theoretical-based predicted thickness obtained from the MPc dimensions (Figure 3.5) and 
theoretically calculated monolayer mass values (Table 3.2), allowed for conclusions to be 
drawn regarding the nature of the immobilised MPc film.   Table 3.4. illustrates the 
Sauerbrey- and Voigt-determined immobilised MPc film parameters. 
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Table 3.4.  QCM-D Analysis of Metallophthalocyanine Immobilisation on 11-Amino Undecane Thiol Self-Assembled Monolayer. 
Metallophthalocyanine a 
 Sauerbrey Model Voigt Model   
Film Thickness  
(nm) b 
Mass (ng/cm2) b 
Ave. 
Mass (ng/cm2) 
Viscosity 
 (kg/m.sec) c 
Shear Modulus  
(Pa) c 
Film Thickness 
(nm) 
Mass (ng/cm2) 
Ave. 
Mass (ng/cm2) 
Sauerbreym 
d 
Voigt m 
 
AlPcSmix 
0 3.09 ±0.17 308.52 ±16.93 
391.42 ±72.52 
(18.53 % CV) 
2.04E-03 2.47E+05 3.01 301.25 
565.57 ±177.51 
(31.39 % CV) 
0.69 
1 4.09 ±0.65 481.52 ±19.81 3.17E-03 5.63E+05 6.25 624.52 
2 4.07 ±0.12 407.36 ±12.03 2.48E-03 1.79E+05 6.75 675.27 
3 3.68 ±0.11 368.29 ±11.00 2.18E-03 1.69E+05 6.61 661.23 
CoPcSmix 
0 0.80 ±0.05 80.41 ±5.24 
104.04 ±59.13 
(56.83 % CV) 
7.98E-03 4.45E+04 0.94 94.24 
129.41 ±65.13 
(50.33 % CV) 
0.80 
1 1.92 ±0.04 191.48 ±4.13 3.41E-03 8.68E+05 2.27 226.86 
2 0.93 ±0.02 61.01 ±52.84 1.00E-02 1.00E+03 1.03 103.38 
3 0.83 ±0.02 83.25 ±1.69 8.65E-03 1.00E+03 0.93 93.15 
CuTSPc 
0 0.67 ±0.02 67.14 ±1.58 
165.48 ±68.37 
(41.32 % CV) 
5.41E-03 9.99E+03 0.83 82.56 
198.13 ±79.46 
(40.10 % CV) 
0.84 
1 1.72 ±0.05 172.49 ±4.36 3.08E-03 2.68E+04 2.60 260.07 
2 2.19 ±0.12 219.29 ±11.92 6.67E-03 2.13E+06 2.37 237.46 
3 2.03 ±0.02 202.99 ±1.87 8.12E-03 2.75E+06 2.12 212.42 
GePcSmix 
0 1.75 ±0.11 192.8 ±12.00 
165.93 ±21.29 
(12.83 % CV) 
1.81E-03 3.45E+05 3.09 309.34 
246.17 ±59.91 
(24.34 % CV) 
0.67 
1 1.71 ±0.10 170.99 ±10.55 2.66E-03 3.02E+05 2.48 248.16 
2 1.43 ±0.09 142.82 ±8.56 4.06E-03 1.02E+06 1.65 165.37 
3 1.57±0.26 157.09 ±0.22 1.83E-03 2.07E+05 2.62 261.82 
ZnPcSmix 
1A 1.29 ±0.08 129.14 ±7.11 
222.19 ±135.37 
(60.93 % CV) 
4.49E-03 1.45E+06 1.43 142.93 
355.21 ±226.74 
(63.83 % CV) 
0.63 
1B 3.39 ±0.17 338.38 ±16.96 1.92E-03 2.74E+05 5.84 583.81 
1C 3.14 ±0.14 313.81 ±13.86 2.17E-03 5.17E+05 4.3 429.95 
2A 1.30 ±0.03 130.17 ±2.72 2.75E-03 2.29E+05 1.97 196.90 
2B 1.26 ±0.06 126.1 ±6.36 1.43E-03 1.89E+04 4.25 424.71 
2C 4.88 ±0.33 487.64 ±33.27 1.80E-03 3.64E+05 7.82 782.49 
3A 2.60 ±0.36 259.50 ±36.38 1.19E-03 4.98E+05 3.56 355.71 
3B 1.17 ±0.05 117.04 ±5.4 2.21E-03 3.21E+05 1.82 181.76 
3C 0.98 ±0.03 97.96 ±3.26 5.73E-04 3.01E+06 0.99 98.61 
CoTCPc 
0 1.00 ±0.08 99.62 ±7.85 
218.82 ±80.95 
(36.99 % CV) 
1.88E-03 2.32E+07 0.95 94.85 
311.18 ±167.07 
(53.69 % CV) 
0.70 
1 2.53 ±0.09 253.31 ±9.15 2.82E-03 2.89E+05 3.70 346.16 
2 2.43 ±0.29 242.85 ±28.87 2.14E-03 7.40E+05 3.06 303.68 
3 2.70 ±0.35 279.5 ±35.30 2.39E-03 2.22E+05 5.00 500.01 
a: Surface modification molecules  
b: Sauerbrey-determined film parameter.  Standard deviation is obtained from 3 overtone responses. 
c:  Viscoelastic film parameters indicating film rigidity levels 
d: Indicates level of film hydration 
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Immobilisation of AlPcSmix 
From the MPc dimensions and theoretical monolayer mass, one would predict an edge-on 
monolayer of AlPcSmix to demonstrate a rigid film with a thickness of approximately      
1.375 nm to 0.769 nm and immobilised mass ranging between 205.56 03 ng.cm-2 and                
510.03 ng.cm-2 (Table 3.2).  If the MPc molecule adopted a planar conformation, a film 
thickness of approximately 0.364 nm (according to the atomic radius of Al), and film mass 
between 69.29 ng.cm-2 and 307.38 ng.cm-2, would be expected (Table 3.2).  Sauerbrey 
modelling of the immobilisation of AlPcSmix revealed film thicknesses ranging between 3.09 
nm and 4.09 nm, and immobilised mass between ~308 ng.cm-2 and ~481 ng.cm-2. The f/D 
values for surfaces 2 and 3 suggested the deposition of viscoelastic MPc films, in addition to 
the underestimation of the Sauerbrey equation, therefore required analysis using the Voigt-
based modelling system.  Voigt modelling for the AlPcSmix film deposition indicated film 
thicknesses between 3.01 nm and 6.75 nm, and immobilised mass values between             
~301 ng.cm-2 and ~675 ng.cm-2.   
 
Although the Sauerbrey and Voigt values differ significantly for the surface modification 
with AlPcSmix, both modelled film thickness values rule out the possibility of the MPc 
immobilising in a monolayer if adopting a planar conformation.  This is not to say that planar 
conformations of the MPcs molecules are not present, rather that a monolayer is not achieved.  
This conclusion corresponded with those of the D vs. f plot, suggesting multilayer deposition.  
HPLC analysis of the AlPcSmix sample revealed the presence of tetra-, tri-, di-, and         
mono-sulphonated species within the preparation (Table 3.1).  This presence of di- and 
mono-sulphonated MPc molecules permits the possibility of MPc aggregate formation.    Due 
to the fact that the determined Sauerbrey film thickness, which may be an underestimation, 
ranged from approximately double, and even three times larger than that of the expected 
edge-on monolayer maximum thickness versus the planar monolayer thickness (Table 3.2), 
one may conclude that aggregated MPc column structures are present on the surface.  This 
occurrence, taken into consideration with the, what is assumed to be, low ave. f  % CV   
(Table 3.3) of the MPc film, suggests that the immobilised film was either a composed of a 
multilayer of edge-on orientated molecules, or, more likely, aggregated planar columns with 
similar height dimensions.  The likelihood of complete monolayer formation in the edge-on 
orientation occurring in this case, in the presence of di- and mono- sulphonated species, was 
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improbable.  The immobilisation of the AlPcSmix molecules resulted in film which 
demonstrates a viscosity higher than that of water (ηwater = 0.765 ×10
-3 kg/m.sec; at T°C 20 
[Internet Reference 2]) and high shear modulus, confirming high film rigidity.   
 
Assessing the correlation between the Sauerbrey- and Voigt-determined mass, and the 
subsequent film hydration level, was achieved through calculating the Sauerbrey mass over 
Voigt mass value.  For the immobilisation of AlPcSmix this value was determined on average 
to be 0.69, for the four surfaces, suggesting that 31% of the Voigt mass was the result of the 
immobilised films interaction with water molecules.   The deposited AlPcSmix film on the    
11-AUT SAM surface were therefore concluded to demonstrate high levels of hydration, and 
possible multilayer edge-on orientation, or aggregate formation.  Similarly, the f and D shifts, 
and modelled Sauerbrey and Voigt film parameters, were utilised to assess the remainder of 
the immobilised MPc films.   
 
Immobilisation of CoPcSmix 
Immobilisation of the CoPcSmix sample resulted in the deposition of a film with a reasonably 
high f versus D ratios (Table 3.3), suggesting that the Sauerbrey determine film thickness and 
mass were valid, in addition to the immobilised films being rigid in nature.   Low % CV 
values calculated from the averaged f shifts for overtones 7 – 11, implied a fairly 
uniform/sharp film interface with the buffer solution.   
 
Sauerbrey and Voigt analysis of the film parameters indicated the deposition of MPc mass 
(Table 3.4), which correlated with the immobilisation of a monolayer of planar orientated 
MPc molecules (Table 3.2). This was observed as the deposition of mass which did not 
exceed the maximum theoretically determined value for the immobilisation of a planar 
orientated monolayer (318.80 ng.cm-2).  However, adsorbed mass values were recorded 
which were lower than that of the minimum theoretically determined value for a planar 
monolayer, therefore suggesting the possibility of sub-monolayer deposition (99.72 ng.cm-2).  
Both the Sauerbrey- and Voigt-determined film thickness of the CoPcSmix immobilised films 
suggested the deposition of either a monolayer of edge-on orientated MPc molecules, or a 
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multilayer, as the recorded thickness values were greater than the minimum theoretically 
determined film thickness (0.763 nm) for an edge-on monolayer (Table 3.4).  HPLC analysis 
of CoPcSmix suggested the presence of only tetra-sulphonated species (Table 3.1).  Due to the 
high degree of sulphonation of a high portion of the MPc molecules, one may omit the 
possibility of MPc aggregation occurring.  This conclusion was supported by the 
spectrophotometric analysis of CoPcSmix
 aggregation, which indicated no signs of MPc 
aggregation (Figure 3.4).  The high degree of sulphonation may furthermore promote planar 
orientation of the molecules on the SAM surface.  In addition, low standard % CV (Table 
3.3) of the average f shifts, suggested a fairly uniform film interface, therefore leading one to 
accept the proposed planar orientation.  This was supported by the significantly high film 
viscosity values.  The use of the film thickness parameter in assessing the MPc immobilised 
films was therefore concluded as unreliable, in comparison to the adsorbed mass values.    
 
The Sauerbrey mass over Voigt mass value of 0.80 indicated approximately 20% of the 
immobilised film was due to the interaction with water molecules.  The latter percentage of 
water is substantially lower than that observed with AlPcSmix immobilisation (31%).  This, 
together with the % CV of the average f shifts being, on average, lower than that recorded for 
AlPcSmix films, supports the assumption that a more ordered layer is deposited, possibly 
planar monolayer in nature.  The assumption of CoPcSmix monolayer corresponded with the 
deductions made from the D vs. f plot analyses. 
 
Immobilisation of CuTSPc 
Similarly to CoPcSmix immobilisation, monitoring of CuTSPc immobilisation on 11-AUT 
SAM coated surfaces resulted in high f over D values with low shift in D (Table 3.3), 
suggesting the deposition of a highly rigid film whose film parameters may be accurately 
determined through the Sauerbrey equation.   The low % CV calculated for the average f 
shifts, for overtone 7-11, suggests a uniform interface between the immobilised film and 
buffer solution.   
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Comparison between the Sauerbrey and Voigt-determined film mass parameters (Table 3.4), 
with the theoretically determined mass values for planar and edge-on monolayer deposition 
(Table 3.2), indicated that monolayer, or sub-monolayer CuTSPc films were immobilised.  
The latter was concluded as the modelled parameters did not exceed that of the maximum 
theoretically determined planar monolayer mass (320.46 ng.cm-2), however, the adsorbed 
mass levels were reported to be below that of the theoretical minimum planar orientated 
monolayer mass (100.23 ng.cm-2).  The possibility of a monolayer depositing is supported by 
HPLC analysis, which indicated CuTSPc contains only tetra-sulphonated molecules, 
implying that the molecules take on monomer form when in aqueous solution (Table 3.1). 
Both the Voigt determined viscosity and shear modulus values were, on average, high for the 
immobilisation of the CuTSPc molecules, confirming their rigid immobilisation.  The 
Sauerbrey mass over Voigt mass value suggests approximately 16% of the Voigt-determined 
film mass was due to the presence of water molecules in the film.  In conclusion, CuTSPc 
films were determined to be highly rigid monolayers composed of planar orientated MPc 
molecules, corresponding to the D vs. f plots deductions. 
 
Immobilisation of GePcSmix 
On observation of the f and D shifts recorded for the immobilisation of the GePcSmix        
(Table 3.3), the process of immobilisation appears to vary significantly for the four 
experiments performed.  HPLC analysis of the sample suggests the presence of both tetra- 
and mono-sulphonated MPc molecules (Table 3.1).  The low degree of sulphonation of the 
mono-sulphonated molecules is assumed to permit MPc aggregation, which may have 
contributed to that irreproducibility of the MPc immobilisation.  Δf/ΔD values determined for 
surfaces 1 and 2 indicated the deposition of a fairly rigid film (>10 Hz/1E-06), while surfaces 
0 and 3 suggest the deposition of a fairly viscoelastic film (<10 Hz/1E-06), whose adsorbed 
mass may have been underestimated when being assessed using the Sauerbrey equation.  The 
low % CV reported for the average f shift, when assessing surfaces 0, 1 and 2, may be 
assumed to be indicative of a uniform film interface.  Conversely, a high ave. f % CV was 
calculated for the MPc utilised for surface 3, possibly suggesting either varied MPc 
orientation, or aggregation of the MPc molecules on the SAM surface.   
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The Sauerbrey-determined adsorbed GePcSmix mass on the 11-AUT SAM surfaces        
(Table 3.4) indicated the deposition of planar orientated MPc monolayers, as the maximum 
level of adsorbed mass fell within the theoretically determined mass range (Table 3.2) for a 
planar monolayer (74.39 ng.cm-2 to 323.69 ng.cm-2), and was well below the minimum 
adsorbed theoretical mass value for an edge-on orientated monolayer (264.25 ng.cm-2).  The 
Voigt-determined film mass parameter indicated the possibility of planar orientated 
immobilisation of MPc monolayers on surfaces.  However, the results also suggest the 
possible deposition of edge-on orientated monolayers, as surfaces 0, 1, and 3 indicated the 
deposition of MPc mass of ~309 ng.cm-2, ~248 ng.cm-2, ~262 ng.cm-2, respectively (Table 
3.4).  The high film rigidity of the GePcSmix film on surface 2 demonstrated the highest level 
of rigidity, when comparing to surfaces 0, 1, and 3, as observed by the higher f/D values 
(Table 3.3), and higher viscoelastic properties determined through Voigt analysis (Table 3.4), 
in addition to the lowest level of surface roughness (Table 3.3) and film hydration (Table 
3.4). These film characteristics, in combination with the HPLC analysis indicating tetra- and 
mono-sulphonated species were present, and the spectrophotometric analysis indicating 
possible minor aggregation in PBSMg/Ca, suggest a planar orientated monolayer was deposited 
on surface 2, while surfaces 0, 1, and 3, may demonstrate mixed MPc orientation, and/or 
deposited aggregates.  The deposition of a multilayer corresponds to the conclusions drawn 
from the D vs. f plots. 
 
Immobilisation of ZnPcSmix 
Monitoring of ZnPcSmix immobilisation revealed the process demonstrated low 
reproducibility (Table 3.3).  Highly variable results, between the replicants, were determined 
for the immobilisation of ZnPcSmix films, in terms of film rigidity (f/D), and film interface 
properties (ave. f % CV).  Furthermore, analysis of the ZnPcSmix film deposition, using the 
Sauerbrey and Voigt models, indicated highly variable results, in terms of film thickness, 
adsorbed mass, film hydration (Sauerbreymass/Voigtmass), and viscoelastic parameters, namely 
film viscosity and shear modulus   (Table 3.4).   HPLC analysis of the MPc sample indicated 
the presence of tetra-sulphonated species, as well as an unidentifiable broad band (Table 3.1), 
which was confirmed to be MPc aggregates, via spectrophotometric analysis (Figure 3.4).  
This low reproducibility of film deposition was therefore attributed to the deposition of MPc 
83 
 
aggregates on the 11-AUT SAM surface.  The deposition of ZnPcSmix multilayers on the 
SAM surface are in accordance with the D vs. f plot conclusions. 
 
Immobilisation of CoTCPc 
Immobilisation of the CoTCPc sample was carried out using the zero-length linker, EDC, in 
the presence of NHS (Section 3.2.3.2).  The ordered method of MPc deposition resulted in 
fairly consistent average f and D shifts when monitoring the deposition of CoTCPc films, 
with the exception of surface 0 (Table 3.4).  However, the deposited films demonstrated 
variability in film rigidity (f/D), and film interface roughness (ave. f % CV) (Table 3.3).   
 
Sauerbrey analysis of the film parameters indicated the possibility of planar orientated 
monolayers being deposited on all surfaces, as the experimentally determined adsorbed mass 
values (Table 3.4) were similar to the theoretically determined mass values for a planar 
monolayer (~84 ng.cm-2 to ~269 ng.cm-2; Table 3.2).  However, the Sauerbrey adsorbed mass 
values determined for surfaces 1, 2, and 3, may also be interpreted to indicate the deposition 
of edge-on monolayers (~272 ng.cm-2 to ~486 ng.cm-2; Table 3.2).   The Voigt determined 
mass parameters, suggested edge-on orientated monolayer deposition of the CoTCPc 
molecules on surfaces 1, 2, and 3, while surface 0 was indicated to consist of a planar 
orientated monolayer.   The latter film was reported to demonstrate a fairly sharp interface 
(i.e. low ave. f % CV; Table 3.3), rigid nature (f/D and shear modulus), and low film 
thickness, which contributed to the assumption that a planar orientated monolayer was 
deposited.  Furthermore, the high film thickness (Table 3.4), adsorbed MPc mass, and 
viscoelastic parameters recorded for the deposition of CoTCPc on surfaces 1, 2, and 3, 
suggest the deposition of either edge-on monolayers or multilayer deposition. 
 
Experimental Reproducibility 
High variations in f and D shifts, and therefore Sauerbrey- and Voigt-based parameters, were 
recorded for each immobilisation of the individual MPc molecules, when comparing the 
immobilisation data generated from the separate experiments between the replicants      
(Table 3.3 and Table 3.4).  Both the Sauerbrey- and Voigt-determined parameters 
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demonstrated similar reproducibility trends, where GePcSmix indicated the highest level of 
immobilisation reproducibility, followed by AlPcSmix, (CoTCPc, CuTSPc), CoPcSmix, and 
ZnPcSmix (Table 3.4). This occurrence highlights the irreproducibility of the immobilisation 
processes, which may prove to be of concern when analysing antibody binding.  However, in 
order for accurate comparisons to be achieved, identical immobilised MPc films, for the 
entire set of MPc molecules, would be required.  Due to the varying chemical nature of each 
MPc sample, and therefore varying intermolecular interactions, this would be an unrealistic 
goal when designing a rapid means of assessment.  Optimisation of the immobilisation step 
may be achieved through further modification of the MPc molecule itself, however, this 
would alter the chemical structure of the MPc molecule and therefore jeopardise the accuracy 
of protein binding analysis, as well as increasing the sample preparation time.   
 
For ease of comparison, concluding remarks on the above discussed immobilised MPc films 
were summarised in Table 3.5. 
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Table 3.5.  Summary of Conclusions Derived on the Immobilised Metallophthalocyanine Films 
Surface 
Degree of Ring 
Substitution 
a 
MPc Aggregation 
b Film Rigidity 
(ΔF/ΔD) 
c 
Assembly 
Mechanism 
c 
Film Interface 
(Ave. F % STDev) c 
Proposed MPc  
Orientation 
d 
Surface Coverage 
e 
AlPcSmix 
0 
Tetra-, Tri-, Di- and Mono- Aggregates present 
Rigid  (>10) Multilayer Sharp (5.45%) Edge-On Multilayer 
1 Rigid (>10) Multilayer Sharp (4.07%) Edge-On Multilayer 
2 Viscoelastic (<10) Multilayer Sharp  (2.85%) Edge-On Multilayer 
3 Viscoelastic (<10) Multilayer Sharp (2.96%) Edge-On Multilayer 
CoPcSmix 
0 
Tetra-; Tri- 
Inconclusive: 
Possible photodegradation 
Rigid  (>10) Monolayer Sharp (6.64%) Planar Monolayer; or Sub-Monolayer 
1 Rigid  (>10) Monolayer Sharp (2.15%) Planar Monolayer 
2 Rigid  (>10) Monolayer Sharp (1.71%) Planar Monolayer; or Sub-Monolayer 
3 Rigid  (>10) Monolayer Sharp (1.94%) Planar Monolayer, or Sub-Monolayer 
CuTSPc 
0 
Tetra- 
Inconclusive: 
Possible photodegradation 
Rigid  (>10) Monolayer Sharp (2.40%) Planar Monolayer; or Sub-Monolayer 
1 Rigid  (>10) Monolayer Sharp  (4.32%) Planar Monolayer 
2 Rigid  (>10) Monolayer Sharp (5.56%) Planar Monolayer 
3 Rigid  (>10) Monolayer Sharp (0.88%) Planar Monolayer 
GePcSmix 
0 
Tetra- and Mono- Aggregates present 
Viscoelastic (<10) Multilayer Sharp (6.22%) Planar/Edge-On Monolayer, or Multilayer 
1 Rigid  (>10) Multilayer Sharp (6.27%) Planar Monolayer 
2 Rigid  (>10) Multilayer Sharp (5.67%) Planar Monolayer 
3 Viscoelastic (<10) Multilayer Rough (16.02%) Planar/Edge-On Monolayer; or Multilayer 
ZnPcSmix 
1A 
Tetra- and Aggregates Aggregates present 
Rigid  (>10) Multilayer Sharp (5.39%) Planar Multilayer 
1B Viscoelastic (<10) Multilayer Sharp (5.01%) Planar/Edge-On Multilayer 
1C Viscoelastic (<10) Multilayer Sharp (4.39%) Planar/Edge-On Multilayer 
2A Rigid  (>10) Multilayer Sharp (2.06%) Planar Multilayer 
2B Rigid  (>10) Multilayer Sharp (1.88%) Planar/Edge-On Multilayer 
2C Viscoelastic (<10) Multilayer Sharp (6.83%) Edge-On Multilayer 
3A Viscoelastic (<10) Multilayer Rough (14.14%) Planar/Edge-On Multilayer 
3B Viscoelastic (<10) Multilayer Sharp (4.59%) Planar Multilayer 
3C Rigid  (>10) Multilayer Sharp (3.29%) Planar Multilayer 
CoTCPc 
0 
Tetra- 
Inconclusive: 
Possible photodegradation 
Rigid  (>10) Monolayer Sharp (7.90%) Planar Monolayer 
1 Viscoelastic (<10) Monolayer Rough (12.61%) Planar/Edge-On Monolayer 
2 Rigid  (>10) Monolayer Sharp  (3.60%) Planar/Edge-On Monolayer 
3 Rigid  (>10) Monolayer Rough (11.77%) Edge-On Monolayer 
 a and b:  based on MPc characterisation studies using HPLC and spectrophotometric analysis 
   c: based on the QCM-D D vs. f plots 
   d:  derived from a comparison of the experimentally determined adsorbed mass and theoretically determine monolayer mass values 
   e:  assumptions drawn from a – d results 
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3.3.3. QCM-D Analysis of Biomolecular Interactions with MPc-Modified Surfaces 
Directly following each immobilisation procedure, analysis of blood protein adsorption on 
the newly modified surface was conducted using QCM-D.  The latter studies were carried out 
as previously stated, where human serum (HS)  or plasma (HP) was introduced to the surface, 
followed by the desired probe, namely, anti-human albumin (AbHSA), anti-human C3c 
(AbC3c), and anti-human fibrinogen proteins (AbHPF)  (Figure 3.6).   
 
 
Figure 3.6.  Schematic representation of the experimental process utilised in assessing the 
biomolecular interactions which occur with Metallophthalocyanines.  Antibodies 
utilised were anti-human albumin, anti-human C3c, or anti-human fibrinogen. 
 
Each subsequent layer, following MPc immobilisation, was assessed as though being an 
independent layer, in contrast to being a second, or third, layer.  Simplistically, film 
properties generated from the underlying layer, namely film thickness (δf), film viscosity (ηf) 
and shear modulus (μf), were utilised as a basis for predicting the unknown Voigt model 
parameters.  From this point forward, f shifts, D shifts, and film parameters discussed  refer to 
the shifts generated by the addition of the particular layer rather than the absolute value.   
 
3.3.3.1. QCM-D Monitoring and Quantification of Blood Protein Adsorption to 
MPc-Modified Surfaces 
Analysis of the human blood protein coat adsorbed to the MPc-modified sensor surfaces 
served as a means to assess experimental reproducibility and general MPc interactions with 
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blood proteins, rather than the biomolecular interactions that take place at the MPc interface.  
Precise, selective examination of these biomolecular interactions, via QCM-D, is impractical 
due to the complex, heterogeneous nature of the blood samples.    
 
QCM-D Response Analysis 
A brief overview of the QCM-D shifts in f and D (Table 3.6) in response to blood protein 
adsorption, indicated Δf/ΔD values greater than 10 in all cases, with the exception of the 
following surfaces:  GePcSmix (3); and ZnPcSmix  (2B, 3C), for one or more of the selected 
onvertones.   The majority of the Δf/ΔD values confirmed the deposition of fairly rigid 
protein films (i.e. Δf/ΔD >10), as well as validating the Sauerbrey determined adsorbed mass.  
The deposited blood protein coat appears to demonstrate a fairly uniform/sharp film interface, 
as indicated by the low average f percentage coefficient of variation (Table 3.6).  This 
occurrence is predicted as the blood protein molecules are expected to ‘fill in’ the MPc film 
interface, and undergo conformational changes due to adsorption to the surface [18].  
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Table 3.6. QCM-D Shifts in Frequency and Dissipation Shifts Due to Human Serum/Human 
Plasma Adsorption on MPc-Modified Surfaces 
Metallophthalocyanine a 
Δf7 
ΔD7 
Δf9 
ΔD9 
Δf11 
ΔD11 
Ave. 
Δf b 
Ave. f  
% CV 
Ave. 
ΔD b 
AlPcSmix 
0 
HS 
15.76 15.43 14.26 -42.75 ±0.84 1.96 2.83 ±0.10 
1 14.88 13.94 13.87 -67.95 ±2.32 3.41 4.78 ±0.09 
2 13.85 13.75 12.93 -62.66 ±0.99 1.58 4.64 ±0.10 
3 HP 17.70 17.58 16.96 -54.98 ±1.36 2.47 3.16 ±0.03 
CoPcSmix 
0 
HS 
13.72 13.28 13.36 -55.09 ±1.27 2.31 4.10 ±0.06 
1 15.46 15.80 14.36 -45.47 ±0.87 1.91 2.99 ±0.12 
2 28.14 24.02 27.01 -46.26 ±1.51 3.26 1.76 ±0.14 
3 HP 15.35 13.95 13.57 -72.12 ±1.79 2.48 5.06 ±0.21 
CuTSPc 
0 
HS 
18.33 18.42 18.27 -50.36 ±0.89 1.77 2.75 ±0.05 
1 17.10 20.84 19.76 -53.36 ±0.85 1.59 2.80 ±0.34 
2 24.24 22.57 21.47 -41.77 ±1.76 4.21 1.84 ±0.04 
3 HP 17.08 17.21 19.19 -36.08 ±0.64 1.77 2.03 ±0.14 
GePcSmix 
0 
HS 
11.98 11.64 11.36 -53.64 ±1.44 2.61 4.6 ±0.01 
1 13.73 14.18 15.36 -46.22 ±1.17 2.53 3.21 ±0.24 
2 17.59 16.79 16.13 -56.71 ±1.52 2.68 3.37 ±0.06 
3 HP 8.83 13.09 13.38 -44.01 ±0.71 1.61 3.87 ±0.92 
ZnPcSmix 
1A 
HS 
14.82 14.82 14.47 -45.51 ±0.98 2.15 3.10 ±0.03 
1B 21.80 20.98 19.51 -38.10 ±1.23 3.23 1.84 ±0.06 
1C 15.91 14.71 13.79 -43.97 ±1.06 2.41 2.98 ±0.14 
2A 14.63 14.66 14.34 -40.56 ±0.76 1.87 2.79 ±0.03 
2B 10.49 9.76 9.86 -25.87 ±1.04 4.02 2.58 ±0.06 
2C 11.18 10.93 10.52 -29.84 ±0.82 2.75 2.74 ±0.01 
3A 
HP 
16.03 15.56 11.09 -36.98 ±1.64 4.43 2.66 ±0.44 
3B 16.95 15.56 14.77 -45.30 ±0.58 1.28 2.88 ±0.16 
3C 9.86 9.51 9.35 -25.34 ±0.69 2.72 2.65 ±0.02 
CoTCPc 
0 
HS 
13.68 13.17 12.79 -67.32 ±1.70 2.53 5.10 ±0.04 
1 12.84 11.65 12.21 -96.16 ±2.15 2.24 7.87 ±0.27 
2 14.58 14.97 13.34 -65.70 ±1.87 2.85 4.60 ±0.21 
3 HP 11.28 11.10 11.79 -67.28 ±1.00 1.49 5.91 ±0.27 
a: Surface modification molecules  
b: Average values determined using responses obtained from overtones 7 -11 
 
Sauerbrey and Voigt Based Analysis 
The focus of the modelled data for blood protein analysis (Table 3.7) was that of the adsorbed 
mass, in terms of its dependence on the underlying film interface, and reproducibility.     
Figure 3.7 summaries the Sauerbrey- and Voigt-determined adsorbed blood protein mass 
values observed when assessing each MPc-modified surface.   
 
According to the modelled mass shifts, both Sauerbrey and Voigt, recorded for HS adsorption 
to the MPc films (Table 3.7), similar levels of adsorbed protein were observed to deposit on 
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the films previously proposed to be planar orientated monolayers, namely CoPcSmix, CuTSPc, 
and GePcSmix (Table 3.5).  In addition, higher levels of HS adsorption occurred on the 
AlPcSmix, proposed multilayers, in comparison to the ZnPcSmix multilayers.  This variation in 
HS binding may be attributed to the topography (i.e. MPc orientation, and monolayer or 
multilayer) and/or chemical composition (the net charge, and metal core) of the immobilised 
films.  However, similar, sharp MPc film interface properties were determined for both the 
AlPcSmix and ZnPcSmix immobilised multilayer films (Table 3.3), therefore suggesting the 
chemical properties of the MPc film are the influential factors governing the HS adsorption. 
 
Sauerbrey-based data modelling of blood protein adsorption to the modified surfaces 
indicated protein binding to the GePcSmix-modified surface to be the most reproducible, 
followed by CoPcSmix, CuTSPc, ZnPcSmix, CoTCPc, and AlPcSmix (Table 3.7).  These 
occurrences may be explained by the nature of the MPc film, namely, the orientation which 
the MPc molecule is assumed to adopt when deposited on the underlying SAM.   
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Table 3.7.  QCM-D Analysis of Human Serum and Human Plasma Adsorption on MPc-
Modified Surfaces  
MPc a BP b 
Sauerbrey Model Voigt Model ΔSauerbreym 
e 
Voigt m 
 
Δ Mass 
(ng/cm2) c 
Ave. Δ Mass 
(ng/cm2)  
Δ Viscosity  
(kg/m.sec) d 
Δ Shear Modulus  
(Pa) d 
Δ  Mass 
(ng/cm2) 
Ave. Δ Mass 
(ng/cm2) 
AlPcSmix 
0 
HS 
765.05 ±14.95 
1034.12 ±237.78 
(22.99 % CV) 
Decrease Decrease 870.70 
1233.86 ±314.90 
(22.52 % CV) 
0.88 
1 1215.99 ±41.39 Increase Increase 1431.18 0.85 
2 1121.32 ±17.67 Increase Increase 1399.7 0.80 
3 HP 983.84 ±24.24 --- Increase Increase 913.45 --- 1.08 
CoPcSmix 
0 
HS 
985.81 ±20.41 
875.82 ±95.51 
(10.91 % CV) 
Decrease Increase 1178.84 
1010.97 ±150.21 
(14.86 % CV) 
0.84 
1 813.81 ±15.39 Increase Decrease 964.81 0.84 
2 827.83 ±26.89 Decrease Increase 889.26 0.93 
3 HP 1290.65 ±31.74 --- Decrease Increase 1484.70  0.87 
CuTSPc 
0 
HS 
901.27 ±15.51 
867.90 ±107.59 
(12.40 % CV) 
Decrease Decrease 1029.59 
1093.89 ±302.82 
(27.68 % CV) 
0.88 
1 954.86 ±14.65 Decrease Decrease 1423.7 0.67 
2 747.58 ±31.45 Increase Decrease 828.38 0.90 
3 HP 645.69 ±11.33 --- Decrease Increase 761.26 --- 0.85 
GePcSmix 
0 
HS 
959.85 ±25.74 
933.99 ±96.45 
(10.33 % CV) 
Increase Increase 1171.38 
1138.59 ±46.08 
(4.05 % CV) 
0.82 
1 827.25 ±20.42 Increase Increase 1085.91 0.76 
2 1014.87 ±27.24 Increase Increase 1158.48 0.88 
3 HP 787.61 ±12.62 --- Increase Decrease 1337.13 --- 0.59 
ZnPcSmix 
1A 
HS 
814.44 ±15.74 
670.51 ±142.38 
(21.23 % CV) 
Increase Increase 935.45 
860.79 ±272.89 
(31.70 % CV) 
0.87 
1B 681.77 ±22.03 Increase Increase 756.6 0.90 
1C 786.80 ±18.89 Increase Increase 881.66 0.89 
2A 743.12 ±34.2 Increase Increase 1348.62 0.55 
2B 462.99 ±18.58 Increase Increase 584.47 0.79 
2C 533.91 ±14.71 Increase Increase 657.93 0.81 
3A 
HP 
661.77 ±29.39 
641.95 ±179.40 
(27.95 % CV) 
Increase Increase 720.8 
739.34 ±162.16 
(21.93 % CV) 
0.92 
3B 810.62 ±10.4 Increase Decrease 909.97 0.89 
3C 453.46 ±12.34 Increase Increase 587.25 0.77 
CoTCPc 
0 
HS 
1204.61 ±14.79 
1367.04 ±306.76 
(22.44 % CV) 
Increase Decrease 1305.76 
1649.55 ±562.05 
(34.07 % CV) 
0.92 
1 1720.87 ±34.15 Increase Increase 2298.16 0.75 
2 1175.65 ±33.51 Increase Increase 1344.72 0.87 
3 HP 1204.05 ±2.23 --- Increase Increase 1650.15 --- 0.73 
a: Surface modification molecules  
b: Blood protein sample adsorbed to the test surface 
c:  Sauerbrey-determined film parameter.  Standard deviation is obtained from 3 overtone responses. 
d:  Viscoelastic film parameters indicating film rigidity levels 
e: Indicates level of film hydration 
 
In the case of CoPcSmix, CuTSPc and GePcSmix surfaces, a monolayer of planar orientated 
MPc molecules was concluded to be a possibility (Table 3.5). This planar orientation of the 
MPc molecules on the SAM surface are predicted to result in a more uniform HS deposited 
film. ZnPcSmix- and AlPcSmix-modified surfaces, however, are predicted to be composed of 
MPc multilayers, and/or aggregates.  The presence of MPc multilayer or aggregates on the 
SAM surface decreases the reproducibility of the MPc film topography, and therefore 
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decreases the reproducibility of protein binding to the already variable MPc-modified surface.  
Both the MPc orientation, as well as the MPc film surface charge may explain the high 
variability of protein binding to the CoTCPc surfaces.  CoTCPc films were determined to be 
monolayers composed of edge-on MPc molecules, therefore suggesting the protein 
interaction is not due to the metal core.  Protein binding to the latter monolayers is expected 
to differ greatly, similarly, to planar monolayers due varying surface charge densities.  The 
adsorption of blood proteins has been reported to be dependent on the surface characteristics, 
such as charge, morphology as well as material composition [103]. 
 
 
 Figure 3.7.  Sauerbrey (Blue) and Voigt (Red) determined human serum (S) and human plasma 
(P) mass adsorbed to previously immobilised metallophthalocyanines films.  Error 
bars indicate standard deviation (n = 3), with the exception of ZnPcSmix where (n = 6). 
 
A comparison between the amount of adsorbed HS mass and the MPc film interface 
roughness (ave. f % CV of MPc immobilisation process) revealed little correlation between 
the two (Figure 3.8).  This fact highlights the dependence of serum protein binding on the 
surface charge, and/or chemical composition. 
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Figure 3.8. Sauerbrey- (I) and Voigt- (II) determined adsorbed human serum mass versus 
immobilised MPc film interface property. The MPc film interface property illustrated 
is the average f percentage coefficient of variation, which is an indication of surface 
roughness. 
 
According to HP adsorption analysis to the ZnPcSmix-modified surfaces, the process 
demonstrated a similar level of reproducibility to that of HS adsorption (Table 3.8).  Little 
deduction could be made concerning HP adsorption to the MPc-modified surfaces, as film 
parameters were recorded to be highly variable, between each MPc surface, in terms of 
adsorbed mass and, topography, and hydration (Table 3.6 and 3.7). 
 
3.3.3.2. QCM-D Monitoring and Quantification of Probe Antibody Binding to 
MPc-Modified Surfaces 
When assessing target antibody binding to blood protein coated MPc-modified surfaces the 
proposed MPc surface topography, determined previously, was taken into consideration.  
Reproducibility of adsorbed blood protein detection, using target antibodies, was assessed 
using ZnPcSmix-modified surfaces, as this MPc preparation demonstrated the highest level of 
cytotoxicity in MCF-7 cell lines (Chapter 5).  Analysis of the experimental reproducibility 
using the total set of MPc surfaces was not feasible due to the constrained availability of the 
probe antibodies.   
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Crude analysis of the f and D shifts recorded for the antibody probe binding, to the blood 
protein surfaces, provided limited information on the properties of the deposited antibody 
films (Table B.1).  Focus was therefore directed towards adsorbed antibody mass.  Due to the 
varying MPc film interface characteristics, it was necessary to assess probe antibody binding 
mass as a proportion of the total adsorbed blood protein, mass, therefore eliminating the level 
of film interface roughness, in terms of exposed surface area, as an influencing factor.  This 
was achieved via assessing the Antibodymass/Blood Proteinmass (Abm/BPm).   Table 3.8 
summarises the Sauerbrey- and Voigt-determined film parameters of the bound probe 
antibody film.  
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Table 3.8.  QCM-D Analysis Antibody Binding to Adsorbed Human Serum and Plasma 
Proteins on the MPc-Modified Surfaces 
MPc  Probe a 
Sauerbrey Model  Voigt Model  
 
Δ Mass  
(ng/cm2) b 
Ave. Δ 
Mass  
(ng/cm2) 
ΔAbm c 
ΔBbm 
 
Δ Viscosity  
(kg/m.sec) d 
Δ Shear Modulus  
(Pa) d 
Δ  Mass  
(ng/cm2) 
Ave. Δ  
Mass  
(ng/cm2) 
ΔAbm c 
ΔBbm 
 
ΔSauerbreym 
e 
Voigt m 
 
AlPcSmix 
AbHSA 71.05 ±4.84 --- 0.06 Increase Increase 82.33 --- 0.06 0.86 
AbC3c 127.27 ±2.00 --- 0.11 Increase Increase 94.53 --- 0.07 1.35 
AbHPF 2185.43 ±58.65 --- 2.22 Increase Increase 2220.05 --- 2.43 0.98 
CoPcSmix 
AbHSA 443.27 ±24.51 --- 0.54 Decrease Decrease 635.70 --- 0.66 0.70 
AbC3c 105.03 ±7.17 --- 0.13 Increase Increase 101.19 --- 0.11 1.04 
AbHPF 2056.81 ±19.92 --- 1.59 Increase Increase 2118.46 --- 1.43 0.97 
CuTSPc 
AbHSA 309.16 ±26.31 --- 0.32 Decrease Decrease 675.65 --- 0.47 0.46 
AbC3c 53.8 ±7.10 --- 0.07 Decrease Decrease 69.20 --- 0.08 0.78 
AbHPF 1049.52 ±44.37 --- 1.63 Decrease Increase 1120.18 --- 1.47 0.94 
GePcSmix 
AbHSA 651.25 ±124.97 --- 0.79 Decrease Decrease 2655.25 --- 2.45 0.25 
AbC3c 669.09 ±56.63 --- 0.66 Decrease Decrease 996.25 --- 0.86 0.67 
AbHPF 982.77 ±30.42 --- 1.25 Increase Increase 337.27 --- 0.25 2.91 
ZnPcSmix 
AbHSA 
 
79.12 ±7.25 
363.48 
±503.42 
0.10 Decrease Decrease 97.10 
434.50 
±569.58 
0.10 0.81 
66.58 ±8.33 0.10 Increase Increase 114.29 0.15 0.58 
944.74 ±23.26 1.20 Increase Increase 1092.12 1.24 0.87 
AbC3c 
 
100.05 ±3.75 
73.26 
±23.40 
0.13 Decrease Increase 132.95 
99.36 
±29.48 
0.10 0.75 
62.94 ±2.79 0.14 Decrease Decrease 87.35 0.15 0.72 
56.79 ±3.94 0.11 Decrease Increase 77.79 0.12 0.73 
AbHPF 
 
1563.94 
±260.34 667.88 
±788.57 
2.36 
Increase Decrease 2703.13 
1099.50 
±1398.35 
3.75 0.58 
360.03 ±27.53 0.44 Decrease Decrease 460.89 0.51 0.78 
79.68 ±7.30 0.18 Decrease Decrease 134.47 0.23 0.59 
CoTCPc 
AbHSA 63.77 ±8.50 --- 0.04 Decrease Increase 86.85 --- 0.04 0.73 
AbC3c 315.79 ±15.71 --- 0.27 Increase Increase 366.37 --- 0.27 0.86 
AbHPF 1292.69 ±24.04 --- 1.07 Increase Increase 1625.92 --- 0.99 0.80 
a: Probe antibody for the detection of adsorbed HSA (AbHSA), complement factor C3 (AbC3c), and HPF(AbHPF) 
b: Sauerbrey-determined film parameter.  Standard deviation is obtained from 3 overtone responses. 
c: Antibody probe mass as a proportion of total blood protein mass 
d:  Viscoelastic film parameters indicating film rigidity levels 
e: Indicates level of film hydration 
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Human Serum Albumin Detection 
Analysis of AbHSA probe binding to the blood protein coat deposited on the MPc films, 
suggests; through Sauerbrey analysis the GePcSmix coated surface demonstrates the highest 
level of bound and exposed HSA, followed by CoPcSmix, ZnPcSmix, CuTSPc, AlPcSmix, and 
CoTCPc-modified surfaces; through Voigt analysis, GePcSmix, again, demonstrates the 
highest level of HSA, followed by CuTSPc, CoPcSmix, ZnPcSmix, CoTCPc, and AlPcSmix-
modified surfaces (Table 3.8).  However, analysis of the probe antibody, as a proportion of 
the total blood protein bound (Abm/BPm), suggests high levels of HSA were deposited on the 
GePcSmix-modified surface, followed by CoPcSmix, CuTSPc, AlPcSmix and CoTCPc-modified 
surfaces (Table 3.8).  The categorisation of ZnPcSmix-modified surfaces was influenced by 
the low reproducibility of the probe antibody binding results, however, two out of the three 
replicants indicate similar results, suggesting ZnPcSmix surfaces would demonstrate higher 
levels of HSA in comparison to AlPcSmix, but lower levels in comparison to CuTSPc     
(Table 3.8).  The levels of AbHSA (Abm/BPm) adsorbed to the MPc-modified surface did not 
exceed that of the positive control (i.e. AbHSA-modified surface) levels (Chapter 2; Table 2.6).  
 
According to Figure 3.9, similar Abm/BPm responses were recorded for the CoPcSmix and 
CuTSPc-modified surfaces.  Both the above mentioned films were concluded to be composed 
of a monolayer of planar orientated MPc molecules, therefore exposing the hydrophobic ring 
structure to a large extent.  According to the preliminary planar surface studies (Chapter 2; 
Section 2.3.2.3) higher levels of AbHSA (Abm/BPm) were recorded on hydrophobic gold in 
comparison to negatively charged MUA.  However, the immobilised MPc films demonstrated 
differences in the film interface (Table 3.3; ave. f % CV).  This leads one to consider that 
surface charge carries a greater influence over HSA binding in comparison to surface 
topography and chemical composition. 
 
The CoTCPc film immobilised for the detection of HSA was concluded to be a monolayer 
composed of edge-on orientated molecules.  Lower levels of AbHSA binding (Abm/BPm) were 
recorded in comparison to that of the planar orientated CoPcSmix surface.  An explanation for 
this occurrence may be the decrease in surface hydrophobicity of the CoTCPc surface, as 
CoTCPc immobilisation analysis suggested the edge-on conformation was adopted.  This 
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edge-on conformation is predicted to result in a higher negative surface charge in comparison 
to the aromatic planar conformation.  This increase in negative charge corresponds with the 
preliminary studies (Chapter 2; Section 2.3.2.3). 
 
Reproducibility 
Although analysis of the surface modification process with ZnPcSmix revealed similar surface 
topographies of the deposited films, large variations were observed when assessing the HSA 
binding, via the proposed method of utilising AbHSA as a probe (Figure 3.9).  Higher levels of 
AbHSA binding were detected on the MPc film which demonstrated the sharpest interface 
(ave. Δf % CV: 4.39), of which the MPc orientation analysis suggested a film composed of 
mixed orientated MPc molecules. Lower levels of binding were reported on films which 
demonstrated slightly rougher film interfaces.  According to literature, HSA has a greater 
affinity towards negatively charged surfaces, as well as hydrophobic over hydrophilic 
surfaces [18, 96].  As sulphonated MPc molecules are comprised of both hydrophobic and 
hydrophilic portions, therefore variations in the orientation of the MPc molecules on the 
surface may greatly influence the surface charge characteristics [104].  Without further 
knowledge of the MPc film surface charge, it is uncertain if the detection of HSA binding to a 
target surface, utilising the proposed QCM-D method, has a low reproducibility, or in fact if 
it is due to the variability of the MPc surface formation. 
 
  
 Figure 3.9. Sauerbrey- (I) and Voigt- (II) determined adsorbed anti-human albumin mass, as a 
proportion of total blood protein mass, versus immobilised MPc film interface 
property. The MPc film interface property illustrated is the average f percentage 
coefficient of variation. 
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Human Serum C3c Detection 
According to Sauerbrey analysis of AbC3c probe binding, GePcSmix, demonstrated the highest 
level of total antibody bound, followed by CoTCPc, AlPcSmix, CoPcSmix, ZnPcSmix, and 
CuTSPc-modified surfaces.  Voigt analysis, however, suggests a different trend where 
GePcSmix demonstrates the highest level of antibody binding, followed by CoTCPc, 
CoPcSmix, ZnPcSmix, AlPcSmix, and CuTSPc.  Evaluation of AbC3c binding, and therefore 
subsequent detection of complement C3, utilising the Abm/BPm values, suggests similar 
trends for both the Sauerbrey and Voigt models, where GePcSmix, indicates the highest level 
of detection, followed by CoTCPc, ZnPcSmix, CoPcSmix, and (AlPcSmix or CuTSPc).      
Figure 3.10 illustrates the Sauerbrey- and Voigt-determined adsorbed AbC3c mass, as a proportion 
of total blood protein mass, versus immobilised MPc film interface property.  In each case, the levels 
of AbC3c (Abm/BPm), were within the range of the positive and negative controls (Chapter 2; 
Table 2.6). 
 
The level of complement C3 detected on the AlPcSmix-modified surfaces served as an 
indication of the levels acceptable in the biological system, which would not activate an 
immune response, as sulfonated AlPc preparations have been utilised in biomedical 
application [104].    
 
In conclusion, higher levels of complement C3, in comparison to AlPcSmix, were detected on 
all surfaces, with the exception of the CuTSPc-modified surfaces.  The higher level of 
antibody binding to the CoTCPc surface was unexpected due to the low levels detected on the 
planar orientated CoPcSmix, as the CoTCPc film was assumed to be orientated in the edge-on 
position.  This orientation is expected to expose carboxyl groups to the surface, which are 
known to be non-activating of the complement system [9, 18, 29].   
 
Reproducibility 
Reproducibility analysis, using ZnPcSmix-modified surfaces, revealed similar levels of 
antibody binding, regardless of the variations in MPc film topography (Figure 3.10).  
Detection of complement C3 binding using a probe antibody appears to be more reproducible 
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demonstrating variability below 30%.  The small size of the complement C3c protein may 
have attributed to the higher reproducibility, as it limits the number of antibody molecules 
that may bind to the target protein.   
 
   
Figure 3.10. Sauerbrey (I) and Voigt (II) determined adsorbed anti-human C3c mass, as a 
proportion of total blood protein mass, versus immobilised MPc film interface 
property. The MPc film interface property illustrated is the average f percentage 
coefficient of variation. 
 
Human Plasma Fibrinogen Detection 
Sauerbrey determined AbHPF bound mass suggested the highest levels of exposed HPF 
molecules on surfaces coated with AlPcSmix-coated surfaces followed by CoPcSmix, CoTCPc, 
CuTSPc, GePcSmix, and ZnPcSmix-modified surfaces.  Voigt-determined parameters revealed 
a similar trend, with the exception of ZnPcSmix-modified surfaces demonstrating a higher 
level than GePcSmix-coated surfaces (Table 3.8).  Furthermore, analysis of AbHPF detection of 
surface bound HPF, using Abm/BPm, indicated the highest levels of HPF were deposited on 
the AlPcSmix-modified films, followed by the CuTSPc, CoPcSmix, and either GePcSmix, or 
CoTCPc-modified surfaces (Figure 3.11).  In the case of HPF detection, the levels of AbHPF 
recorded to bind to the MPc-modified surfaces, when assessing Abm/BPm, exceeded that 
generated by the positive control (i.e. AbHPF-modified surface).  This occurrence highlights 
the HPF orientation as a highly influential factor when detecting bound levels using antibody 
probes. 
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Reproducibility 
Detection of HPF on ZnPcSmix-modified surfaces revealed low experimental reproducibility, 
as highly variable levels of target antibody were reported to bind (Figure 3.11).  However, a 
trend was observed, where an increase in surface roughness correlated with an increase in 
antibody binding.  Fibrinogen is reported to be a flexible, elongated (47 x 4.5 x 4.5 nm3) 
protein, which demonstrates an affinity towards hydrophobic surfaces [105, 106].  The structural 
dimensions of the protein may explain the variations observed in AbHPF binding.  The sharper 
surfaces may allow for side-on adsorption of the HPF molecule (planar), while the ‘rougher’ 
surfaces may inhibit this action, therefore resulting in the possibility of conformational 
change, leading to a V-shape orientation, where larger portions of the protein are surface 
exposed, in comparison to the planar orientated molecule. Although this may occur when 
assessing a macro-surface modified with MPc molecules, this is not a realistic representation 
of what may occur when the MPc molecules are solubilised as in PDT application.   
 
However, greater levels of HPF were detected on the surface modified with CoPcSmix
 
molecules in comparison to CuTSPc molecules, even though similar surface topographies 
were observed.  This fact highlights the dependency of HPF binding on chemical 
composition.   
 
   
Figure 3.11. Sauerbrey (I) and Voigt (II) determined adsorbed anti-human fibrinogen mass, as a 
proportion of total blood protein mass, versus immobilised MPc film interface 
property. The MPc film interface property illustrated is the average f percentage 
coefficient of variation. 
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3.4. CONCLUSION 
In summary, the detection of bound HSA, indicated by probe AbHSA bound mass as a 
proportion of the total HS adsorbed mass, demonstrated the following binding trend:  
GePcSmix > CoPcSmix > CuTSPc > ZnPcSmix > AlPcSmix > CoTCPc (Table 3.8).  The 
experimentally determined results therefore suggest that GePcSmix, CoPcSmix, CuTSPc, and  
ZnPcSmix molecules would demonstrate a circulation half-life greater than that of the 
AlPcSmix preparation, which is currently being utilised in biomedical applications 
[49, 56].   
 
The experimentally determined binding trend of complement C3c, and therefore complement 
C3, was recorded as follows:  GePcSmix > CoTCPc > ZnPcSmix > CoPcSmix >              
(CuTSPc and/or AlPcSmix) (Table 3.8). The higher levels of detected adsorbed complement 
C3 on the GePcSmix-, CoTCPc-,  ZnPcSmix-, and CoPcSmix-modified surfaces, in comparison 
to the AlPcSmix-modified surface, suggests the possibility of the surfaces inducing 
complement activation. 
 
HPF protein detection analysis, using AbHPF as a probe molecule, suggested the following 
binding trend when assessing MPc-modified sensor surfaces:  AlPcSmix > CuTSPc > 
CoPcSmix > (GePcSmix or CoTCPc).  Highly variable results were obtained for the 
reproducibility analysis using ZnPcSmix-modified surfaces, however, a correlation between 
the surface topography (i.e. roughness) and HPF detection was identified.   
 
It is important to note, the accuracy of the proposed experimental design in representing real 
life biomolecular occurrences is flawed, as deposited MPc films do not realistically represent 
the MPc surfaces that would be encountered when in dispersed in solution for application in 
PDT.  However, the alternative methods utilised in assessing protein binding present their 
own set of drawbacks.  For example, spectroscopic analysis has been reported to assess 
protein interactions with MPc molecules, such as HSA and AlPcS4 molecules in solution 
[99].   
This technique allows for the analysis of binding kinetics and the identification of binding 
sites, however, it is limited to analysis of one protein, therefore, it may not be utilised as an 
alternative to the proposed method of analysis.  Furthermore, analysis of binding kinetics, 
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utilising a single protein, may be carried out using QCM-D technology [107].  Another means 
of blood protein adsorption analysis on target particles is that of two-dimensional gel 
electrophoresis (2D-PAGE) [10].  This method, however, requires extensive sample 
preparation, which is both time consuming and financially costly, in addition to the method 
demonstrating ‘false-positives’.   
 
In addition, MPc molecules, deposited in a film arrangement, have been reported to 
demonstrate application in biosensors, as electrocatalysts for biologically significant 
molecules, for example lactate and nitric oxide [55, 108].  The analysis of the biomolecular 
interactions that occur at the MPc film interface are therefore of great importance in sensor 
design, and optimisation. 
 
In terms of experimental reproducibility, MPc immobilisation is of the greatest concern.    
High variability was reported, even when assessing identical MPc preparations, chiefly when 
immobilising MPc samples which demonstrated aggregation in the sample buffer, PBSMg/Ca, 
such as AlPcSmix, GePcSmix and ZnPcSmix.  Possible means of improving immobilisation 
reproducibility may be through chemical modification of the MPc molecule itself, dispersal 
of the MPc molecules to limit aggregation, or alterations to the deposition process, such as 
electrochemical deposition or SAM composition modifications.   
 
Chemical modification of the MPc molecules may be achieved through altering ring 
substituents to promote more controlled binding to a chosen SAM surface, therefore limiting 
random immobilisation.  An example of such modifications may include the introduction of 
an amine group to a chosen number of substituent, which will be immobilised on a carboxyl 
terminating SAM, such as a mercapto undecanoic acid SAM.  However, problems associated 
with this technique may arise when assessing MPc preparations with tri-, di- and      mono-
substitutions, as control over the position of the substituent modification is challenging.  
Chemical modifications, if not strictly regulated and assessed, may result in interference with 
protein binding analysis.   
 
102 
 
Addition of surfactants, such as sodium dodecyl sulphate (SDS) and Triton X-100, although 
resulting in monomerisation of the MPc aggregates, is predicted to result in protein 
denaturation of the SAM layer, therefore prohibiting the use protein linkers to aid 
immobilisation  [99, 102].  Chemical modification of the MPc preparation would therefore be 
required to facilitate immobilisation to the gold sensor surface.   
 
Electrochemical deposition of the MPc molecules to the sensor surface has been reported to 
achieve immobilisation with high reproducibility [109].  Although this deposition may be 
achieved utilising Electrochemical Quartz Crystal Microbalance (E-QCM) technology, 
extensive optimisation of the immobilisation process will be required.  Alterations to the 
composition of the SAM, such as utilisation of various length linkers, may aid in the control 
of the immobilisation of the MPc molecules, however, optimisation would be required for 
each MPc samples, therefore extending experimental time.  The aim of the proposed method 
of protein detection is to develop a rapid means of assessment. Introducing a sample 
preparation step would therefore eliminate this aspect of the experimental procedure. 
 
Additionally, reproducibility of the level of blood protein adsorption appears to be reliant on, 
not only surface charge and composition, but also MPc film topography.  Although this level 
varies, it is not an indication of alterations to the composition, and patterning, of the adsorbed 
protein coat. 
 
Analysis of AbHSA, for the detection of adsorbed HSA, suggests low reproducibility of the 
method, however, this may not be the case, as variations in MPc surface charge may greatly 
influence HSA binding.  Moreover, the low reproducibility may be due to conformation 
changes in HSA following adsorption to the MPc film.  Further analysis into HSA adsorption 
to each surface, as an independent protein, would be required to assess conformational 
changes.  Detection of complement component C3c was reported to be a more reproducible 
process, while HPF results suggested fibrinogen binding is dependent on surface topography.  
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In conclusion, with optimisation of the immobilisation process, and analysis of the effect of 
adsorption on target protein conformation, QCM-D technology may be utilised for the 
detection of target proteins adsorbed to MPc molecules, through target antibody binding. 
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CHAPTER 4:   
IMPORTANCE OF NANOSTRUCTURES IN BIOMEDICAL APPLICATION: 
CARBON NANOTUBES 
 
4.1. INTRODUCTION 
4.1.1. Multi-Walled Carbon Nanotube Functionalisation 
CNT surface functionalisation through chemical oxidation not only increases CNT dispersion 
(by increasing hydrophobicity), but also promotes CNT purification, via oxidation of 
synthesis catalysts, such as Fe, Ni, V and Y, as well as removing amorphous carbon [110].  For 
the purpose of this research, given the wide utilisation thereof, two methods of acid 
functionalisation were of immediate interest, where CNTs were functionalised through 
oxidation using nitric and sulphuric acid, and nitric acid alone during extended 
ultrasonication.  Figure 4.1 schematically illustrates the acid functionalisation of CNTs 
through these two methods.   
 
Nitric and sulphuric acid functionalisation of the CNTs results in the ‘cutting’, and 
exfoliating of the CNT walls, as well as functionalising the CNT sidewalls with carboxyl 
groups [76].  Initial functionalisation of the nanotubes occurs at end cap defect sites, which 
results from hexagon-heptagon pair strain.  Removal of the end caps is rapid, generating 
open-ended tubes bearing carboxyl substituents.  The ‘cutting’ of the CNTs is a result of the 
‘attacking’ of the nanotubes surface by high temperature microscopic domains generated by 
cavity bubbles collapsing, during sonication.  This ‘attacking’ of the nanotubes generates 
defect sites, which are susceptible to chemical oxidation, and therefore functionalisation, 
producing carboxylic acid groups [76].  The second method employed involves the mild 
oxidation of the CNTs in nitric acid.  Unlike the nitric and sulphuric acid functionalisation, 
this process does not ‘cut’ the nanotubes, or functionalise the side walls, rather, it results in 
the functionalisation of the nanotube ends with the carboxyl groups, through cap digestion 
[75].  This second method results in longer tubes with less surface exposed carboxyl groups, in 
theory.  The functionalisation of the CNTs with carboxyl groups generates a net negative 
charge on the nanoparticle and increases the CNT hydrophilic nature, which aids in particle 
dispersal through electrostatic repulsion [75].  Both afore mentioned acid functionalisation 
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techniques result in the exfoliation of the CNT walls and the removal of the metal impurities 
and amorphous carbon, and subsequently increasing the purity of the CNT sample [75, 76].   
 
Figure 4.1.  Schematic representation of the chemical oxidation functionalisation of CNTs.    
 
4.1.2. Chapter Aims and Objectives 
The aim of this section of research was to assess the applicability of the proposed method of 
protein detection, using QCM-D technology, for functionalised MWCNT biocompatibility 
analysis. 
 
Objectives 
1. Chemically functionalise MWCNTs via chemical oxidation using nitric and sulphuric 
acid (a:FMWCNTs), and nitric acid alone (b:FMWCNTs) 
2. Characterise the FMWCNTs in terms of chemical functionalisation-induced 
morphological changes 
3. Immobilise FMWCNT to the gold QCM-D sensor surface to produce FMWCNT-
modified surfaces 
4. Monitor and quantify blood protein adsorption to the prepared FMWCNT-surfaces, 
using QCM-D 
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5. Monitor and quantify probe antibody binding to the previously prepared blood 
protein coated surfaces, using QCM-D 
 
4.2. INSTRUMENTATION AND METHODOLOGY 
 
4.2.1. Instrumentation 
MWCNT functionalisation involved the utilisation of centrifugation using a Beckman Coulter 
(Avanti J-E) centrifuge, and heat drying of the final FMWCNT preparations using the Prolab 
PL001 oven.  Characterisation of the morphological changes in multi-walled carbon 
nanotubes, as a result of acid functionalisation, was carried out using Joel Transmission 
Electron Microscopy   (Jem-1210; 110 kV).   
 
4.2.2. Additional Reagents 
MWCNTs utilised were purchased from Sigma-Aldrich (> 90% purity).  The dimension of 
the stock of MWCNTs is as follows:  outer diameter of 10-15 nm, inner diameter of 2-6 nm, 
length of 0.1-10 μm.  Acid functionalisation of the MWCNTs was performed using 
concentrated sulphuric acid (95%; Merck), and nitric acid (55%; Merck). 
 
The buffer utilised in the immobilisation of the acid functionalised MWCNTs, and 
carboxylated metallophthalocyanines, was 2-(N-morpholino)ethanesulfonic acid         
(Sigma-Aldrich), commonly known as MES.  50 mM MES buffer solutions, prepared using 
MilliQ water, were adjusted to a pH value of 4.7 using 0.2 mM KOH.  MES is reported as an 
optimum buffer for ethyl(dimethylaminopropyl) carbodiimide (EDC) and                             
N-hydroxysuccinimide (NHS) activity, due to the lack of phosphate ions.   
 
4.2.3. Methodology 
4.2.3.1. Acid Functionalisation of Multi-Walled Carbon Nanotubes 
Chemical oxidation through ultrasonication in concentrated sulphuric and nitric acid was 
undertaken.  Acid functionalisation was employed to allow for immobilisation on the crystal 
surface, as well as increasing the CNT purity.   
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The protocol carried out on MWCNTs for carboxyl functionalisation involved the dissolution 
of the CNTs in either a 1:3 solution of 55% nitric acid and 95% sulphuric acid                        
(a:FMWCNTs), or pure 55 % nitric acid (b:FMWCNTs), in a concentration of 0.03 g/ml of 
CNTs.  The solution was ultrasonicated, while covered, for periods of 2, 4, 6, 8 and 24 hrs, in 
the case of a:FMWCNTs, and 4, 8, 12, 20 hrs, in the case of b:FMWCNTs.  Following 
sonication, MilliQ water was added to make up a volume of approximately 250 ml.  This 
MWCNT solution was then centrifuged at a speed of 12 000 rpm for a period of 15 min, at 
4°C.  The supernatant was removed and replaced with MilliQ water.  Centrifugation was 
repeated until a supernatant with approximately pH 7.0 was obtained.  Once the final 
supernatant was removed, the CNT solution was heat dried at 70.0°C to obtain functionalised 
multi-walled carbon nanotubes (FMWCNTs). 
 
4.2.3.2. Characterisation of Acid Functionalised Multi-Walled Carbon Nanotubes 
Characterisation of non-functionalised and acid functionalised (a:FMWCNTs and                 
b:FMWCNTs) to monitor structure and texture changes was carried out using Transmission 
Electron Microscopy (TEM).  0.1 mg/ml suspensions of each sample were prepared in 
ethanol.  Prior to analysis, CNT solutions were ultrasonicated (S10H Elmasonic) for a period 
of 10 min to fully disperse the MWCNTs.  The prepared FMWCNT ethanolic solutions were 
drop-dried on carbon coated copper grids, and visualised using TEM. 
 
4.2.3.3. Surface Modification with FMWCNTs 
The immobilisation of FMWCNTs was facilitated via the formation of amide bonds between 
the nanoparticle carboxyl group and 11-amino undecane thiol (11-AUT) SAM terminating 
amine groups, mediated by EDC/NHS.  The production of the NHS-activated molecule has 
been reported to be achieved in reduced time using an MES buffer at the optimum pH of 
approximately 5.0, while the stability of the NHS-activated molecules ester group is 
substantially decreased above pH 5.0. Hence the immobilisation was performed in MES 
buffer at pH 4.7 [77].  Figure 4.2 schematically illustrates the linking action of EDC/NHS in 
the immobilisation of FMWCNTs to 11-AUT SAM-modified gold sensor surface. 
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Figure 4.2.  Schematic representation of the EDC/NHS activity in immobilisation of FMWCNTs 
to 11-AUT SAM-modified surface. 
 
As illustrated in Figure 2.2, carboxyl functionalised MWCNT incubation with EDC and NHS 
(A), results in the formation of a highly reactive, and unstable, acylurea derivative, which 
forms a stable ester in the presence of NHS (B).  In the presence of an amino group           
(i.e. 11-AUT SAM), a nucleophilic substitution reaction occurs between ester and the amino 
group, resulting in the formation of an amide bond, and therefore the generation of 
FMWCNT-modified surface (C) [111]. 
 
The immobilisation protocol for FMWCNTs onto the 11-AUT SAM was performed ex situ, 
due to concerns regarding aggregation of the FMWCNTs in situ for QCM-D.  FMWCNTs 
suspensions were prepared by ultrasonicating dried FMWCNTs in MES buffer (pH 4.7) for a 
period of 30 min.   15m M EDC and 15m M NHS was then introduced to the suspension, to 
activate the carboxyl groups.  The FMWCNTs-EDC/NHS solution was ultrasonicated, in the 
dark, for a period of 30 min prior to the introduction of 11-AUT SAM modified sensor 
crystals.  Immobilisation was allowed to take place for approximately 12 hrs before rinsing 
the nano-modified surface with ethanol and water, and then drying with nitrogen gas.   
 
4.2.3.4. QCM-D Monitoring and Quantification 
For the determination of blood protein binding, and subsequent probe antibody binding, to 
acid functionalised MWCNTs a similar approach was utilised as to that used for protein 
analysis of various surfaces (Chapter 2; Section 2.2.4).  
 
A                                                              B                                                                               C 
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4.3. RESULTS AND DISCUSSION 
Section 4.3.1 investigates the visible surface changes, and changes in particle dispersion, of 
MWCNTs, as a result of chemical oxidation.  Section 4.3.2 assesses the interaction between 
the FMWCNT-modified surface and blood proteins, namely HS and HP, using QCM-D.  
Section 4.3.3 focuses on the QCM-D aided detection of HSA, complement C3c, and HPF 
through the antibody-antigen specific interactions, in a similar manner as outlined in     
Chapter 2.3.1. 
 
4.3.1. Characterisation of Acid Functionalised Multi-Walled Carbon Nanotubes 
Transmission Electron Microscopy (TEM) was utilised to monitor aggregant morphological 
changes of the MWCNTs as a result of acid functionalisation.  This means of assessment has 
been well documented in literature [112-114]. 
 
Figure 4.3. illustrates TEM imaging of non-functionalised MWCNTs, which served as a 
comparison for the FMWCNT preparations.  According to TEM results, non-functionalised 
MWCNTs indicated tightly associated agglomerates of MWCNTs, with finer tubules 
protruding from the mass (Figure 4.3: A).  Large rod-shaped structures were also observed, 
which were assumed to be CNT aggregates, where the tubules are orientated parallel to one 
another, and possibly coated with sample contaminants, namely, metallic catalysts and 
amorphous carbon, as observed in the rough, nodular nature of the structure surfaces    
(Figure 4.3: B).   
 
Several characteristics of the CNT structure have been reported to result in the formation of 
nanotube aggregates, firstly, CNTs are reported to be hydrophobic in nature, therefore 
resulting in nanotube aggregation through Van der Waals interactions, secondly, CNTs have 
displayed a tendency to wrap around the metal catalysts introduced during the synthesis 
process, and thirdly, the long, thin nature of the tubules permits entanglement during 
synthesis, generating congeries [115-118].  Acid functionalisation of the CNTs, using nitric and 
sulphuric acid, aimed at improving nanotube dispersion, has been well documented in        
literature [75, 112].   
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A      B  
Figure 4.3.  Transmission Electron Microscope imaging of non-functionalised MWCNTs.  Scale 
bars are represented by the white line bottom left of each image. 
 
Figure 4.4 illustrates the TEM images of MWCNTs chemically oxidised, using nitric and 
sulphuric acid, for periods of 2 hrs, 4 hrs, 6 hrs, 8 hrs, and 24 hrs (a:FMWCNs).   
 
 
 
 
                    Scale:  500 nm                                           Scale:  1000 nm 
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2 hrs 
 
A  
 
B  
Scale:  5000 nm Scale:  2000 nm 
4 hrs 
A  B  
Scale:  5000 nm Scale:  2000 nm 
6 hrs 
A  B  
Scale:  5000 nm Scale:  2000 nm 
8 hrs 
A  B  
Scale:  2000 nm Scale:  2000 nm 
24 hrs 
A  B  
Scale:  2000 nm Scale:  2000 nm 
Figure 4.4.  Transmission Electron Microscopy images of nitric acid and sulphuric functionalised 
MWCNTs (a:FMWCNTs).  Acid treatment times ranged from 2 hrs to 24 hrs. Scale bars are 
represented by the white line bottom left of each image.  Arrows are discussed in text. 
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Noticeable changes were observed in the structure of the CNTs following the 2 hr chemical 
oxidation (Figure 4.4; 2 hrs).  Tubules appeared thicker in diameter, suggesting aggregation 
in a parallel orientation, and shorter in length, indicating the ‘cutting’ action of the nitric and 
sulphuric acid has occurred.  In addition, nodules were observed, predominantly at the tubule 
ends, indicating the presence of defect sites due to the oxidation process (arrow in         
Figure 4.4; 2 hrs B).  Following 4 hrs of oxidation, an increase in dispersal of the 
a:FMWCNT preparation was observed, along with an overall decrease in the size of the 
nodules, tubule diameter and length (Figure 4.4; 4 hrs B).  It is important to note the high 
level of variability, in terms of CNT length, following chemical oxidation with nitric and 
sulphuric acid.  This high variability highlights reproducibility as a possible problem area 
when assessing biological interactions with the functionalised preparations.  
 
Six hrs of chemical oxidation resulted in FMWCNT samples composed of a mixture of 
aggregates demonstrating both thick and thin diameters (Figure 4.4; 6 hrs).  The overall level 
of defect sites present on the tubules, observed as nodules, decreased, in comparison to the 
FMWCNT sample treated for 4 hrs, as defect sites due to the cutting action of the acid 
treatment to shorten the CNTs.  This was observed in the lack of nodules present on the 
majority of the open-ended tubules (arrow in figure 4.4; 6 hrs A).  Furthermore, fine tubules 
were observed protruding from the surface of the thicker tubules, indicating detangling of 
individual CNTs from the MWCNT aggregate (arrow in figure 4.4; 6 hrs B).  Following 8 hrs 
of acid functionalisation, CNTs displayed separation of tubules from the aggregates more 
frequently (arrow in figure 4.4; 8 hrs A), along with a decrease in nodules present on the 
surface.  24 hrs of functionalisation, with nitric and sulphuric acid, resulted in the overall 
shortening of the tubular length (Figure 4.4; 24 hrs A), and indicated further increase in 
dispersion, observed as the presence of finer tubules protruding from the aggregates (arrow in 
figure 4.4; 24 hrs B).  In addition, large aggregates of contamination were observed, assumed 
to be amorphous carbon that has been exfoliated from the CNT surface and degradation 
products of CNT oxidation. 
 
In general, acid functionalisation of MWCNTs, utilising nitric and sulphuric acid, resulted in 
an increase in particle dispersal, and a decrease in observed nanotube length, which 
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corresponded to an increase in functionalisation time (Figure 4.4).  These observations 
correlate with literature [112, 113, 117]. 
According to literature, nitric acid functionalisation of CNTs is limited to surface exfoliation 
and carboxyl functionalisation of the tubule ends [2].  Figure 4.5 illustrates the TEM images 
visualising the structural changes of MWCNTs as a result of chemical oxidation with nitric 
acid for the periods of 4 hrs, 8 hrs, 12 hrs and 20 hrs (b:FMWCNT).   
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4 hrs 
 
A  
 
B  
 Scale:  1000 nm Scale:  500 nm 
8 hrs 
A  B  
 Scale:  1000 nm Scale:  200 nm 
12 hrs 
A  B  
 Scale:  500 nm Scale:  1000 nm 
20 hrs 
A  B  
 Scale:  1000 nm Scale:  500 nm 
Figure 4.5.  Transmission Electron Microscopy images of nitric acid functionalised MWCNTs 
(b:FMWCNTs).  Nitric acid treatment times ranged from 4 hrs to 20 hrs. Scale bars are 
represented by the white line at bottom left of each image.  Arrows are discussed in text. 
 
The changes observed in the nanotube structure following nitric acid functionalisation 
(Figure 4.5), were less apparent in comparison to the changes observed during 
functionalisation using nitric and sulphuric acid (Figure 4.4). Following 4 hrs of chemical 
oxidation with nitric acid, fine tubules were present, similar to those observed in the pristine 
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MWCNT sample (Figure 4.3; A).  Surface defects were visible on the nanotube surface, 
which were observed as nodules (arrows in figure 4.5; 4 hrs A).  However, an increase in 
particle dispersion was noted, including the presence of contamination aggregates, assumed 
to be amorphous carbon and metallic catalysts (Figure 4.5; 4 hrs B).  Fine tubules were 
observed to protrude from the latter aggregates.  It has been documented that nanoparticle 
aggregates of amorphous carbon surround the CNTs when functionalising with nitric acid 
alone [75].  The detanglement of nanotubes may be explained by the decrease in surface 
contaminants, and increase in carboxylation at the site of the tubule ends [112, 113].  8 hrs of 
acid functionalisation resulted in an increase in nanotube dispersions, and the generation of 
smaller aggregates of amorphous carbon (Figure 4.5; 8 hrs) 
 
A noticeable increase in nanotube dispersion was observed following functionalisation for   
12 hrs, where individual tubes were observed in isolation (Figure 4.5; 12 hrs).  Defects sites 
were still visible on the surface of the nanotubes, as indicated by the arrow in                 
Figure 4.5; 12 hrs A.  Similar observations were recorded for the FMWCNT sample 
following 20 hrs of functionalisation.  However, surface defects were observed in the 
nanotube structure, which were unique to the 20 hr preparation.  The latter defects were 
observed as ‘kinks’ in the nanotube structure, resulting in a helical conform (arrows in   
Figure 4.5; 20 hrs B).  It was therefore unexpected to visualise alterations on the tubule 
surface walls.  A possible explanation for the presence of these defects is due to interactions 
between the metal catalyst and the nanotube surface, resulting in the CNTs wrapping around 
the impurities. 
 
In conclusion, nitric acid functionalisation of MWCNTs was observed to increase particle 
dispersal, as functionalisation time increased.  This increase in particle dispersal indicates the 
effective exfoliation of the nanotube surface, removing impurities, and/or confirming 
carboxyl functionalisation. 
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4.3.2. QCM-D Analysis of Biomolecular Interactions with FMWCNT-Modified 
Surfaces  
Surface modification analysis of the 11-AUT SAM surfaces with the acid functionalised 
MWCNTs was not carried out using QCM-D monitoring, due to aforementioned physical 
limitations of the QCM-D system, and similar such techniques, e.g. SPR. Immobilised 
FMWCNT film parameters, such as film mass, thickness, viscosity and shear modulus, were 
therefore unattainable.  Following surface modification, using the prepared FMWCNT, blood 
protein adsorption, and subsequent probe antibody binding was analyses using QCM-D. 
 
4.3.2.1. QCM-D Monitoring and Quantification of Blood Protein Adsorption on 
FMWCNT-Modified Surfaces 
The film surface characteristics of the blood protein coating, subsequently adsorbed to the 
FMWCNT-modified surface, were utilised as an indication of firstly, the effectiveness of the 
EDC/NHS immobilisation of FMWCNT on the SAM surface, and secondly to obtain a crude 
indication of the film surface topography, in addition to providing a means of protein 
detection.   
 
Table C.1 presents the relevant frequency (f) and dissipation (D) responses recorded for blood 
protein adsorption to the FMWCNT-modified surfaces as a function of acid functionalisation 
time and treatment method (a: H2SO4:HNO3; and b: HNO3).  Of interest were the f/D values 
derived from overtones 7, 9, and 11, and the average f and D responses.  In general, f/D 
values greater than 10 were recorded, suggesting the deposition of fairly rigid films, in 
addition to validating the utilisation of the Sauerbrey model.  Furthermore, low coefficient of 
variation percentages were determined, on average, from the f shifts, indicating the sharp 
nature of the blood protein coat interface. Deviations from the general trends are proposed to 
be the result of the highly varied nature of the FMWCNT immobilised film. 
 
Sauerbrey- and Voigt-determined film parameters of the blood protein coat are summarised 
in Table 4.1.  In each case, the adsorbed blood protein films were reported to be fairly rigid in 
nature, as indicated by the high film viscosity and shear moduli recorded.  Furthermore, 
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varying degrees of film hydration were reported (Sauerbeymass/Voigtmass) between the 
modified surfaces, suggesting varying degrees of protein denaturation occur between the 
surfaces. It is important to note that the accuracy of film analysis using the viscoelastic model 
(i.e. Voigt model), is questionable, as the FMWCNT immobilised films are not in compliance 
with the requirements of the mathematical model.  In particular, due to the length variations 
noted in TEM, the film is not laterally homogeneous or infinite, and not                              
thin-film [Alternative Reference 1].   
 
Table 4.1.  Sauerbrey and Voigt Modelled Analysis of Blood Protein Adsorption on FMWCNT-
Modified 11-Amino Undecane Thiol SAM Surfaces 
FMWCNT a 
Sauerbrey Model Voigt Model 
Sauerbreym d 
Voigt m 
 
Areal Mass 
(ng/cm2) b 
Ave. Mass 
% CV 
Viscosity 
(kg/m.sec) c 
Shear 
Modulus 
(Pa) c 
Areal Mass 
(ng/cm2) 
Ave. Mass 
% CV 
2 a:fMWCNT 
HS 622.66 ±14.59 
5.57 
2.28E-03 8.03E+04 1168.24 
25.86 
0.53 
HS 673.76 ±21.91 3.88E-03 8.37E+05 807.03 0.71 
HP 1138.30 ±25.55 --- 4.37E-03 4.51E+05 1461.81 --- 0.86 
4 a:fMWCNT 
HS 684.15 ±22.28 
20.22 
2.99E-03 3.96E+05 956.87 
4.84 
0.88 
HS 513.00 ±22.13 2.11E-03 2.50E+05 893.60 0.89 
HP 781.59 ±25.92 --- 2.57E-03 2.97E+05 1210.98 --- 0.83 
6 a:fMWCNT 
HS 762.42 ±19.52 
1.52 
3.59E-03 1.04E+06 883.06 
1.32 
0.57 
HS 778.95 ±27.88 4.01E-03 1.14E+06 899.66 0.87 
HP 827.38 ±18.8 --- 2.97E-03 2.02E+06 867.28 --- 0.85 
8 a:fMWCNT 
HS 536.20 ±20.98 
30.12 
3.87E-03 1.29E+06 610.16 
32.16 
0.86 
HS 826.36 ±25.66 3.78E-03 9.64E+05 969.32 0.78 
HP 682.58 ±47.68 --- 3.00E-03 1.09E+06 865.82 --- 0.65 
24 a:fMWCNT 
HS 326.27 ±6.31 
53.21 
5.44E-03 1.23E+06 367.05 
55.08 
0.95 
HS 719.92 ±13.87 3.82E-03 1.03E+06 835.33 0.79 
HP 511.30 ±8.76 --- 4.51E-03 8.55E+05 601.25 --- 0.85 
4 b:fMWCNT 
HS 768.90 ±37.04 
9.73 
4.14E-03 6.58E+05 950.95 
26.71 
0.81 
HS 882.54 ±27.7 2.83E-03 1.94E+05 1393.82 0.84 
HP 1024.00 ±26.79  4.18E-03 1.13E+06 1164.17 --- 0.88 
8 b:fMWCNT 
HS 784.88 ±19.3 
9.10 
3.89E-03 9.52E+05 932.78 
25.38 
0.78 
HS 892.88 ±19.33 3.05E-03 2.57E+05 1340.72 0.63 
HP 831.26 ±16.79 --- 4.37E-03 7.77E+05 997.44 --- 0.67 
12 b:fMWCNT 
HS 721.32 ±9.87 
7.18 
4.41E-03 2.41E+06 760.88 
2.22 
0.83 
HS 651.59 ±51.22 2.98E-03 9.81E+05 785.10 0.73 
HP 962.66 ±24.49 --- 3.55E-03 5.50E+05 1251.94 --- 0.59 
20 b:fMWCNT 
HS 580.17 ±28.91 9.30 
 
3.35E-03 5.97E+05 746.21 
13.84 
0.83 
HS 661.80 ±26.05 3.07E-03 4.71E+05 908.14 0.77 
HP 928.39 ±304.93 --- 1.86E-03 9.72E+04 1663.58 --- 0.56 
a: Surface modification molecule  and blood protein sample adsorbed to the test surface 
b: Sauerbrey-determined adsorbed mass.  Standard deviation is obtained from 3 overtone responses. 
c:  Viscoelastic film parameters indicating film rigidity levels 
d: Indicates level of film hydration 
 
Analysis of the level of adsorbed blood protein mass, as a function of MWCNT 
functionalisation time is illustrated in Figure 4.6 and 4.7, for a:FMWCNT- and    
b:FMWCNT-modified surfaces, respectively.  Blood protein adsorption to the modified 
surfaces provides a crude means of assessing surface hydrophobicity, as blood proteins are 
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reported to demonstrate a higher affinity towards such surfaces [35].  This observation was 
previously corroborated when assessing HS adsorption to the unmodified gold surface and              
SAM-modified surfaces (Chapter 2; Section 2.3.2.2), where the highest level of HS was 
detected to adsorb to the gold hydrophobic surface.  In general, lower levels of both HS and 
HP were recorded to adsorb to the negatively charged SAM-modified surface (MUA SAM), 
in comparison to the unmodified gold surface.  Therefore, acid functionalisation of MWCNTs 
should, in theory, decrease the level of blood protein adsorption. 
 
 
Figure 4.6.  Sauerbrey- (I), and Voigt- (II) determined adsorbed human serum (Red) and 
human plasma (Blue) protein mass to the nitric and sulphuric acid functionalised 
MWCNT-modified surfaces.  Dashed arrows indicate observed trends. 
 
HS adsorption to the a:FMWCNT-modified surfaces indicated fairly stable level of mass 
addition, independent of the functionalisation time, when assessing the Sauerbrey-determined 
parameter, with the exception of 24 hrs a:FMWCNT prepared surface (Figure 4.6; I), where a 
lower level of adsorbed blood protein was recorded.  Voigt analysis of the adsorbed mass, 
however, indicated a general decrease in mass correlating with an increase in 
functionalisation time (Figure 4.6; II).  As previously mentioned, HS proteins demonstrate a 
greater binding affinity toward hydrophobic surfaces, in comparison to negatively charged 
surfaces.  This decrease in bound HS mass with increasing in functionalisation time, therefore 
suggests the surface, and more specifically the a:FMWCNT sample, increases in negative 
charge, and/or decreases in hydrophobicity, as the functionalisation time is increased.  This 
theory is supported by the TEM imaging results, which displayed an increase in nanotube 
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dispersal with an increase in functionalisation time, indicating a decrease in hydrophobicity, 
and impurities, and an increase in CNT carboxylation (Figure 4.4). 
  
Sauerbrey and Voigt analysis of HP adsorption indicated a general decrease in adsorbed mass 
corresponding with an increase in functionalisation time (Table 4.1).  HP adsorption to planar 
surfaces in the preliminary studies (Chapter 2; Section 2.3.2.2), suggested little variance 
between mass deposition on hydrophobic and negatively charged surfaces.  However, film 
hydration analysis indicated less hydrated HP films (Table 2.5; Sauerbreym/Voigtm) were 
deposited on the hydrophobic planar surfaces, in comparison to negatively charged        
SAM-modified surfaces.  Investigation into the hydration of the HP films adsorbed to the 
a:FMWCNT-modified surfaces (Sauerbeymass/Voigtmass) indicated an apparent increase in 
hydration with an increase in functionalisation time (Table 4.1).  This increase in film 
hydration with increase in functionalisation time, in conjunction with the preliminary analysis 
of adsorbed HP film hydration on planar surfaces, suggests a decrease in hydrophobicity 
and/or increase in negative charge occurs as functionalisation time increases (Table 4.1).  
This conclusion is in agreement with the deduction made from HS adsorption to the 
a:FMWCNT-modified surfaces.   
 
Investigation into reproducibility of the HS adsorption process, between the two prepared 
samples (Table 4.1; Ave. Mass % CV), indicates low levels of Sauerbrey determined HS 
mass reproducibility for the 4 hr, 8 hr and 24 hr a:FMWCNT-modified surfaces, and low 
levels of Voigt determine HS mass reproducibility for the 2 hr, 8 hr and 24 hr      
a:FMWCNT-modified surfaces.  The low reproducibility of the HS adsorption process is 
attributed to the variability of the acid functionalisation products (Figure 4.4), and therefore 
the subsequent variability of the FMWCNT- modified film. 
 
Sauerbrey and Voigt analysis of HS adsorption to the surfaces modified with b:FMWCNTs 
indicated a general decrease in adsorbed mass with increasing CNT-functionalisation time 
(Figure 4.7), which correlates with a decrease in surface hydrophobicity and/or increase in 
the negative charge of the surface, similar to the behaviour observed for a:FMWCNTs.  
Similar levels of reproducibility were determined for the Sauberbrey adsorbed HS mass 
120 
 
(Table 4.1; Ave. Mass % CV), however, reproducibility decreases substantially when 
assessing protein adsorption using the Voigt model, with the exception of the 12 hr and 20 hr 
preparations.  The more favourable reproducibility of HS adsorption to the 12 hr and 20 hr 
b:FMWCNT-modified surfaces, suggests reproducibility is improved with prolonged 
functionalisation.  This increase in reproducibility with increased functionalisation may be 
attributed to the improved, and more uniform dispersion of the b:FMWCNT preparations, as 
well as the increase in the purity of the MWCNT preparations, as observed via TEM analysis 
(Figure 4.5), therefore resulting in more reproducible deposition of the CNTs on the SAM 
surfaces.  
 
HP adsorption to b:FMWCNT-modified surfaces, however, demonstrated a general increase 
in adsorbed mass with an increase in functionalisation time, therefore contradicting the 
previously proposed assumption.  According to the studies performed in Chapter 3       
(Section 3.3.3.1), the adsorption of HPF, a component of HP, is greatly influenced by the 
underlying surface topography.  It is therefore proposed that the unexpected HP adsorbed 
mass trend is the result of the variability in the surface topography of the b:FMWCNTs 
which can itself be partially observed via tracking of topography of attaching protein film.  
The assumption of the latter high variability is supported by the TEM imaging of the CNT 
sample, which indicated a network of tubules was present following each functionalisation 
time (Figure 4.5).  It was therefore necessary to assess protein adsorption in terms of the 
generated HS or HP surface topography (Table C.1;  Ave. f % CV). 
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Figure 4.7.  Sauerbrey- (I), and Voigt- (II) determined adsorbed human serum (Red) and 
human plasma (Blue) protein mass to the nitric acid functionalised MWCNT-
modified surfaces. Dashed arrows indicate observed trends. 
 
Assessment of the blood protein adsorption as a factor of the deposited protein interface 
sharpness is illustrated in Figure 4.8 for a:FMWCNT-modified surfaces. 
 
  
Figure 4.8.  Sauerbrey- (I), and Voigt- (II) determined adsorbed human serum (Red) and 
human plasma (Blue) protein mass to the a:FMWCNT-modified surfaces as a 
function of the blood protein film interface.  The blood protein film interface 
property illustrated is the average f percentage coefficient of variation, which is an 
indication of surface roughness. Dashed arrows indicate observed trends. 
 
The level of HS adsorbed mass (Table 4.1) to the a:FMWCNT-modified surfaces appeared to 
be independent of the film interface topography generated (Table C.1; ave. f % CV), 
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observable by the absence of an apparent trend (Figure 4.8).  HP adsorption demonstrated a 
general decrease in adsorbed mass, with an increase in surface roughness, with the exception 
of 8 hrs and 24 hrs a:FMWCNT samples (Figure 4.8).  These deviation from the general 
trend, exhibited by 8 hrs and 24 hrs sample, may be the result of increased CNT dispersion, 
therefore generating surface topographies different to those of 2 hrs, 4 hrs and 6 hrs prepared 
surfaces (Figure 4.2).  The topography-dependent adsorption of HP (Figure 4.6 and 4.8) 
indicates a more nuanced dependence of protein attachment to surfaces than can be tracked 
using merely bound masses (Figure 4.7). 
 
Both the HS and HP adsorption to the b:FMWCNT-modified surface appeared to be 
independent of the surface topography, with the exception of the 20 hr a: FMWCNT sample 
(Table 4.1).  Surface topographies generated by the immobilisation of b:FMWCNTs is 
predicted to be far more complex than that of the a:FMWCNTs surfaces, due to the long, 
thin, unique fibrous networks present in the b:FMWCNTs preparations assessed via TEM 
(Figure 4.4).  The surface topography-independent adsorption of blood protein to the            
b:FMWCNTs-modified surfaces is therefore concluded to be an effective means of crudely 
assessing surface charge and hydrophobicity. 
 
4.3.2.2. QCM-D Monitoring and Quantification of Probe Antibody Binding 
The f and D shifts observed for the probe antibody binding to the prepared target surfaces, in 
general, indicated highly viscoelastic films were deposited, therefore suggesting the 
underestimation of the adsorbed Sauerbrey-determined film parameters (Table C.2).  Minimal 
deductions could be derived from the f and D responses alone. 
   
Voigt analysis of the deposition of probe antibody films indicated a general decrease in the 
viscoelastic film properties, namely viscosity and shear modulus, in comparison to the 
underlying blood protein film, and varying levels of film hydration (Table 4.2).   The 
anticipated inability of the Voigt-based model to accurately derive the film parameters of the 
deposited protein layers on the FMWCNT-modified surfaces, due to FMWCNT-films via 
Voigt viscoelastic model, therefore inhibits in-depth analysis of the film parameters. 
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Table 4.2.  Sauerbrey and Voigt Modelled Analysis Probe Antibody Binding to Blood Protein 
Coated FMWCNT-modified surfaces 
fMWCNT a Probe b 
Sauerbrey Model Voigt Model 
Sauerbreym f 
Voigt m 
∆ Mass  
(ng/cm2) c  
∆Abm d 
∆BPm 
∆ Viscosity 
(kg/m.sec)  e 
∆ Shear 
Modulus 
(Pa) e 
∆ Mass 
(ng/cm2) 
∆Abm 
∆BPm 
2 a: FMWCNT 
AbHSA 998.49 ±55.86 1.60 Decrease Increase 719.17 0.62 1.39 
AbC3c 32.47 ±6.62 0.05 Decrease Increase 37.72 0.05 0.11 
AbHPF 197.2 ±15.27 0.17 Decrease Decrease 320.07 0.22 0.75 
4 a: FMWCNT 
AbHSA 146.59 ±27.2 0.21 Decrease Decrease 1325.25 1.38 0.72 
AbC3c 32.36 ±2.41 0.06 Decrease Increase 50.34 0.06 0.73 
AbHPF 209.91 ±18.11 0.27 Decrease Increase 319.33 0.26 0.86 
6 a: FMWCNT 
AbHSA 188.53 ±8.71 0.25 Decrease Decrease 250.51 0.28 0.64 
AbC3c 70.96 ±7.55 0.09 Decrease Decrease 94.38 0.10 0.75 
AbHPF 787.03 ±82.58 0.95 Decrease Decrease 981.75 1.13 0.73 
8 a: FMWCNT 
AbHSA 516.14 ±33.02 0.96 Decrease Decrease 720.15 1.18 0.67 
AbC3c 97.17 ±9.29 0.12 Decrease Decrease 132.29 0.14 0.62 
AbHPF 329.99 ±24.65 0.48 Decrease Decrease 468.83 0.54 0.66 
24 a: FMWCNT 
AbHSA 238.52 ±12.4 0.73 Decrease Decrease 326.91 0.89 0.80 
AbC3c 81.2 ±5.29 0.11 Decrease Decrease 121.9 0.15 0.70 
AbHPF 153.66 ±15.56 0.30 Decrease Decrease 270.78 0.45 0.57 
4 b: FMWCNT 
AbHSA 510.8 ±65.52 0.66 Decrease Decrease 954.18 1.00 0.54 
AbC3c 63.91 ±5.87 0.07 Increase Increase 42.35 0.03 0.45 
AbHPF 1153.89 ±79.32 1.13 Decrease Increase 1309.08 0.89 0.88 
8 b: FMWCNT 
AbHSA 237.36 ±37.75 0.30 Decrease Decrease 532.68 0.57 0.54 
AbC3c 50.53 ±9.71 0.06 Decrease Increase 140.22 0.10 1.51 
AbHPF 184.67 ±26.2 0.22 Decrease Decrease 443.34 0.44 0.36 
12 b: FMWCNT 
AbHSA 87.18 ±2.73 0.12 Decrease Increase 81.32 0.11 0.42 
AbC3c 27.26 ±14.03 0.04 Decrease Decrease 65.08 0.08 0.51 
AbHPF 311.46 ±45.07 0.32 Decrease Decrease 742.32 0.59 0.61 
20 b: FMWCNT 
AbHSA 3472.12 ±443.75 5.98 Decrease Decrease 6405.16 8.58 0.42 
AbC3c 12.07 ±3.96 0.02 Decrease Increase 23.48 0.03 0.42 
AbHPF 1294.77 ±35.50 1.40 Decrease Increase 1336.38 0.80 0.97 
a: Surface modification molecule  
b:  Probe antibody for the detection of adsorbed HSA (AbHSA), complement factor C3 (AbC3c), and HPF(AbHPF) 
c: Sauerbrey-determined film parameter.  Standard deviation is obtained from 3 overtone responses. 
d: Antibody probe mass as a proportion of total blood protein mass 
e:  Viscoelastic film parameters indicating film rigidity levels 
f: Indicates level of film hydration 
 
The total Sauerbrey- and Voigt-determined AbHSA binding to the a:FMWCNT- and 
b:FMWCNT- modified surface are illustrated in Figure 4.9; A and B, respectively. A general 
decrease in Sauerbrey–determined adsorbed mass, from 2 hr, to 8 hr and 24 hr samples, with 
an increase in functionalisation time (Figure 4.9; A) was observed, while an increase in probe 
antibody binding was observed from 4 hr to 8 hr samples.  The Voigt-determined adsorbed 
mass indicated a slight difference in trend, where adsorbed AbHSA mass decreased from 4 hr, 
to 8 hr and 24 hr samples, and from 2 hr to 6 hr samples (Figure 4.9; A).  This lack of a 
continuous trend may be either the result of the complex nature of the functionalised 
MWCNT samples, or the nature of the deposited film.  Analysis of AbHSA binding to the 
b:FMWCNT-modified surfaces indicated a general decrease in both the Sauerbrey- and 
Voigt-determined adsorbed mass, corresponding to an increase in time, with the exception of 
the 20 hr sample (Figure 4.9; B).  In the case of a:FMWCNT-modified surfaces, this decrease 
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in HSA detection suggests a decrease in HSA binding on increasingly negative surfaces, 
while the decrease in HSA detection on b:FMWCNTs, with increase in functionalisation 
time, suggests a decrease in HSA binding on increasing exposure of the hydrophobic 
MWCNT sidewalls, due to increase in CNT dispersion. 
 
 
Figure 4.9. Sauerbrey- (Red) and Voigt- (Blue) determined adsorbed anti-human albumin mass 
to the human serum coated a: FMWCNT (A) and b:FMWCNT (B) modified 
surfaces. The 20 hr b:FMWCNT preparation was omitted from the figure B. Dashed 
arrows indicate observed trends. 
 
Due to the complex nature of the FMWCNTs, and their subsequent variable immobilisation 
and blood protein adsorption patterns, it was necessary to assess the antibody adsorption as a 
proportion of the total adsorbed blood protein, therefore eliminating the level of exposed 
CNT surface area as an influencing factor in the deposition of blood proteins.  This was 
achieved via assessing the Antibodymass/Blood Proteinmass (Abm/BPm) value as a function of 
the functionalisation time (Table 4.2).  Figure 4.10 illustrates the Abm/BPm versus 
functionalisation time for AbHSA binding.  This means of assessment generated similar trends 
to that observed when assessing total antibody binding.  However, a more accurate 
comparison to the AbHSA binding results obtained from the analysis of planar surfaces 
(Chapter 2; Section 2.3.2.3) may be made.  
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Figure 4.10.  Sauerbrey- (Blue) and Voigt- (Red) Determined Anti-Human Albumin Adsorbed 
Mass to a: FMWCNT- (▲) and b: FMWCNT- (■) modified surfaces as a 
Proportion of the Total Human Serum Adsorbed Mass.  20 hrs b: FMWCNT was 
omitted from the figure. Dashed arrows indicate observed trends. 
 
Figure 4.10 illustrates a general decrease in Abm/BPm values, when assessing AbHSA binding 
to a:FMWCNT-modified surfaces, from the 4 hr to 8 hr, and 24 hr, and from the 2 hr to 6 hrs 
samples, and AbHSA binding to a:FMWCNT-modified surfaces, from 4 hrs to 8 hrs, and       
12 hrs.    This means of assessment indicated similar results to that of the total adsorbed 
probe antibody mass results, and therefore identical conclusions were drawn, where levels of 
HSA  decreased with increasing negative charge (Figure 4.9; A) and hydrophobicity              
(Figure 4.9; B). 
 
The detected level of HSA absorption, via analysis of Abm/BPm, on FMWCNT-modified 
surfaces, did not exceed that of the positive control (Chapter 2; Section 2.3.2.3), with the 
exception of the 20 hr b:FMWCNTs.  The deviation of the 20 hr b:FMWCNT preparation 
from the general trend may be attributed to the high levels of exfoliated amorphous carbon 
present in solution, following nitric acid functionalisation for an extended period of time. 
This amorphous carbon may be closely associated with the immobilised FMWCNTs, and/or 
may interact directly with the SAM surface, therefore influencing HS protein adsorption, and 
subsequent probe antibody binding. 
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Analysis of the Sauerbrey- and Voigt-determined adsorbed Abm/BPm values, for detection of 
complement factor C3c, on the a:FMWCNTs- and b:FMWCNT-modified surfaces are 
illustrated in Figure 4.11.   
 
Figure 4.11.  Sauerbrey- (Blue) and Voigt- (Red) Determined Anti-Human C3c Adsorbed Mass 
to a: FMWCNT- (▲) and b: FMWCNT- (■) modified surfaces as a Proportion of 
the Total Human Serum Adsorbed Mass.   
 
A general increase in AbC3c binding, with an increase in functionalisation time, when 
assessing a:FMWCNT-modified surfaces, with the exception of the 24 hr sample         
(Figure 4.11) was observed.  AbC3c binding to the protein coated b:FMWCNT-modified 
surfaces, on the other hand, demonstrated a general decrease in the antibody adsorbed mass 
corresponding to an increase in functionalisation time, with the exception of the 4 hr sample.   
 
This increase in AbC3c binding, and therefore complement C3 detection, when examining 
a:FMWCNT-modified surfaces, with increasing functionalisation time, suggests complement 
C3 deposition increases with increasing surface negativity, and/or purity,  and/or the possible 
decrease in surface hydrophobicity.  However, according to complement factor C3 detection 
studies on planar surfaces, and literature, a decrease in Abm/BPm value indicates an increase 
in negative charge on the surface  (Chapter 2; Table 2.6), which therefore contradicts the 
aforementioned increase [40].  One possible explanation for this unexpected occurrence is 
dependent on the nature of the deposited MWCNT film, in terms of both the surface charge 
and orientation of the MWCNTs particles.  It was proposed that the formation of the 
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MWCNT aggregates is due to the hydrophobic nature of the nanotube wall and presence of 
metallic impurities [117].  TEM imaging of the a: FMWCNT samples indicated the CNTs were 
present in the form of rigid rod-shaped aggregates, demonstrating reasonably large tube 
diameters, which were reduced in size with an increase in functionalisation time (Figure 4.2).  
In the case of planar deposition of the a:FMWCNTs aggregates on the SAM surface, the level 
of exposed hydrophobic surface is expected to increase with particle dispersion, and therefore 
with functionalisation time.  This increase in surface hydrophobicity corresponds with the 
experimentally determined increase in AbC3c adsorption as functionalisation time increases. 
 
The experimentally determined bound AbC3c, and therefore adsorbed complement C3 levels, 
deposited on the b:FMWCNT surfaces, indicate a decrease in bound complement C3 levels 
with increase in MWCNT functionalisation time, and therefore increase in negative charge, 
purity, and/or increase in hydrophobicity (in the case of b:FMWCNT-modified surfaces).  
These results correspond with literature, and preliminary studies of planar surfaces, (Chapter 
2; Table 2.6).  The levels of AbC3c bound on the FMWCNT-modified surfaces, in terms of 
Abm/BPm, fall within the range of the positive and negative controls (Chapter 2;           
Section 2.3.2.3). 
 
The Sauerbrey- and Voigt-determined Abm/BPm value for the deposition of AbHPF on the 
FMWCNT-modified surfaces are illustrated in Figure 4.12.   
 
Figure 4.12.  Sauerbrey- (Blue) and Voigt- (Red) Determined Anti-Human Fibrinogen Adsorbed 
Mass to a:FMWCNT- (▲) and b:FMWCNT- (■) modified surfaces as a 
Proportion of the Total Human Serum Adsorbed Mass.   
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A general increase in binding, corresponding with an increase in functionalisation time, for 
both the FMWCNT samples, with the exception of 6 hr and 24 hr a: FMWCNT and 4 hr      
b:FMWCNT surfaces were observed.   Detected adsorbed HPF levels, in terms of Abm/BPm, 
did not exceed that of the positive control surface (Chapter 2; Section 2.3.2.3).  As indicated 
in Table 4.4, hydrophobic surfaces (i.e. gold) demonstrate the highest level of AbHPF/HP 
binding in comparison to hydrophilic SAM surfaces [35, 36].  The experimentally determined 
levels of adsorbed HPF are therefore contradictory to the predicted response to decreasing 
hydrophobicity with increase in functionalisation times.   
 
Surface topography has been indicated as an influential factor influencing the orientation of 
the fibrinogen molecules on the surface, and therefore the level of detected fibrinogen 
(Chapter 3; Section 3.3.3.2).  The high level of variability in both the a:FMWCNT- and 
b:FMWCNT-modified surfaces is therefore a limiting factor in the analysis of HPF 
interactions with FMWCNTs, utilising the proposed method of detection.  An additional 
factor proposed to influence the binding of HPF, and therefore the subsequent AbHPF , in 
terms of protein orientation, is that of surface charge density.  Figure 4.13 schematically 
illustrates the proposed HPF orientation on surfaces demonstrates low surface charge density 
(A), and high surface charge density (B).  Initial adsorption of HPF is reported to occur 
between the HPF αC-domain and the substrate, followed by reorientation of the protein, 
allowing substrate interaction with the D-domains [28].  In the case of HPF adsorption to 
surfaces demonstrating low charge density (i.e. low acid functionalised MWCNTs), the 
planar orientation of the protein is predicted to occur (Figure 4.13; A).  However, adsorption 
of HPF to highly charged surfaces (i.e. highly acid functionalised MWCNTs), the protein is 
predicted to adopt a V-shaped orientation, where larger portions of the protein are surface 
exposed, in comparison to the planar orientated molecule (Figure 4.13; B).  This higher level 
of HPF exposure, predicted to occur on surface modified with highly functionalised MWCNT 
preparations, may explain the increase in AbHPF bound levels.  Although the increase in 
detected HPF levels is due to the charge characteristics of the FMWCNTs, the response is not 
indicative of the ‘real-life’ situation, where the CNT preparations are suspended in solution 
(i.e. blood). 
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Figure 4.13.  Schematic illustration of surface topography on human plasma fibrinogen binding.  
A, and B illustrates the proposed HPF adsorption to surfaces demonstrating low, and 
high negative charge density, respectively.  
 
4.4. CONCLUSION 
The assessment of HS and HP adsorption to the a:FMWCNT-modified surfaces allowed for 
the crude analysis of the surface hydrophobicity and negative charge. However, the surface 
topography-dependence was evident when assessing b:FMWCNTs.  This dependence on 
surface topography emphasises further analysis of the FMWCNT surface is required.  This 
may be achieved by performing preliminary studies on the FMWCNT preparations aimed at 
assessing degree of functionalisation, using Raman Spectroscopy, or via simple acid-base 
titration techniques [76].  Analysis of the deposition patterns of the FMWCNT on the SAM 
surface, to assess surface topography and aggregation, may be addressed using Atomic Force 
Microscopy (AFM) and Scanning Electron Microscopy (SEM) [119]. 
 
In general, the levels of detected HSA deposited to the FMWCNT-modified surfaces 
corresponded with the predicted outcomes, based on the theoretical-based predictions of the 
acid functionalisation of MWCNTs.  Due to the experimentally determined HSA adsorption 
results corresponding with the theoretical predictions, the detection of HSA on      
FMWCNT-modified surfaces, using the proposed QCM-D technique, was therefore 
concluded to be successful in crudely assessing HSA adsorption to nanoparticles.  A decrease 
in AbHSA binding, and therefore HSA adsorbed, was observed with an increase 
functionalisation time on both the a:FMWCNT- and b:FMWCNT-modified surfaces.  HSA 
adsorption is reported to increase the circulation half-life of therapeutic particles, once 
introduced to the circulatory system [18].  The decrease in adsorbed HSA, as a result of acid 
functionalisation, is therefore undesirable.  The proposed HSA detection method,  using 
QCM-D to monitor subsequent antibody binding, may serve as a useful guide to the extent of 
A                                                  B 
FMWCNT-modified 
sensor surface 
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functionalisation (low amounts) which could extend circulation times, as well as aid in the 
design and development of more biocompatible MWCNT preparations. 
 
As observed with AbHSA binding, a decrease in AbC3c binding, corresponding to an increase 
in functionalisation time, was reported on the surfaces modified with b:FMWCNTs, while an 
increase in AbC3c was observed on the a: FMWCNT-modified surfaces.  This decrease in the 
detection of adsorbed complement factor C3c, on b:FMWCNT-modified surfaces, 
corresponds with literature, which reports carboxyl-bearing surfaces as non-complement 
activating [40].  Although the increase in AbC3c observed, with increasing functionalisation 
time, on a:FMWCNT-modified surfaces was unexpected, the occurrence may be explained 
by the increase in CNT dispersion.  The positive correlation between AbC3c binding, and 
subsequent detection of the complement activating potential of the FMWCNT-films, with the 
theoretical prediction, suggests the success of the proposed detection method. 
 
The monitoring and quantification of AbHPF binding to the FMWCNT-modified surfaces, for 
the detection of adsorbed HPF, demonstrated a considerable dependence on the surface 
topography and charge density.  This significant dependence of the immobilisation of the 
target particles, and the subsequent film surface parameters, suggests the proposed method of 
HPF detection is not applicable for MWCNT biocompatibility analysis. 
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CHAPTER 5 
METALLOPHTHALOCYANINE-INDUCED CYTOTOXICITY IN MCF-7 CELL 
LINE 
 
5.1. INTRODUCTION 
5.1.1. Metallophthalocyanine Application in Photodynamic Therapy 
Metallophthalocyanine complexes have demonstrated biomedical application in the 
photodynamic treatment of various cancers, namely, lung, stomach, bladder, skin and 
oesophageal cancer [48].  Therapeutic efficiency of MPc molecules as photosensitising agents 
is owed to their ability to generate reactive oxygen species upon irradiation with visible light 
and their proposed selective localisation within tumours [49, 120].  The physical properties of 
MPc molecules, their application in PDT, and the mechanism of PDT are outlined 
extensively in chapter 4. 
 
According to literature, cellular uptake and biodistribution of the Pc therapeutic is governed 
by the physical properties of the molecules, namely the side chain, composition and position, 
and the nature of the molecules core, i.e. the metal ion [95]. MPc molecules which utilised 
paramagnetic, or open shell metal ions, such as Cu2+, and Co2+ ions, are reported to result in 
the generation of short triplet lifetimes, therefore rendering the molecule photoinactive. 
However, MPc molecules with diamagnetic, or closed shell metal ions, such as Al3+ and Zn2+, 
generate high triplet yields, favourable for PDT [121].   
 
Although aggregation poses a problem with MPc PDT efficiency, due to dissipative loss of 
the electronic energy, this is reported to be hindered via the addition of serum proteins, 
namely serum albumin [49, 95].  Following intravenous administration, hydrophilic MPc 
molecules are reported to adsorb serum proteins, in particular serum albumin, which aids in 
the distribution of the therapeutic within the blood system. Serum albumin, a dominant 
protein that plays a significant role in drug delivery, binds readily to sulphonated MPc 
molecules through electrostatic interactions [95, 122].  The administration of hydrophobic MPc 
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molecules, on the other hand, results in strong binding of lipoproteins, which aids in the 
selective transport of the therapeutic to malignant tissue [123]. 
 
5.1.2. Cytotoxicity of Metallophthalocyanine Molecules 
Cytotoxicity of MPc molecules, following irradiation with visible light, has been well 
documented in literature, however, toxicity studies aimed at particle toxicity, omitting 
irradiation, to my knowledge, has not yet been a research focus [47, 95, 124-126].   
 
Sulphonated AlPc preparations are currently being utilised as a photosensitising agent for the 
photodynamic treatment of various cancers [60, 61, 95, 99].  Their toxicity following irradiation 
exposure, cellular uptake, and biodistribution has been well documented in mammalian cell 
lines, in particular that of AlPcS4 molecules 
[47].  Water-soluble AlPcS4 molecules are 
reported to be free of both systemic and local toxicity, when irradiation is omitted [47, 126].  
The degree of sulphonation has been highlighted as playing a significant role in cellular 
uptake, as an increase in lipophilicity (i.e. decrease in sulphonation) corresponds with an 
increase in cellular uptake [126].   AlPcS4 molecules are reported to demonstrate poor 
penetration in cancer cells, and rather accumulate around the tumour in the connective tissue, 
while AlPcS2 molecules demonstrate efficient penetration, due to their amphiphilic nature 
when ring substituents are adjacently situated [95, 124].   
 
5.1.3. Chapter Aims and Objectives 
Aims 
The following studies address MPc-induced cytotoxicity, in the presence of natural light, 
within the mammalian breast cancer cell line, MCF-7.  The central aim was to test the 
cytotoxicity of the MPc preparations and identify any correlation between the composition of 
the adsorbed blood protein coat, assessed in chapter 4, with the biological response.   
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Objectives 
1. Identification of MPc Interference with Cytotoxicity Analysis 
a. Spectrophotometric analysis of MPc preparations 
b. Spectrophotometric analysis of MTT and WST-1 cell proliferation assays 
2. Validation of the WST-1 cell proliferation assay 
3. Assessment of the cytotoxicity, in natural light, of the MPc preparations 
4. Analysis of the correlation between serum/plasma protein binding, assessed in chapter 
4, and MPc-induced cytotoxicity 
 
5.2. INSTRUMENTATION AND METHODOLOGY 
5.2.1. Instrumentation and Additional Reagents 
Absorbance of the WST-1 and MTT formazan was measured using a spectrophotometric 
microplate reader, Powerwave XS (Bio-Tek Instruments, Inc.) at the test wavelength of 460 
nm and the reference wavelength of 600 nm.  Absorbance spectral scans were performed 
between 200 nm and 999 nm for the detection of MPc absorbance interference. 
 
MCF-7 human mammary epithelial cells were obtained from the American Type Culture 
Collection (ATCC). The cells were cultured in a Dulbecco’s Modified Eagle Medium 
(DMEM) obtained from ATCC, medium supplemented with 5% foetal calf serum, 100 U/ml 
penicillin, 10μg/ml streptomycin, and 25 ng/ml amphotericin B.  MPc preparations were 
initially dispersed in dimethyl sulfoxide (Fluka Chemicals). The cell proliferation reagent, 
WST-1, and cell proliferation kit, MTT, were obtained from Roche, L-ascorbic acid was 
purchased from Sigma. 
 
5.2.2. Methodology 
5.2.2.1. MPc Preparation 
MPc samples were dispersed, via ultrasonication, in DMSO, at a concentration of 1 mg/ml.  
Dilutions were prepared, ranging between 0 – 10 μg/ml, from the DMSO-stock solution using 
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DMEM culture media.  Ultrasonication was performed following each dilution to ensure 
complete dispersal of the MPc molecules. 
 
5.2.2.2. Identification of MPc Interference with Cytotoxicity Analysis 
5.2.2.2.1. Spectrophotometric Analysis of MPc Preparations 
Absorbance spectrophotometric analysis of MPc dilutions prepared in PBSMg/Ca buffer and 
PBSMg/Ca-DMEM was carried out to assess the absorbance detection range of the MPc 
preparations for the identification of possible MPc interference with cytotoxicity analysis.   
 
5.2.2.2.2. Spectrophotometric Analysis of MTT and WST-1 Cell Proliferation 
Assays 
Spectrophotometric analysis of the tetrazoluim salts employed in the MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) and WST-1 (4-[3-(-iodophenyl)-2-
(4-nitrophenyl)2H-5-tetrazolio]-1,3-benzene disulfonated) cell proliferation assays were 
carried out, including analysis of the respective formazan cleavage products.  Cell-free 
reduction of the tetrazolium salts was achieved through the incubation of the tetrazolium salts 
with L-ascorbic acid, for a period of 1 hr.  Ascorbic acid-induced reduction of both the MTT 
and WST-1 tetrazolium salts has been reported in literature [128, 129].  Prior to the absorbance 
measurements of the MTT formazan product, the Solubilisation solution, containing 10 % 
SDS in 0.01 mM HCl, was added and incubated for a period of 1 hr, followed by shaking for 
1 min. 
 
5.2.2.3. MCF-7 Culture Preparation 
All cell cultures were grown in 75 cm3 culture flasks and maintained at 37°C under a 9% CO2 
atmosphere.  For sample preparation, cells were allowed to grow to near confluence, at which 
time cells were washed with PBS buffer (pH 7.4).  Washed cells were detached from the 
flasks by treating with trypsin, followed by centrifugation in DMEM growth media.  The cell 
populations were determined via Trypan blue staining, followed by a cell count using a 
hemocytometer.  
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5.2.2.4. WST-1 Cell Proliferation Assay 
5.2.2.4.1. Validation of WST-1 Cell Proliferation Assay 
For the control experiment, cells were seeded at concentrations ranging from 0 - 6 ×104 
cells/ml into a 96-well microplate plate to a final volume of 100 μl/well, followed by an 
incubation at 37°C and 9% CO2, for a period of 48 hrs.  WST-1 Cell Proliferation Reagent 
was introduced (10 μl/well) and the samples were incubated for a further 6 hrs.  Absorbance 
of the samples was measured at 460 nm (reference λ = 600 nm), following shaking for 1 min.  
 
Analysis of interference of the MPc sample preparation with the WST-1 assay efficiency was 
assessed through performing WST-1 cell proliferation assays of cell-free samples containing 
MPc concentrations ranging from 0 – 10 μg/ml.  Prepared MPc samples were added to the 
microplate wells, to give a final volume of 100 μl/well. WST-1 reagent was introduced and 
incubated for a further 6 hrs. Absorbance of the samples was measured at 460 nm (reference 
λ = 600 nm), following shaking for 1 min.   
 
5.2.2.4.2. Cytotoxicity Analysis of MPc Preparations 
For the study of MPc-induced cytotoxicity, cells were seeded into 96-well microplates at a 
concentration of 6 ×103 cells/well, to a final volume of 50 μl/well.  Prepared sample plates 
were incubated at 37°C and 9% CO2, for a period of 48 hrs.  Following the incubation 
prepared MPc samples were added, to give a final volume of 100 μl/well.  The samples were 
incubated for a period of 48 hrs under the prior conditions.  The wells were emptied and 
flooded with DMEM culture media, which was subsequently cleared, to remove residual MPc 
molecules.  WST-1 reagent was added, in a 1:11 dilution with DMEM to result in a final 
volume of 110 μl/well, and incubated for a further 6 hrs.  Absorbance of the samples was 
measured at 460 nm (reference λ = 600 nm), following shaking for 1 min.  % MCF-7 survival 
was calculated with respect to the absorbance intensity of the MPc-free cell sample, which 
was designated 100 %. The concentration of the MPc molecules which resulted in half the 
maximal response (IC50) was calculated from the trendline linear equation (y = mx + c), 
where y was designated the value of 50, and x was determined. 
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5.3. RESULTS AND DISCUSSION 
Section 5.3.1. investigates MPc interference that may be encountered when assessing 
cytotoxicity using colourimetric-based assays, namely WST-1 and MTT cell proliferation 
assays. Section 5.3.2.  addresses the WST-1 cell proliferation assay validation.  Section 5.3.3. 
reports on the MPc-induced cytotoxicity recorded using the WST-1 cell proliferation assay, 
and section 5.4.4.  examines the correlation between human serum albumin and complement 
factor C3 binding levels, detected using QCM-D, and the results obtained from the 
cytotoxicity analysis. 
 
5.3.1. Identification of MPc Interference with Cytotoxicity Analysis 
5.3.1.1. Spectrophotometric Analysis of MPc Preparations 
Absorbance spectral scans were performed on the MPc preparations, dispersed in PBSMg/Ca-
DMEM, to determine the absorbance ranges of the MPc molecules.  Figure 5.1 illustrates the 
absorbance spectra recorded for the target MPc preparations, namely, AlPcSmix, CoPcSmix, 
CuTSPc, GePcSmix, ZnPcSmix, and CoTCPc.  The spectrophotometric analysis identified       
B-band and Q-band absorbance peaks ranging from approximately 240 nm - 440nm, and      
500 nm - 800 nm, respectively [95, 124].  The presence of absorbance peaks identifies the 
wavelength range in which MP-interference will occur when using an absorbance-based 
detection assay.  However, the CoPcSmix, CuTSPc, and CoTCPc preparations indicated minor 
absorbance, of approximately 0.100, within the wavelength range of 440 nm – 500 nm.  This 
occurrence suggests MPc-interference is unavoidable when utilising an absorbance-based 
assay to assess MPc-induced cytotoxicity of CoPcSmix, CuTSPc, and CoTCPc.  It was 
therefore concluded that an optimum assay, which would experience the lowest level of MPc 
interference, would demonstrate a detection range between 440 nm and 500 nm. 
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Figure 5.1.  Absorbance spectral scans of MPc preparations prepared in PBSMg/Ca-DMEM.  
Spectrophotometric analysis performed to determine the absorbance detection ranges 
of the MPc preparations. 
 
5.3.1.2. Spectrophotometric Analysis of MTT and WST-1 Cell Proliferation 
Assays 
Spectrophotometric analysis of both the WST-1 and MTT tetrazolium salts, and their 
respective formazan cleavage products, was performed to aid in the selection of an optimum 
cell proliferation assay, in terms of MPc absorbance interference, for the examination of 
MPc-induced cytotoxicity.  Figure 5.2 illustrates the absorbance spectra of the relevant 
compounds solubilised in DMEM.  With respect to the tetrazolium salts, both the WST-1 and 
MTT reagents demonstrated low intensity peaks at approximately 560 nm.  In addition, the 
WST-1 cleavage product spectral scan indicated an absorbance peaks at 438 nm, which 
demonstrated a peak range between 350 nm and 600 nm, while the MTT product indicated an 
absorbance peak at 567 nm, ranging between 400 nm and 650 nm.  These absorbance ranges 
B-Band Q-Band 
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correspond with literature which reports the optimum detection of the formazan product is 
achieved between 420 nm and 480 nm when using the WST-1 reagent, and between 550 nm 
and 600 nm when using the MTT reagent.   
 
According to the required specifications of a colourimetric assay intended for MPc use, 
outlined in section 5.3.1.1, an optimum assay would demonstrate an absorbance detection 
range between 440 nm and 500 nm.  The use of the MTT cell proliferation assay was 
therefore concluded as an unreliable means of analysing sulphonated MPc cytotoxicity, as the 
detection wavelength of the formazan product occurs within the Q-band range of the MPc 
spectral scans (500 nm – 800 nm).  This was an unexpected occurrence as the application of 
the MTT assay, for the analysis of sulphonated MPc-induced cytotoxicity, has been well 
documented in literature [129-131].  Use of the WST-1 cell proliferation assay for the analysis of 
MPc-induced cytotoxicity was favoured for the application in these studies.   
 
Cell 
Proliferation 
Reagent 
Tetrazolium Salt  Formazan Product 
WST-1 
 
 
 
MTT 
 
 
 
Figure 5.2.  Absorbance spectrophotometric analysis of the tetrazolium salts, and the respective 
cleavage products, employed in the WST-1 and MTT cell proliferation assays. 
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5.3.2. Validation of WST-1 Cell Proliferation Assay 
MCF-7 Cell Proliferation Analysis 
Analysis of MCF-7 cell proliferation was performed to validate the WST-1 cell proliferation 
assay.  As illustrated in figure 5.3, an increase in the absorbance intensity, at 460 nm, with an 
increase in cell population was observed.  The tetrazolium salt (WST-1) is cleaved to produce 
water-soluble formazan, via mitochondrial dehydrogenase activity, therefore allowing the 
spectrophotometric detection of metabolically active cells through the measuring of the latter 
product.  An increase in the formazan product, and therefore absorbance intensity at 460 nm, 
is an indication of an increase in the number of viable cells/well [49].  The experimentally 
determined correlation between the absorbance intensity and the cell concentration 
corresponds with the theoretical prediction. 
 
MCF-7 cells were chosen due to their availability, great range of pathophysiological changes, 
and high sensitivity [132]. The utilisation of a cancer cell line was favoured in this study as 
PDT is directed towards cancer treatment, as well as the fact that MPc molecules are reported 
to retain preferentially within malignant tumours [61]. 
 
Figure 5.3.  MCF-7 cell proliferation studies using Cell Proliferation Reagent WST-1.  
Absorbance intensity, at 460 nm, measuring the level of WST-1 formazan cleavage 
product, and therefore cell viability, assessing increasing concentrations of MCF-7 
cells.  The absorbance intensity was measured for the cell population range from        
0 – 6 × 103 cells/well.  Error bars represent standard deviation (n = 3). 
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Analysis of Sample Preparation Influence 
Investigation into the influence of the MPc preparations, dispersed in DMSO/DMEM, was 
achieved through performing the WST-1 cell proliferation assay in the absence of MCF-7 
cells.  Figure 5.4. indicates the absorbance intensities recorded at 460 nm for these 
procedures.  Absorbance analysis reported fairly stable absorbance intensities for the 
AlPcSmix, GePcSmix, and ZnPcSmix preparations over the selected concentration range, while 
slight concentration-dependent shifts in absorbance intensity were recorded for CoPcSmix, 
CuTSPc, and CoTCPc preparations.  In addition, the absorbance spectra of the MPc 
preparations in PBSMg/Ca-DMEM (Figure 5.1) suggested absorbance interference, at 460 nm, 
when assessing CoPcSmix, CuTSPc, and CoTCPc preparations. This occurrence suggests the 
concentration-dependent shifts, observed in figure 5.4., are the result of the presence of the 
MPc molecules within the sample, rather than an interaction between the WST-1 tetrazolium 
salt. However, these MPc-induced shifts in absorbance intensity are expected to have little 
influence over the MPc MCF-7 cytotoxicity analysis, as the MPc-free cellular induced 
formazan absorbance intensity is reported as approximately 0.57, when assessing 6 × 103 
cells/well (Figure 5.1).  In addition, a dose-dependent change in the absorbance of WST-1, 
with increasing MPc concentration was not observed.  MPc-induced interference was 
therefore concluded to be negligible. 
 
Figure 5.4.  Analysis of MPc interference with WST-1 cell proliferation assay efficiency.   The 
absorbance intensity at 460 nm was recorded following incubation of the MPc 
preparation with the WST-1 reagent.  Error bars represent standard deviation (n = 3). 
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Assessment of the effect of DMSO addition to the cell culture samples revealed the solvent 
demonstrated  minor cytotoxicity over cell induced absorbance intensity at 460 nm, when 
assessing the lower concentrations, however, little, or no interference was reported at 
concentrations higher than 0.5 µl/ml (v/v) (Figure 5.5.).  DMSO usage in cell culture analysis 
has been well documented, and has been reported to be highly suitable for use with MTT 
assays [133, 134].  The usage of both DMSO and serum proteins has demonstrated an 
improvement in the detection of MTT formazan generated by cell cultures.  However, DMSO 
grade, and storage conditions, namely exposure to air, has been suggested to negatively 
influence absorbance, and therefore detection of the MTT formazan dye [134].  The latter may 
be an explanation for the deviating absorbance of the WST-1 formazan product when MCF-7 
cells are supplemented with DMSO dilutions.  The absorbance trend of the DMSO 
supplemented cells, in terms of percentage MCF-7 viability, was utilised as a comparison 
when assessing the cytotoxicity of each MPc preparation. 
 
Figure 5.5.  Analysis of the effect of DMSO on cell viability as measured by WST-1 cell 
proliferation assay efficiency.  The absorbance intensity at 460 nm was recorded 
following incubation of the DMSO supplemented cell preparation with the WST-1 
reagent.  Error bars represent standard deviation (n = 3). 
 
5.3.3. MPc-Induced MCF-7 Cytotoxicity 
AlPcSmix-Induced Cytotoxicity 
Analysis of AlPcSmix-induced cytotoxicity in MCF-7 cells revealed fluctuations in percentage 
survival following administration of low MPc concentrations (Figure 5.6).  Both the presence 
of the organic solvent, DMSO, and serum protein supplemented DMEM culture media, are 
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reported to increase monomerisation of the MPc molecules in solution [49, 95, 136].  According 
to the QCM-D analysis of AlPcSmix-modified SAM surfaces, high levels of human serum 
(HS) protein adsorption, 1034.12 ng.cm-2 – 1233.86 ng.cm-2, were detected to deposit at this 
surface (Chapter 4; Section 4.3.3). This high degree of serum protein adsorption, together 
with the low levels of MPc concentration, and therefore high protein to MPc ratio, may 
provide an explanation for the varying percentage survival at low MPc concentrations, as the 
higher protein to MPc ratio is expected to decrease MPc aggregation.  An increase in MPc 
monomerisation may influence cellular toxicity, firstly via increasing the photoactivity of the 
MPc molecules, and/or secondly, via increasing the proportion of the MPc preparation 
available for cellular uptake [135, 136].  This reasoning was applied to the remainder of the MPc 
cytotoxicity analyses to explain percentage survival fluctuations at low MPc concentrations.  
Slight decreases in the percentage MCF-7 survival were recorded at MPc concentrations of 
2.5 μg/ml (85.95 ±9.70 %) and 5 μg/ml (91.52 ±12.57 %), however, the trend observed over 
the MPc concentration range, 0 – 10 μg/ml, appears to be similar to that observed when 
assessing DMSO supplemented cells, therefore suggesting the AlPcSmix preparation was not 
cytotoxicy, or at least cytostatic.  This corresponds with literature as sulphonated AlPc 
preparations are reported as non-toxic under conditions eliminating irradiation, and are 
currently being utilised for their biomedical application in the photodynamic treatment of 
various cancers [104].   A means of examining the influence of ambient light within the current 
study would be to assess cytotoxicity under conditions eliminating light completely.   
 
Figure 5.6.  AlPcSmix-induced cytotoxicity in MCF-7 cell line.  MPc preparations were prepared in 
DMSO and DMEM culture media.  The MCF-7 cell population utilised was                    
6 × 10-3 cells/well.  Absorbance intensity was measured at 460 nm.  The error bars 
represent standard deviation (n = 3). 
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Insufficient studies have been reported in literature utilising the remainder of the MPc 
molecules assessed in this study, in terms of the exact chemical structure (i.e. metal core 
coupled with ring substitutions) to make comparison with the cytotoxicity results obtained in 
the current study.  The following studies are therefore novel, in terms of both the MPc 
molecules assessed and the cell line utilised. 
 
Modified and Unmodified CoPc-Induced Cytotoxicity 
As observed with low concentrations of AlPcSmix, fluctuations in percentage survival were 
recorded for all three samples, namely, CoPc, CoPcSmix and CoTCPc (Figure 5.7).  QCM-D 
analysis of CoPcSmix and CoTCPc-modified SAM surfaces reported HS protein adsorption of 
approximately 875.82 ng.cm-2 – 1010.97 ng.cm-2, and 136.04 ng.cm-2 – 1649.55 ng.cm-2, on 
each surface, respectively.  As previously discussed the high level of HS adsorption is 
predicted to result in MPc monomerisation, therefore affecting cellular uptake and increasing 
the MPc photoactivity.  The CoPc samples demonstrated an increase in percentage MCF-7 
survival in comparison to CoPcSmix and CoTCPc samples, between the concentration range 
of 1 μg/ml and 10 μg/ml.  Furthermore, similar percentage survival trends were observed, 
over the selected MPc concentration range, for the modified and unmodified CoPc 
preparations.  Although the modified CoPc molecules demonstrated a slightly more cytotoxic 
effect in comparison to the unmodified CoPc molecules, the percentage survival trends 
observed were similar to that observed when assessing the influence of DMSO, therefore 
suggesting the molecules were cytostatic.  The variations in the cytotoxicity reported for the 
three CoPc preparations, although slight, highlight the potential effect of ring substitution on 
toxicity.  
 
For this study, it was proposed that the addition of negatively charged ring substitutions to the 
MPc molecules results in an increase in the cytotoxicity.  This increase in cytotoxicity 
highlights a concern regarding the biomedical application of MPc molecules.  For 
intravenous administration of an MPc therapeutic, the particles are required to be hydrophilic 
in nature [50].  MPc hydrophilicity, and therefore solubility, is dependent on ring subsititution.   
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Figure 5.7.  Cytotoxicity of modified and unmodified CoPc’s in MCF-7 cell line. MPc 
preparations were prepared in DMSO and DMEM culture media.  The MCF-7 cell 
population utilised was 6 × 10-3 cells/well.  Absorbance intensity was measured at   
460 nm.  The error bars represent standard deviation (n = 3). 
  
MPc molecules composed with Co2+ metal ions as the central core have been demonstrated to 
produce short triplet lifetimes, therefore highlighting their inefficiency as a PS agent in the 
photodynamic treatment of cancer [5].  The inclusion of the non-substituted CoPc in the 
toxicity studies was performed to assess the influence of the ring substitutions on MCF-7 
cytotoxicity.  
 
CuTSPc-Induced Cytotoxicity 
Cytotoxicity analysis of the CuTSPc preparations indicated minor decreases in MCF-7 cell 
viability occurred at low MPc concentration (Figure 5.8).  Analysis of HS adsorption to 
CuTSPc-modified SAM surfaces, via QCM-D analysis, indicated protein adsorption ranging 
between 867.90 ng.cm-2 and 1093.89 ng.cm-2.  It was therefore concluded that the variations 
in cell viability, as a result of low concentrations of CuTSPc, may be due to an increase in 
monomerisation of the molecules within the DMSO supplemented DMEM growth media, as 
previously stated.  The general trend of the percentage MCF-7 survival curve indicated a 
slight increase in cell viability corresponding to an increase in CuTSPc concentration, similar 
to that of the trend recorded for DMSO supplemented cells.  It was therefore concluded that 
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the CuTSPc preparation was non-toxic up to the concentration of 10 μg/ml.  As stated with 
CoPc molecules, CuPc molecules generate short triplet lifetimes, and are therefore not 
favoured for application in PDT [121].   
 
Figure 5.8.  CuTSPc-induced cytotoxicity in MCF-7 cell line. MPc preparations were prepared in 
DMSO and DMEM culture media.  The MCF-7 cell population utilised was                   
6 × 10-3 cells/well.  Absorbance intensity was measured at 460 nm.  The error bars 
represent standard deviation (n = 3). 
 
GePcSmix-Induced Cytotoxicity 
According to the WST-1 cytotoxicity analysis, GePcSmix samples demonstrate no 
cytotoxicity, up to a concentration of 10 μg/ml (Figure 5.9).  However, an increase in MPc 
concentration corresponded with a general decrease in cell viability, demonstrating a similar 
trend to the DMSO response, therefore suggesting GePcSmix as being non-toxic, or cytostatic.  
QCM-D analysis of HS protein binding to GePcSmix-modified SAM surfaces reported high 
levels of protein binding, approximately 933.99 ng.cm-2 – 113.59 ng.cm-2.  These high levels 
of HS protein coating suggest monomerisation may have attributed to the deviations if 
percentage MCF-7 cell survival at low MPc concentrations. GePcSmix preparations have been 
reported to demonstrate photophysical and photochemical behaviour superior to that of other 
MPcSmix samples, including that of AlPcSmix 
[137].  The cytostatic nature of the GePcSmix, in 
natural light, is an excellent feature of the molecule, which would promote its use in 
biomedical applications, as unintentional photoactivation of the molecule would be avoided, 
therefore decreasing the photosensitivity side-effect [58]. 
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Figure 5.9.  GePcSmix-induced cytotoxicity in MCF-7 cell line. MPc preparations were prepared in 
DMSO and DMEM culture media.  The MCF-7 cell population utilised was                   
6 × 10-3 cells/well.  Absorbance intensity was measured at 460 nm.  IC50 was recorded to 
be 6.6 μg/ml. The error bars represent standard deviation (n = 3). 
 
ZnPcSmix-Induced Cytotoxicity 
According to WST-1 assay results (Figure 5.10), ZnPcSmix demonstrated a concentration-
dependent decrease in the percentage MCF-7 cell survival, therefore suggesting the MPc 
preparation as being cytotoxic. The IC50 of the viability curve was determined to be          
6.58 μg/ml. The effective dose concentration of encapsulated ZnPc molecules, for the in vivo 
application in PDT, in human test subjects, has been reported to be as low as 35 μg/kg [28]. 
Assuming the average weight of an individual is 70 kg, and on average there is 4.7 L of blood 
within the body, the average dose concentration administered would be approximately      
0.52 μg/ml.  This is well below the in vitro IC50 recorded for ZnPcSmix cytotoxicity.  While 
sulfonated ZnPc preparations have been assessed, in terms of their application as PS agent in 
the photodynamic treatment of cancer, little is reported on their influence on cellular cultures, 
in particular, cytotoxicity [61, 121].   
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Figure 5.10.  ZnPcSmix-induced cytotoxicity in MCF-7 cell line. MPc preparations were prepared in 
DMSO and DMEM culture media.  The MCF-7 cell population utilised was 6 × 10-3 
cells/well.  Absorbance intensity was measured at 460 nm.  The error bars represent 
standard deviation (n = 3).  Comparison with unpaired student t-test of % MCF-7 
survival with DMSO versus MPc (p = 0.01). 
 
5.3.4. Comparison Between MPc Protein Binding Analysis and Cytotoxicity Studies 
MPc-induced cytotoxicity results generated from the WST-1 cell viability assay were 
assessed against the protein analysis results obtained utilising QCM-D technology       
(Chapter 4).  A comparison with the fibrinogen studies was unachievable due to the culture 
media being supplemented with serum, which is prepared from plasma through the removal 
of fibrin and other clotting factors [138].   
 
A comparison between the detected antibodies bound to the HS coat adsorbed to MPc-
modified surfaces, namely AbC3c and AbHSA, and the cell viability of MCF-7 cells following 
incubation with 10 μg/ml of MPc preparations, indicated no apparent link between the 
composition of the adsorbed protein coat and cellular toxicity (Figure 5.11 and 5.12).  This 
lack of correlation suggests one of three things, firstly, the influence of the adsorbed protein 
composition on biocompatibility is far more complex to be predicted through the adsorption 
of just two proteins.  Secondly, photoactivation of the MPc molecules, by natural light, may 
have played a role in the generation of cytotoxicity, and thirdly, the cytotoxicity analysis 
using cell proliferation assays may not be an accurate representation of the MPc-induced 
biological effects.   Analysis of the effects of MPc photoactivation, in the presence of 
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ambient light, may be achieved through performing the WST-1 cytotoxicity assays under 
conditions where light is removed completely.  In the event of cytotoxicity still being 
observed, MPc photoactivation-induced cytotoxic effects may be eliminated as a possible 
cause of toxicity.  Analysis of the influence of the protein coat complexity, and the accuracy 
of the WST-1 cytotoxicity investigations may be achieved utilising in vivo analysis. 
 
Figure 5.11.  Comparison between Sauerbrey-determined adsorbed antibody mass and the 
percentage cell survival of MCF-7 cells following the administration of MPc 
preparations.  Adsorbed anti-human C3c and anti-human albumin are represented by 
I and II, respectively.  The MPc concentration administered was 10 μg/ml. 
 
 
Figure 5.12.  Comparison between Voigt-determined adsorbed antibody mass and the 
percentage cell survival of MCF-7 cells following the administration of MPc 
preparations.  Adsorbed anti-human C3c and anti-human albumin are represented 
by I and II, respectively.  The MPc concentration administered was 10 μg/ml. 
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5.4. CONCLUSION 
Cytotoxicity analysis of MPc preparations, using the Cell Proliferation Reagent WST-1, 
indicated high levels of cytotoxicity generated by the ZnPcSmix preparations, where an IC50 of 
6.58 μg/ml was calculated.   A large MPc concentration-dependent decrease in cell viability 
was observed when assessing 10 μg/ml of ZnPcSmix preparations (-65.40 %), followed by 
minor cytotoxicity levels for GePcSmix (-28.60 %), CoTCPc (-28.58 %), CoPcSmix (17.13 %), 
and no detection of cytotoxicity for AlPcSmix (-4.18 %).  Incubation with CuTSPc 
preparations, however, resulted in an increase in cell viability (+ 8.86 %), suggesting minor 
MPc-induced growth.  The cytostatic nature recorded for AlPcSmix preparations corresponds 
with literature, as AlPcSn preparations have been utilised in biomedical applications 
[47]. 
 
Although cytotoxicity was recorded for ZnPcSmix, and minor cytotoxicity for GePcSmix, 
CoPcSmix and CoTCPc, it was unclear whether toxicity was a result of the presence of the 
MPc molecules, or in fact, activation of the molecules, by natural light, to generate toxic 
reactive oxygen species.  Further studies would have to be performed, aimed at assessing 
cytotoxicity, while eliminating natural light.  Another means of assessing photoactivation of 
the MPc preparations in natural light involves the assessment of the generation of reactive 
oxygen species.  These studies may be carried out using photometric detection methods 
aimed at investigating the superoxide anion and singlet oxygen concentrations [139]. 
 
Analysis directed at examining the link between adsorbed serum proteins and cytotoxicity 
were inconclusive, therefore raising further questions regarding biocompatibility of MPc 
molecules.  It is well understood that the composition of the protein coat adsorbed to 
therapeutic particles, in terms of protein identity, adsorption pattern, and amount, govern the 
biological responses generated, namely biodistribution and biocompatibility. A means of 
assessing the influence of the serum protein coat on the cytotoxicity assay analysis includes 
performing the cytotoxicity analysis on MPc preparations in serum free DMEM, or varying 
concentrations of the serum supplemented DMEM.  However, further knowledge of the 
protein kinetics, affinities, as well as the stoichiometry of both adsorbed and free protein 
appears to be essential when developing a method aimed at biocompatibility prediction 
through protein adsorption analysis [92].   
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CHAPTER 6:  
OVERALL CONCLUSIONS 
The aim of the current study was to design a rapid means of assessment, using QCM-D 
technology, for target particle biocompatibility, in terms of identifying key influential 
proteins present in the blood protein corona adsorbed to the biomaterial surface.  The target 
proteins of interest included, human serum albumin (HSA), complement factor C3c, and 
human plasma fibrinogen (HPF).  HSA, a dysopsonin, adsorption to biomedical surfaces has 
been of particular interest, with regards to biocompatibility analysis in reported studies, as its 
adsorption governs the circulation half-life of the proposed therapeutic within the biological 
system [18].  In addition, HSA adsorption has been reported to limit further blood protein 
binding, including opsonin proteins such as complement C3 and fibrinogen, therefore 
hindering the activation of the complement and coagulation cascades [38].  High levels of 
adsorbed HSA on biomedical surfaces is therefore favourable, in terms of 
haematocompatibility.  
 
Complement factor C3, and therefore complement C3c, adsorption on biomedical surfaces, 
however, is an unfavourable occurrence, as it is indicative of complement activation.  This 
activation of the complement system suggests the uptake of the therapeutic by the 
mononuclear phagocyte system (MPS), resulting in interference with the biodistribution and 
efficiency of the therapeutic, in addition to the potential to generate negative side effects, 
such as hypersensitivity and anaphylaxis [9].  Similarly, high levels of HPF adsorption 
indicates coagulation cascade activation, and therefore the potential of the biomedical surface 
to induce the formation of blood clots and subsequent occlusion of the blood vessels [42-44].  
Adsorption of both complement C3, and HPF, is therefore unfavourable when designing a 
therapeutic intended for intravenous administration. 
 
The assessment of the above mentioned favourable and unfavourable blood protein 
adsorption patterns on surfaces intended for biomedical application, was proposed to serve as 
a crude but rapid means of biocompatibility analysis. 
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Preliminary analysis of probe antibody detection of target proteins, on generic biomedical 
surfaces, indicated higher levels of HSA on hydrophilic SAM surfaces (Cyst And 11-AUT), 
in comparison to the unmodified SiO2 and gold (Chapter 2; Section 2.3.3.2). Similarly, HPF 
analysis indicated higher adsorbed protein levels on Cyst and 11-AUT SAM-modified 
surfaces, in comparison to the unmodified SiO2.  Complement C3 indicated a binding trend 
which favoured more hydrophobic surfaces, over hydrophilic ones.  It was concluded, from 
the preliminary protein detection analysis, that HSA adsorption is influenced by surface 
charge, while HPF adsorption demonstrates a dependence on surface topography.  
Reproducibility analysis, of probe antibody binding, suggested detection of complement C3 
as the most reproducible (Sauerbrey: 9.15 % CV; Voigt: 5.05 % CV) of the three analyses, 
possibly attributed to by the small size of the target protein.  The lower reproducibility of 
HSA and HPF detection was proposed to be the result of target protein conformational 
change, and variability of adsorbed protein orientation, due to surface topography, 
respectively (Table 2.6).  The experimentally determined binding trends observed aided in the 
analysis of the binding trends observed when assessing target particle modified surfaces, 
namely MPc-modified (Chapter 3) and FMWCNT-modified (Chapter 4) SAM surfaces.   
 
Protein detection analysis on prepared MPc-modified, and FMWCNT-modified, surfaces 
indicated HSA adsorption is greatly influenced by the surface charge, resulting in low 
reproducibility due to target protein conformational change.  Furthermore, surface 
topography-dependence of HPF was evident.  In general, complement C3 detection, using 
AbC3c, proved to be the most reliable of the three analyses, as conformational change was 
limited, and topography-dependence was negligible. However, with further analysis of the 
target surface, in terms of topography, obtainable using AFM and scanning electron 
microscopy (SEM), and surface charge, obtainable through simple titration analysis, the 
variability of the protein detection trend may be accounted for, and therefore experimental 
accuracy may be further assessed.  An alternative means of approaching the concern of 
reproducibility and accuracy involves optimisation of the surface modification process.  This 
may proceed via controlled immobilisation, in terms of target particle patterning on the 
underlying SAM surface, obtainable using variable length linkers (i.e. SAM molecules).   
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Protein corona identification results, although variable in some cases (i.e. HSA and HPF) due 
to variability in surface charge and topography, correlated with literature-based predictions, 
and preliminary studies (Chapter 2).  It was therefore concluded that the proposed protein 
detection method, using QCM-D technology for the monitoring and quantification of probe 
antibody binding, was successful in crudely assessing the protein corona adsorbed on target 
particle-modified surfaces and represents a potentially promising tool for such studies.  
However, further optimisation of the surface modification is required, and/or analysis of the 
modified surface characteristics, in terms of charge and topography, to improve accuracy and 
reproducibility of the proposed means of protein detection.  With optimisation, the proposed 
QCM-D based may prove applicable in drug design studies, in addition to providing essential 
information regarding the complex relationship between blood protein adsorption and 
biocompatibility. 
 
Areas of interest, for future studies, include combining QCM-D technology with alternative 
protein detection methods, such as SPR.  The coupling of QCM-D and SPR techniques has 
been reported to be successful in literature, where SPR analysis served as validation for  
QCM-D application [20-22].  The utilisation of QCM-D, in conjunction with surface 
topography based analyses, such as AFM and SEM, has also been reported [96, 111].   
 
Alternative QCM-D-based studies, we propose, include; analysis of target protein adsorption 
to the modified surfaces, to assess subsequent target protein conformation change and 
binding kinetics; and competitive binding analysis, using a combination of the three target 
proteins.  Analysis of fibrinogen adsorption, and subsequent fibrin clot formation, may also 
prove helpful when assessing biocompatibility.  The latter study has been reported using 
polymer-coated surfaces, where the clot formation was analysed via monitoring film density 
shifts in time-based studies [29]. 
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APPENDIX 
Table A.1.  QCM-D Frequency and Dissipation Shifts Monitoring the Adsorption of Blood 
Proteins to the Target Surfaces 
Surface a 
Blood 
Protein 
Δf7 
ΔD7 
Δf9 
ΔD9 
Δf11 
ΔD11 
Ave. 
Δf b 
Ave. Δ f   
% CV 
Ave. 
ΔD b 
AbHSA 
(new crystal) 
HS 
14.56 13.31 9.16 -43.14 ±1.37 3.18 3.64 ±0.96 
13.54 12.62 12.28 -25.40 ±0.64 2.52 1.98 ±0.05 
10.86 11.14 9.99 -33.79 ±0.94 2.78 3.17 ±0.10 
AbHSA 
 (used crystal) 
10.12 9.79 9.23 -30.67 ±1.3 4.24 3.16 ±0.04 
16.90 15.92 14.59 -23.86 ±0.36 1.51 1.51 ±0.09 
10.42 9.91 9.49 -39.9 0±1.42 3.56 4.02 ±0.05 
AbIgG 
 
HS 9.73 13.36 10.16 -34.26 ±1.57 4.58 3.15 ±0.50 
iHS 7.16 8.33 6.48 -15.72 ±0.99 6.30 2.17 ±0.26 
AbHPF 
 
HP 
12.59 12.50 10.76 -58.40 ±1.27 
2.17 
4.91 ±0.33 
Surface a 
Blood 
Protein 
f7 
D7 
f9 
D9 
f11 
D11 
Ave. 
f b 
Ave. f   
% CV 
Ave. 
D b 
Gold 
HS 
16.74 16.36 16.29 -64.68 ±1.15 1.78 3.93 ±0.03 
35.33 10.56 10.12 -70.34 ±6.30 8.96 3.69 ±5.07 
23.61 22.89 22.66 -66.58 ±0.98 1.47 2.89 ±0.02 
20.27 17.70 16.82 -66.62 ±1.54 2.31 3.67 ±0.27 
20.27 17.66 16.86 -66.61 ±1.56 2.34 3.66 ±0.27 
13.61 13.68 13.04 -71.66 ±1.44 2.01 5.33 ±0.03 
HP 
15.32 14.20 13.47 -55.81 ±0.98 1.76 3.90 ±0.18 
9.00 8.08 7.20 -22.63 ±0.83 3.67 2.81 ±0.21 
16.10 14.44 14.87 -56.03 ±2.26 4.03 3.71 ±0.17 
Silicon Dioxide 
HS 
26.18 26.58 25.32 -62.90 ±0.79 1.26 2.42 ±0.05 
19.85 20.98 19.27 -62.42 ±1.11 1.78 3.12 ±0.12 
18.56 18.41 17.34 -54.34 ±0.95 1.75 3.00 ±0.07 
HP 17.44 17.47 16.61 -52.28 ±1.18 2.26 3.05 ±0.05 
11-AUT SAM 
HS 
15.32 14.88 14.60 -54.62 ±1.41 2.58 3.66 ±0.01 
15.92 15.67 15.30 -64.26 ±1.55 2.41 4.11 ±0.02 
12.68 12.70 12.99 -52.63 ±1.44 2.74 4.12 ±0.17 
HP 13.63 12.85 12.58 -48.44 ±1.05 2.17 3.72 ±0.08 
Cyst. SAM 
HS 
18.43 18.91 17.37 -44.97 ±1.30 2.89 2.47 ±0.07 
18.24 22.79 26.87 -40.74 ±0.28 0.69 1.85 ±0.36 
17.66 16.84 15.94 -45.26 ±0.67 1.48 2.70 ±0.10 
HP 27.44 26.78 24.19 -50.99 ±0.53 1.04 1.96 ±0.12 
MUA SAM 
HS 
18.25 17.14 25.55 -33.16 ±0.73 2.20 1.69 ±0.36 
21.44 22.00 20.77 -40.30 ±0.61 1.51 1.88 ±0.04 
13.67 13.90 13.71 -38.25 ±0.77 2.01 2.78 ±0.07 
HP 12.38 11.96 11.92 -29.10 ±0.63 2.16 2.41 ±0.02 
a: Surface modification molecules utilised in the fabrication of the control surfaces 
b: Average values determined using responses obtained from overtones 7 -11 
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Table A.2.  QCM-D Frequency and Dissipation Shifts Monitoring Probe Antibody Binding to 
Blood Protein Coated Target Surfaces 
Surface a Probe Δf7 
ΔD7 
Δf9 
ΔD9 
Δf11 
ΔD11 
Ave. 
Δf b 
Ave. Δ f   
% CV 
Ave. 
ΔD b 
AbHSA 
(new crystal) 
Ab(A) 
8.57 7.66 6.95 -146.01 ±5.67 3.88 18.97 ±1.22 
9.66 8.89 8.40 -147.21 ±4.96 3.37 16.42 ±0.6 
18.28 16.95 14.73 -127.73 ±2.62 2.05 7.72 ±0.71 
AbHSA 
 (used crystal) 
19.77 17.01 14.81 -121.35 ±1.58 1.30 7.15 ±0.93 
15.14 13.83 12.66 -120.86 ±2.19 1.81 8.75 ±0.62 
18.49 15.98 14.51 -102.38 ±1.72 1.68 6.33 ±0.66 
AbIgG 
 
Ab(C) 7.01 7.65 6.56 -37.88 ±2.60 6.86 5.36 ±0.34 
Ab(C-) 0.92 0.85 233.4 -43.26 ±73.45 169.79 -0.83 ±0.28 
AbHPF 
 
Ab(F) 
65.44 52.35 101.61 -37.18 ±238.28 640.88 2.18 ±0.8 
Gold 
Ab(A) 4.65 4.39 4.05 -6.31 ±0.54 8.56 1.44 ±0.03 
5.14 0.41 1.86 -5.30 ±3.59 67.74 1.68 ±2.81 
4.85 4.15 3.92 -6.78 ±0.69 10.18 1.58 ±0.03 
Ab(C) 24.03 10.54 14.75 -16.27 ±1.65 10.14 1.09 ±0.38 
24.01 10.62 14.6 -16.27 ±1.56 9.59 1.09 ±0.33 
12.88 12.77 11.10 -13.82 ±0.37 2.68 1.13 ±0.08 
Ab(F) 40.89 29.37 23.81 -58.21 ±0.79 1.36 1.95 ±0.49 
28.43 21.87 17.85 -66.15 ±0.46 0.70 3.02 ±0.67 
30.40 19.21 19.91 -46.03 ±2.38 5.17 2.06 ±0.44 
Silicon Dioxide 
Ab(A) 3.35 3.03 2.99 -5.62 ±0.69 12.28 1.80 ±0.11 
Ab(C) -9.59 24.49 5.22 -2.31 ±0.44 19.05 0.18 ±0.234 
Ab(F) 17.91 24.19 13.19 -6.38 ±0.59 9.25 0.37 ±0.10 
11-AUT SAM 
Ab(A) 6.29 5.91 5.77 -11.94 ±0.83 6.95 1.99 ±0.05 
Ab(C) 9.51 8.79 8.61 -15.77 ±0.92 5.83 1.76 ±0.03 
Ab(F) 4.00 3.53 3.25 -11.44 ±1.14 9.97 3.18 ±0.04 
 
Cyst. SAM 
Ab(A) 7.78 7.52 6.59 -17.53 ±1.27 7.24 2.40 ±0.05 
Ab(C) 9.85 11.22 11.33 -7.80 ±0.20 2.56 0.73 ±0.07 
Ab(F) 22.95 35.02 59.90 -65.84 ±0.94 1.43 -1.94 ±0.86 
MUA SAM 
Ab(A) 2.20 1.58 1.91 -4.25 ±0.95 22.35 2.25 ±0.35 
Ab(C) -6.80 -6.06 -5.54 -6.64±0.18 2.71 0.43 ±0.02 
Ab(F) 421.17 146.12 86.73 -2.57 ±0.11 4.28 0.01 ±0.02 
a: Surface modification molecules utilised in the fabrication of the control surfaces 
b: Average values determined using responses obtained from overtones 7 -11 
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Table B.1. QCM-D Change in Frequency and Dissipation Shifts due to Target Antibody 
Binding to Blood Protein Coated MPc-Modified Surfaces 
MPc a Probe a 
f7 
D7 
f9 
D9 
f11 
D11 
Ave. f c 
Ave. f 
% CV 
Ave. D 
AlPcSmix 
AbHSA 13.74 10.54 12.93 -3.97 ±0.26 6.55 0.32 ±0.04 
AbC3c -8.89 8.83 7.30 -7.11 ±0.11 1.55 0.86 ±0.10 
AbHPF 15.30 13.76 12.20 -122.13 ±3.28 2.69 8.94 ±0.77 
CoPcSmix 
AbHSA 6.31 6.11 5.49 -24.77 ±1.36 5.49 4.15 ±0.13 
AbC3c 126.00 52.55 276.00 -5.87 ±0.40 6.81 0.03 ±0.08 
AbHPF 28.93 23.15 20.54 -114.94 ±1.11 0.97 4.84 ±0.77 
CuTSPc 
AbHSA 5.71 5.63 5.21 -17.27 ±1.47 8.51 3.13 ±0.21 
AbC3c 7.58 5.86 5.24 -3.01 ±0.40 13.29 0.49 ±0.03 
AbHPF 12.23 9.38 8.07 -58.65 ±2.48 4.23 6.07 ±1.00 
GePcSmix 
AbHSA 1.85 1.67 1.60 -36.39 ±6.99 19.21 21.16 ±2.47 
AbC3c 5.87 5.27 5.02 -37.39 ±3.17 8.48 6.94 ±0.03 
AbHPF 12.74 20.82 16.16 -54.92 ±1.70 3.10 3.45 ±0.81 
ZnPcSmix 
AbHSA 
 
12.82 12.34 11.33 -4.42 ±0.41 9.28 0.36 ±0.02 
7.96 7.92 7.83 -3.46 ±0.16 4.62 0.44 ±0.02 
14.40 13.38 12.46 -52.79 ±1.30 2.46 3.94 ±0.19 
AbC3c 
 
8.08 7.00 6.61 -5.59 ±0.21 3.76 0.78 ±0.05 
6.36 6.04 5.46 -3.52 ±0.16 4.55 0.59 ±0.02 
5.95 5.22 4.78 -3.17 ±0.22 6.94 0.60 ±0.03 
AbHPF 
 
3.90 3.52 2.95 -87.40 ±14.55 16.65 25.19 ±0.79 
7.82 6.91 6.06 -20.12 ±1.54 7.65 2.92 ±0.15 
4.12 3.72 3.53 -4.45 ±0.41 9.21 1.17 ±0.02 
CoTCPc 
AbHSA 4.56 3.06 4.17 -3.56 ±0.47 13.20 0.92±0.09 
AbC3c 11.95 12.01 9.64 -17.65 ±0.88 4.99 1.59 ±0.14 
AbHPF 10.00 9.85 10.72 -72.24 ±1.35 1.87 7.10 ±0.38 
a: Surface modification molecules utilised in the fabrication of the control surfaces 
b: Probe Antibody 
c: Average values determined using responses obtained from overtones 7 -11 
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Table C.1.  QCM-D Frequency and Dissipation Responses Monitoring Blood Protein 
Adsorption to the FMWCNT-Modified 11-Amino Undecane Thiol SAM Surfaces 
fMWCNT a 
Blood 
Protein 
f7 
D7 
f9 
D9 
f11 
D11 
Ave. f b 
Ave. f 
% CV 
Ave. D 
2 a:fMWCNT 
HS 16.10 15.15 15.13 -34.80 ±0.82 2.36 2.25 ±0.04 
HS 14.45 14.02 13.99 -37.73 ±1.35 3.58 2.67 ±0.06 
HP 16.15 17.07 13.34 -63.61 ±1.43 2.25 4.14 ±0.47 
4 a:fMWCNT 
HS 10.47 10.74 10.94 -38.16 ±1.29 3.38 3.57 ±0.20 
HS 6.15 8.82 7.78 -28.67 ±1.24 4.33 3.88 ±0.87 
HP 8.66 8.66 8.88 -43.68 ±1.45 3.32 5.00 ±0.23 
6 a:fMWCNT 
HS 13.83 13.58 12.18 -42.61 ±1.09 2.56 3.24 ±0.15 
HS 15.46 11.66 13.90 -43.53 ±1.56 3.58 3.22 ±0.38 
HP 17.43 17.24 14.71 -43.98 ±4.61 10.48 2.82 ±0.21 
8 a:fMWCNT 
HS 16.53 9.51 14.89 -29.96 ±1.17 3.91 2.31 ±0.62 
HS 13.99 13.74 12.69 -46.18 ±1.43 3.10 3.43 ±0.08 
HP 12.36 11.69 10.13 -42.35 ±2.18 5.15 3.73 ±0.20 
24 a:fMWCNT 
HS 22.28 24.29 21.66 -18.23 ±0.35 1.92 0.8 0±0.04 
HS 14.59 13.84 13.47 -40.23 ±0.78 1.94 2.88 ±0.06 
HP 17.68 17.68 17.30 -28.57 ±0.49 1.72 1.63 ±0.01 
4 b:fMWCNT 
HS 15.44 9.74 13.20 -42.97 ±2.07 4.82 3.47 ±0.77 
HS 12.46 13.34 13.06 -49.32 ±1.55 3.14 3.81 ±0.21 
HP 15.73 14.54 17.32 -57.22 ±1.50 2.62 3.63 ±0.37 
8 b:fMWCNT 
HS 14.00 13.74 13.02 -43.86 ±1.08 2.46 3.23 ±0.05 
HS 13.60 12.73 13.05 -49.90 ±1.08 2.16 3.80 ±0.12 
HP 15.66 15.47 13.11 -46.45 ±0.94 2.02 3.17 ±0.26 
12 b:fMWCNT 
HS 29.07 22.17 20.08 -40.31 ±0.55 1.36 1.74 ±0.30 
HS 12.05 3.35 10.60 -36.41 ±2.86 7.85 5.57 ±3.84 
HP 11.80 11.84 12.05 -53.80 ±1.37 2.55 4.52 ±0.16 
20 b:fMWCNT 
HS 12.36 12.01 10.73 -32.42 ±1.62 5.00 2.77 ±0.08 
HS 10.55 10.70 11.06 -38.07 ±0.94 2.47 3.54 ±0.12 
HP 42.65 3.46 9.03 -52.12 ±17.62 33.81 6.04 ±5.04 
a: Surface modification molecules utilised in the fabrication of the control surfaces 
b: Average values determined using responses obtained from overtones 7 -11 
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Table C.2. QCM-D Frequency and Dissipation Responses Monitoring Probe Antibody Binding 
to Blood Protein Coated FMWCNT-Modified Surfaces 
fMWCNT a Probe b 
f7 
D7 
f9 
D9 
f11 
D11 
Ave. f c 
Ave. f 
% CV 
Ave. D 
2 a:fMWCNT 
AbHSA 5.66 5.41 5.24 -55.80 ±3.12 5.59 10.26 ±0.18 
AbC3c 7.87 6.01 4.80 -1.76 ±0.3 17.05 0.29 ±0.03 
AbHPF 5.83 5.74 4.25 -11.02 ±0.85 7.71 2.11 ±0.23 
4 a:fMWCNT 
AbHSA 1.50 1.45 1.38 -8.19 ±1.52 18.56 5.66 ±0.82 
AbC3c 4.15 7.28 5.88 -1.81 ±0.13 7.18 0.33 ±0.11 
AbHPF 4.47 4.21 3.93 -11.73 ±1.01 8.61 2.79 ±0.06 
6 a:fMWCNT 
AbHSA 6.91 6.56 5.89 -10.54 ±0.49 4.65 1.64 ±0.06 
AbC3c 7.41 4.50 5.82 -3.97 ±0.42 10.58 0.69 ±0.1 
AbHPF 5.00 3.87 10.7 -46.24 ±1.05 2.27 11.08 ±1.27 
8 a:fMWCNT 
AbHSA 7.24 5.08 6.56 -28.84 ±1.85 6.41 4.66 ±0.72 
AbC3c 5.54 4.76 3.98 -5.43 ±0.52 9.58 1.15 ±0.08 
AbHPF 5.73 4.93 4.28 -20.20 ±1.79 8.86 4.09 ±0.42 
24 a:fMWCNT 
AbHSA 7.22 7.23 6.55 -13.33 ±0.69 5.18 1.9 ±0.02 
AbC3c 4.63 4.38 3.94 -4.54 ±0.3 6.61 1.05 ±0.03 
AbHPF 4.18 3.84 3.51 -8.59 ±0.87 10.13 2.23 ±0.03 
4 b:fMWCNT 
AbHSA 5.41 3.55 4.28 -28.54 ±3.66 12.82 6.58 ±1.02 
AbC3c 88.74 119.02 21.58 -3.57 ±0.33 9.24 0.07 ±0.07 
AbHPF 10.83 8.18 14.56 -64.48 ±4.43 6.87 6.75 ±0.94 
8 b:fMWCNT 
AbHSA 2.79 2.60 5.05 -13.26 ±2.11 15.91 5.25 ±0.21 
AbC3c 21.61 7.08 5.96 -2.82 ±0.54 19.15 0.29 ±0.34 
AbHPF 3.26 3.18 2.45 -10.32 ±1.46 14.15 3.49 ±0.18 
12 b:fMWCNT 
AbHSA 83.31 15.38 9.64 -4.87 ±0.15 3.08 0.29 ±0.22 
AbC3c 2.43 0.26 1.19 -1.52 ±0.78 51.32 1.81 ±1.35 
AbHPF 3.53 3.18 3.35 -17.40 ±2.52 14.48 5.18 ±0.56 
20 b:fMWCNT 
AbHSA 3.60 3.06 2.67 -194.03 ±24.8 12.78 62.51 ±1.39 
AbC3c 3.24 1.93 2.17 -0.95 ±0.28 29.47 0.39 ±0.02 
AbHPF 34.27 4.36 9.78 -72.11 ±19.01 26.36 7.6 ±5.52 
a: Surface modification molecules utilised in the fabrication of the control surfaces 
b: Probe Antibody 
c: Average values determined using responses obtained from overtones 7 -11 
 
 
 
 
 
 
 
 
 
 
 
158 
 
REFERENCES 
1. Richter, R., Mukhopadhyah, A. and Brissonm A. (2003). Pathways of Lipid Vesicle Deposition on 
Solid Surfaces: A Combined QCMD-AFM Study.  Biophysical Journal.  85: 3035-3047 
2. Caruthers, S., Wickline, S. and Lanza, G. (2007).  Nanotechnological applications in medicine.  
Current Opinion in Biotechnology. 18: 26-30 
3. Dobrovolskaia, M., Aggarwal, P., Hall, J. and McNeil, S. (2008).  Preclinical Studies To Understand 
Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle 
Biodistribution.  Molecular Pharmaceutics. 5: 487-495 
4. Dobrovolskaia, M. and McNeil, S. (2007).  Immunological properties of engineered nanomaterials.  
Nature Nanotechnology.  2: 469-478 
5. Lassen, B. And Malmsten, M.  (1996). Structure of Protein Layers during Competitive Adsorption.  
Journal of Colloid and Interface Science.  180:  339-349 
6. Owens, D.E. And Peppas, N.A. (2006).  Opsonisation, biodistribution, and pharmacokinetics of 
polymeric nanoparticles.  International journal of pharmaceutics.  307:  93-102 
7. Aggarwal, P., Dobrovolskaia, M., Hall, J. and McNeil, S. (2008).  Preclinical Studies To Understand 
Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle 
Biodistribution.  Molecular Pharmaceutics. 5: 487-495 
8. Adriaens, A., Bultinck, P., Depal, D., De Wael, K., Temmerman, E., Vandenabeele, P. and Westbroek, 
P. (2005). Study of the deposition and Raman and XPS characterization of a metal ion tetrasulphonated 
phthalocyanine layer at gold surfaces:  density functional theory calculations to model the vibrational 
spectra.  Electrochemistry Communications. 7: 87-96 
9. Andersson, J., Ekdahl, K., Larsson, R., Nilsson, U. And Nilsson, B.  (2002). C3 Adsorbed to a Polymer 
Surface Can Form an Initiating Alternative Pathway Convertase.  The Journal of Immunology.  168:  
5786-5791 
10. Gref., R., Luck, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T. and Muller, R.  
(2000). ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): indluences 
of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake 
and plasma protein adsorption.  Colloids and Surfaces B:  Biointerfaces. 18: 301-313 
11. Göppert, T. and Müller, R. (2005).  Adsorption kinetics of plasma proteins on solid lipid nanoparticles 
for drug targeting.  International Journal of Pharmaceutics.  302: 172-186 
12. Kainthan, R., Janzen, Levin, E., Devine, D. and Brooks, D. (2006). Biocompatibility Testing of 
Branched and Linear Polyglycidol. Biomacromolecules. 7(3): 703-709 
13. Rose, S., Lewis, A., Hanlon, J. and Lloyd, A. (2004). Biological responses to cationically charged 
phosphoycholine-based materials in vitro. Biomaterials. 25: 5125-5135 
14. Salvador-Morales, C., Flahaut, E., Sim, E., Sloan, J., Green, M. and Sim, R. complement activation and 
protein adsorption by carbon nanotubes.  Molecular Immunology. 43: 193-201 
15. Salvador-Morales, C., Zhang, L., Langer, R. and Farokhzah, O. (2009). Immunocompatibility 
properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups. 
Biomaterial. 30: 2231-2240 
16. Gessner, A., Lieske, A., Paulke, B. and Muller, R. (2004). Influence of surface charge density on 
protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. European 
Journal of Pharmaceutics and Biopharmaceutics. 54: 165-170 
17. Dobrovolskaia, M,., Patri, A., Zheng, J., Clogston, J., Ayub, N., Aggarwal, P., Neun, B., Hall, J. and 
McNeil, E. (2009). Interaction of colloidal gold nanoparticles with human blood: effects on particle 
size and analysis of plasma protein binding profiles.  Nanomedicine:  Nanotechnology, Biology, and 
Medicine.  5:  106-117 
18. Andersson, J.  (2003). Complement Activation Triggered by Biomaterial Surfaces.  Mechanisms and 
Regulation.  Acta Universitatis Upsaliensis.  Comprehensive Summaries of Uppsala Dissertations from 
Faculty of Medicine.  1253:  45  
19. Chang, K and Lee, Y. (2005). Application of a flow type quartz crystal mircrobalance immunosensor 
for real time determination of cattle bovine ephemeral fever virus in liquids.  Talanta.  65: 1335-1342. 
20. Spangler, B., Wilkinson, E., Murphy, J. and Tyler B. (2001).  Comparison of the Spreeta® surface 
plasmon resonance sensor and a quartz crystal microbalance for detection of Escherichia coli heat-
labile enterotoxin.  Analytica Chimica Acta.  444:  149-161 
21. Sellborn, A., Andersson, M., Chevallier, J. and Besenbacher, F. (2002).  Methods for research on 
immune complement activation on modified sensor surfaces.  Colloids and Surfaces B.  27:  295-301 
22. Limson, J., Odunuga, O., Green, H., Höök, F. and Blatch, G.  (2004). The use of a quartz crystal 
microbalance with dissipation for the measurement of protein-protein interactions:  a qualitative and 
quantitative analysis of the interactions between molecular chaperones.  South African Journal of 
Science.  100: 678-682 
159 
 
23. Höök, F., Kasemo, B., Nylander, T., Fant, C., Scott, K. and Elwing, H. (2001). Variations in coupled 
water, viscoelastic properties and film thickness of a Mefp-1 protein film during adsorption and cross-
linking: a QCM-D, ellipsometry and SPR study. Analytical Chemistry. 73: 5796-5804 
24. Fält, S., Wågberg, L., Vesterlind, E. (2003). Swelling of Model Films of Cellulose Having Different 
Charge Densities and Comparison to the Swelling Behavior of Corresponding Fibers. Langmuir. 19: 
7895-7903 
25. Lord, S., Modin, C., Foss, M., Duch, M., Simmons, A., Pedersen F., Milthorpe, B., and Besenbacher, 
F. (2006) Monitoring cell adhesion on tantalum and oxidized polystyrene using a quartz crystal 
microbalance with dissipation. Biomaterials.27: 4529- 4537 
26. Kabin, J., Tolstedt, S., Sáez, A., Grant, C. and Carbonell, R.  (1998), Removal of Organic Films From 
Rotating Disks Using Aqueous Solutions of Nonionic Surfactants: Effect of Surfactant Molecular 
Structure. Journal of Colloid and Interface Science.  206: 102–111. 
27. Berglin, M., Andersson, M., Sellborn, A. and Elwing, H.  (2004). The effect of substrate molecular 
mobility on surface induced immune complement activation and blood plasma coagulation.  
Biomaterials.  25: 4581-4590 
28. Hermmersam, A., Foss, M., Chevallier, J. and Besenbacher, F. (2005). Adsorption of fibrinogen on 
tantalum oxide, titanium oxide and gold studied by QCM-D technique. Colloids and Surfaces B: 
Biointerfaces. 43:  208-215 
29. Andersson, M., Andersson, J., Sellborn, A., Berglin, M., Nilsson, B. and Elwing, H.  (2005). Quartz 
crystal microbalance-with dissipation monitoring (QCM-D) for real time measurements of blood 
coagulation density and immune complement activation on artificial surfaces.  Biosensors and 
Bioelectronics.  21:  79-86 
30. Johannsman, D.  (2008). Viscoelastic, mechanical, and dielectric measurements on complex samples  
31. Höök, F. and Rudh, M.  (2005). Quartz crystal microbalances (QCM) in biomacromolecular 
recognition.  Bio Tech International.  17: 8-13 
32. Höök, F. and Kasemo, B.  (2001). Variations in Coupled Water, Viscoelastic Properties, and Film 
Thickness of a Mefp-1 Protein Film during Adsorption and Cross-linking:  A Quartz Crystal 
Microbalance with Dissipation Monitoring, Ellipsometry, and Surface Plasmon Resonance Study.  
Analytical Chemistry.  73:  5796-5804 
33. Vogt, B. Lin, E., Wu, W. and White, C.  (2004). Effects of Film Thickness on the Validity of the 
Sauerbrey Equation for Hydrated Polyelectrolyte Films.  Journal of Physical Chemistry B.  108:  
12685-12690 
34. Voinova, M., Rodahl, M., Jonson, M. and Kasemo, B. (1999). Viscoelastic Acoustic Response of 
layered Polymer Films at Fluid-Solid Interfaces: Continuum Mechanics Approach Physica Scripta. 59: 
391-396 
35. Dietschweiler, C.  Protein adsorption at solid surfaces.  Department of Environmental Sciences, 
Institute of Biogeochemistry and Pollutant Dynamics (IBP), Swiss Federal Institute of Technology 
(ETH), Zűrich. 
36. Cederval, T., Lynch, I., Lindman, S., Berggård, T., Nilsson, H., Dawson, K. And Linse, S.  (2007). 
Proceedings of the National Academy of Sciences.  104: 2050-2055 
37. Wang, D., Chen, B., Ji, J. and Feng, L. (2002). Selective Adsorption of Serum Albumin on Biomedical 
Polyurethanes Modified by Poly(ethylene oxide) Coupling-Polymer with Cibacron Blue (F3G-A) 
Endgroups. Bioconjugate Chemistry. 13: 792-803 
38. Wasdo, S., Barber, D., Denslow, N., Powers, K., Palazuelos, M., Stevens, S., Moudgil, B. and Roberts, 
S. (2008). Differential binding of serum proteins to nanoparticles. International Journal of 
Nanotechnology. 5: 92-115 
39. Das, S., Banerjee, R. and Bellare, J. (2005). Asprin Loaded Albumin Nanoparticles by Coacervation:  
Implications in Drug Delivery. Trends in Biomaterials & Artificial Organs. 18: 203-212 
40. Coico, R., Sunshine, G. and Benjamini, E. (2003). Immunology: A Short Course 5 th edition. John 
Wiley & Son, Inc. USA. 
41. Gorbet, M and Sefton, M. (2004). Biomaterial-associated thrombosis: roles of coagulation factors, 
complement, platelets and leukocytes. Biomaterials. 25: 5681-5703 
42. Hulander, M., Hong, J., Andersson, M., Gerven, F., Ohrlander, M., Tengvall, P. and Elwing, H. (2009).  
Blood Interactions with Nobel Metals: Coagulation and Immune Complement Activation. ACS  
Applied Materials & Interfaces.  1: 1053-1062 
43. Tunc, S., Maitz, M., Steiner, G., Vázquez, L., Pham, M. and Salzer, R.  (2005). In situ conformational 
analysis of fibrinogen adsorbed on Si surfaces. Colloids and Surfaces B: Biointerfaces. 42: 219-225. 
44. Guicai, L., Xiaoli, S., Ping, Y., Ansha, Z. And Nan, H.  (2008). Investigation of fibrinogen adsorption 
on solid surface by quartz crystal microbalance with dissipation (QCM-D) and ELISA.  Solid State 
Ionics. 179: 932-935 
160 
 
45. Wertz, C. and Santore, M.  (1999). Adsorption and Relaxation Kinetics of Albumin and Fibrinogen on 
Hydrophobic Surfaces:  Single-Species and Competitive Behaviour.  Langmuir.  15: 8884-8894 
46. Gessner, A., Lieske, A., Paulke, B. and Müller, R. (2002). Influence of surface charge density on 
protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. European 
Journal of Pharmaceutics and Biopharmaceutics. 54: 165-170 
47. Kolárová, H., Bajgar, R., Tománková, K., Krestýn, E., Doleźal, L. and Hálek, J. (2007).  In vitro Study 
of Reactive Oxygen Species Production during Photodynamic Therapy in Ultrasound-Pretreated 
Cancer Cells.  Physiolical  Research.  56: 27-32 
48. Pazos, M. and Nader, H.  (2007). Effect of photodynamic therapy on the extracellular matrix and 
associated components.  Brazilian Journal of Medical and Biological Research.  40: 1025-1035. 
49. Nyokong, T.  (2008). Electrocatalytic and photosensitising behaviour of metallo-phthalocyanine 
complexes.  Journal of Porphyrins and Phthalocyanines.  12: 1005-1021 
50. Ochsne, M.  (1997). Photophysical and photobiological processes in the photodynamic therapy of 
tumors. Journal of Photochemistry and Photobiology B: Biology.  39: 1-18 
51. Agboola, B.  (2007). Catalytic activities of Metallophthalocyanines towards Detection and 
Transformation of Pollutants.  Rhodes University 
52. Kolárová, H., Kubínek, R., Lenobel, R., Bancirová, M., Strnad, M., Jírová, D. and Lasovský, J. In vitro 
Photodynamic therapy with phthalocyanines on the MCF-7 cancer cells. Second International 
Conference of Photochemistry and Photobiology. 1999. 
 http://www.photobiology.com/photobiology99/contrib/kolarova/index.htm 
53. Pashkovskaya, A., Sokolenko, E., Sokolov, V., Kotova, E. and Antonenko, Y.  (2007). Photodynamic 
activity and binding of sulfonated metallophthalocyanines to phospholipid membranes:  Contribution 
of metal-phosphate coordination.  Biochimica et. Biophysica Acta. 1768: 2459-2465 
54. Martin, P., Gouterman, M., Pepich, B., Renzoni, G. and Schindele, D.  (1991). Effects of Ligands, 
Solvent, and Variable Sulfonation on Dimer Formation of Aluminum and Zinc 
Pthalocyaninesulfonates.  Inorganic Chemistry.  30:  3305-3309. 
55.  Nyokong, T. and Vilakazi, S. (2002). Phthalocyanines and related complexes as electrocatalysts for the 
detection of nitric oxide. Talanta. 61: 27-35 
56. Bedioui, F., Griveau, S., Nyokong, T., Appleby, J., Caro, C., Gulppi, M., Ochoa, G. and Zagal, J.  
(2007). Tuning the redox properties of metalloporphyrin- and metallophthalocyanine-based molecular 
electrodes for the highest electrocatalytic activity in the oxidation of thiols.  Physical Chemistry, 
Chemical Physics. 9: 3383-3396 
57. Fogel, R., Mashazi, P., Nyokong, T. and Limson, J.  (2007). Critical assessment of the Quartz Crystal 
Microbalance with Dissipation as an analytical tool for biosensor development and fundamental 
studies: Metallophthalocyanine-glucose oxidase biocomposite sensor. Biosensors and Bioelectronics. 
23: 95-101 
58. Liu, M., Tai, C., Sain, M., Hu, A. and Chou, F.  (2003). Photodynamic applications of phthalocyanines. 
Journal of Photochemistry and Photobiology A: Chemistry. 165:  131-136 
59. Wael, K., Wastbroek, P. and Temmerman, E.  (2004). Study of the deposition of 
cobalt(II)tetrasulfophthalocyanine layer at gold surface in alkaline solutions.  Journal of 
Electroanalytical Chemistry.  567: 167-173 
60. Camp, P., Jones, A., Neely, R. and Speir, N. (2002).  Aggregation of Copper (II) Tetrasulfonated 
Phthalocyanine in Aqueous Salt Solutions. Journal of Physical Chemistry A.  106: 10725-10732. 
61. Chatterjee, S. and Srivastava, T.  (2000). Spectral investigations of the interaction of some porphyrins 
with bovine serum albumin.  Journal of Porphyrins and Phthalocyanines.  4:  147-157 
62. Fraczek, A., Manaszek, E., Paluszkeiwicz, C. and Blazewicz, M.  (2008). Comparative in vivo 
biocompatibility study of single- and multi-walled carbon nanotubes.  Acta Biomaterialia. 4: 1593-
1602. 
63. Foldvari, M. and Bagonluri, M. (2008). Carbon nanotubes as functional excipients for nanomedicine: 
II. Drug delivery and biocompatibility issues. Nanomedicine: Nanotechnology, Biology, and Medicine. 
4: 183-200 
64. Cheng, C., Müller, K., Koziol, K., Skepper, J., Midgley, P., Welland, M. and Porter, A.  (2009). 
Toxicity and imaging of multi-walled carbon nanotubes in human macrophage cells.  Biomaterials.  
30:  4152-4160 
65. Hamad, I., Hunter, A., Rutt, K., Liu, Z., Dai, H. And Moghimi, M.  (2008). Complement activation by 
PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover.  
Molecular Immunology.  45: 3797-3803 
66. Jos, A., Pichardo, S., Peurto, M., Sánches, E, Grilo, A. and Cameán, A.  (2009). Cytotoxicity of 
carboxylic acid functionalized single wall carbon nanotubes on the human intestinal cell line  Caco-2.  
Toxicology in Vitro.  23:  1491-1496 
161 
 
67. Pulskamp, K., Diabaté, S. and Krug, H.  (2007).  Carbon nanotubes show no sign of acute toxicity but 
induce intracellular reactive oxygen species in dependence on contaminants.  Toxicology Letters.  168:  
58-74 
68. Kaiser, J., Wick, P., Manser, P., Spohn, P. and Bruinink, A.  (2008). Single walled carbon nanotubes 
(SWCNT) affect cell physiology and cell architecture. Journal of Material Science: Material Medicine.  
19: 1523-1527 
69. Shvedova, A., Kisin, E., Porter, D., Schulte, P., Kagan, V., Fadeel, B. And Castranova, V.  (2009).   
Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes:  Two faces of 
Janus?.  Pharmacology & Therapeutics.  121:  192-204 
70. Zhang, T., Xu, M., He, L., Xi, K., Gu, M. and Jiang, Z. (2008). Synthesis and characterization of and 
cytotoxicity of phyosphoryl choline-grafted waters-soluble carbon nanotubes. Carbon. 46: 1782-17 
71. Brown, D., Kinloch, I., Bangert, U., Windle, A., Walter, D., Walker, G., Scotchford, C., Donaldson, K. 
and Stone, V.  (2007). An in vitro study of the potential of carbon nanotubes and nanofibres to induce 
inflammation mediators and frustrated phagocytosis. Carbon. 45: 1743-1756 
72. Bottini, M., Bruckner, S., Nika, K., Bottini, N., Bellucci, S., Magrini, A., Bergamaschi, A. and 
Mustelin, T. (2006). Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicology Letter. 
160: 121-126 
73. Ding, L., Stilwell, J., Zhang, T., Elboudwarej, O., Huijian, J., Selegur, J., Cooke, P., Gray, J. and Chen, 
F. (2005). Molecular characterization of the cytotoxic mechanism of multiwalled carbon nanotubes and 
nano-onions on human skin fribroblasts. Nano Letter. 5: 2448-2464 
74. Datsyuk, V., Malyva, M., Papagelis, K., Parthenios, J., Tasis, D., Siokou, A., Kallitsis, I. and Galiotis, 
C. (2008). Chemical oxidation of multiwalled carbon nanotubes. Carbon. 46: 833-840 
75. Marshall, M., Popa-Nita, S. and Shapter, J. (2006). Measurement of functionalised carbon nanotube 
carboxylic acid groups using a simple chemical process. Carbon. 44: 1137-1141 
76. Kakade, B. and Pillai, K. (2008). An efficient route towards the covalent functionalisation of single 
walled carbon nanotubes. ACS Applied Surface Science. 254: 4936-4943 
77. Green, R., Frazier, R., Shakesheff, K., Davies, M., Roberts, C. and Tendler, S.  (2000). Surface 
plasmon resonance analysis of dynamic biological interactions with biomaterials.  Biomaterials.  21: 
1823-1835 
78. Jung, H., Kim, J., Kim, Y., Tae, G., Kim, Y. And Johannsmann, D. (2009). QCM and AFM Analysis of 
Anticoagulant Activities of Sulfonated Polymers against Fibrin Formation. Langmuir. 25:  7032-7041 
79. Benesch, J., Mano, J. and Reis, R. (2010).  Analysing protein competition on self-assembled mono-
layers studied with quartz crystal microbalance.  Acta Biomaterialia. 6: 3499-3505 
80. Höök, F., Vörös, J., Rodahl, M., Kurrat, R., Böni, P., Ramsden, J., Textor, M., Spencer, N., Tengvall, 
P., Gold, J. and Kasemo, B. (2002). A comparative study of protein adsorption on titanium oxide 
surfaces using in situ ellipsometry, optical waveguide lightmode spectroscopy, and quartz crystal 
microbalance/dissipation. Colloids and Surfaces B:  Biointerfaces. 24: 155-170 
81. Hemmersam, A., Foss, M., Chevallier, J. and Besenbacher, F. (2005). Adsorption of fibrinogen on 
tantalum oxide, titanium oxide and gold studied by QCM-D technique. Colloids and Surfaces B: 
Biointerfaces. 43:  208-215 
82. Toda, M. and Iwata, H. (2010). Effects of Hydrophobicity and Electrostatic Charge on Complement 
Activation by Amino Groups. ACS Applied Materials & Interfaces. 2: 1107-1113. 
83. Chen, D., and Li, J. (2006). Interfacial design and functionalisation on metal electrodes through self-
assembled monolayers. Surface Science Reports. 61: 445-463 
84. Porter, M., Bright, T., Allara, D. and Chidsey, C. (1987). Spontaneously Organized Molecular 
Assemblies. 4. Structural characterization of n-Alkyl Thiol Monolayers on Gold by Optical 
Ellipsometry, Infrared Spectroscopy, and Electrochemisry. Journal of American Chemical Society. 
109: 3559-3568 
85. Molina, S. (2006). Surface Functionalization of a Cantilever Sensor.  Thesis in Chemistry. Texas Tech.  
University. 
86. Kankare, J., Laajalehto, K., Laiho, T., Leiro, J., Lukkari, J. and Meretoja, M. (2005). Chemisorption of 
alkyl thiols and S-alkyl thiosulfates on Pt(111) and polycrystalline platinum surfaces. Surface Science. 
584: 83-89 
87. Bowen, J., Manickam, M., Evans, S., Critchley, K., Kendall, K. and Preece. (2008) The pH-dependent 
adhesion of nanoparticles to self-assembled monolayers on gold. Thin Solid Films. 516: 2987-2999 
88. Ito, S., Matsubayashi, K., Miwa, N., Mori, T., Sawaguchi, T. and Takada, H. (2006). Preclinical studies 
on safety of fullerene upon acute oral administration and evaluation from no mutagenesis. Toxicology. 
225: 48-54 
162 
 
89. You, H., Disley, D., Cullen, D. and Lowe, C.  (1993). Physical adsorption of immunoglobulin G on 
gold studied by scanning tunnelling microscopy.  International Journal of Biological Macromolecules. 
16:  87-91 
90. Stobiecka, M., Hepel, M. and Radecki, J.  (2005). Transient conformation changes of albumin adsorbed 
on gold piezoelectrodes.  Electrochemica Acta. 50: 4873-4887 
91. Barbose, J., Barbosa, M. and Águas, A.  (2004). Inflammatory responses and cell adhesion to self –
assembled monolayers of alkanethiolates on gold.  Biomaterials. 25: 2557-2563 
92. Aggarwal, P., Hall, J., McLeland, B., Dobrovolskaia, M. and McNeil, S.  (2009). Nanoparticle 
interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic 
efficacy.  Advanced Drug Delivery Reviews.  61: 428-437 
93. Mayer, G.  Microbiology and Immunology On-line. Immunology. Complement. University of South 
Carolina School of Medicine.   
http://pathmicro.med.sc.edu/ghaffar/complement.htm  
94. Adkins, J., Varnum, S., Auberry, K., Moore, R., Angell, N., Smith, R., Springer, D. and Pounds, J. 
(2002). Towards a Human Blood Serum Proteome.  Molecular & Cellular Proteomics. 1: 947-955 
95.  Filyasova, A., Kudelina, I. and Feofanov, A. (2001). A spectroscopic study of the interaction of 
tetrasulfonated aluminium phthalocyanine with human serum albumin.  Journal of Molecular 
Structure. 565-566: 173-176 
96. Figueira, V. and Jones, J. (2008). Viscoelastic study of the adsorption of bovine serum albumin on gold 
and its dependence on pH. Journal of Colloidal and Interface Science. 325: 107-113 
97. Shim, M., Wong Shi Kam, N., Chen, R., Li, Y. and Dai, H.  (2002). Functionalization of Carbon 
Nanotubes for Biocompatibility and Biomolecular Recognition. NanoLetters. 2: 285-288 
98. Barbisa, J., Barbosa, M. and Aguas, A. (2004). Inflammatory responses and cell adhesion to self-
assembled monolayers of alkanethiolates on gold. Biomaterials. 25: 2558-2563 
99. Rodriguez, M., Fernández, D., Awruch, J. Braslavsky, S. and Dicelio, L. (2006).  Effect of aggregation 
of a cationic phthalocyanine in micelles and in the presence of human serum albumin.  Journal of 
Porphyrins and Phthalocyanines. 10: 33-42 
100. Nyokong, T.  (2007). Effects of substituents on the photochemical and photophysical properties of 
main group metal phthalocyanines.  Coordination Chemistry Review.  251:  1707-1722. 
101. Ogunisipe, A. and Nyokong, T. (2005).  Photophysical and photochemical studies of sulphonated non-
transitionmetal phthalocyanines in aqueous and non-aqueous media. Journal of Photochemistry and 
Photobiology A: Chemistry. 173:  211-220 
102. Bertoncello, P. and Peruffo, M.  (2008). An investigation on the self-aggregation properties of 
sulfonated copper (II) phthalocyanine (CuTsPc) thin films.  Colloids and Surfaces A: Physiochemical 
Engineering Aspects. 321:  106-112 
103. Rosengren, A., Pavlovic, E., Oscarsson, S., Krajewski, A., Ravaglioli, A. and Piancastelli, A.  (2002). 
Plasma protein adsorption pattern on characterized ceramic biomaterials.  Biomaterials.  23: 1237-1247 
104. Stylii, S., Hill, J., Sawyer, W. and Kaye, A.  (1995). Aluminium phthalocyanine mediated 
photodynamic therapy in experimental malignant glioma.  Journal of Clinical Neuroscience.  2:  146-
151 
105. Toscano, A. and Santore, M. (2006).  Fibrinogen Adsorption on Three Silica-Based Surfaces:  
Conformation and Kinetics. Langmuir. 22: 2588-2597 
106. Nilsson, B., Nilsson, E., Mollnes, T. and Lambris, J. (2007).  The role of complement in biomaterial-
induced inflammation.  Molecular Immunology. 44: 82-91 
107. Marx, K.  (2003). Quartz Crystal Microbalance: A Useful Tool for Studying Thin Polymer Films and 
Complex Biomolecular Systems at the Solution-Surface Interface.  Biomacromolecules.  4:  1099-1120 
108. Wang, K., Xu, J. and Chen, H. (2006). Biocomposite of cobalt phthalocyanine and lactate oxide for 
lactate biosensing with MnO2 nanoparticles as an eliminator of ascorbic acid interference. Sensors and 
Actuators B: Chemical. 107: 768-772 
109. Peeters, K.  (2007). Tetrasulphonated phthalocyanine thin films deposited on gold electrodes:  a study 
using voltammetry and synchrotron micro X-ray fluorescence.  Universiteit Gent.  Faculty of Science.  
Department of Analytical Chemistry. 
110. Singh, K., Pandey, R., Wang, X., Lake, R., Ozkhan, C., Wang, K. And Ozkan, M.  (2006). Covalent 
functionalisation of single walled carbon nanotubes with peptide nucleic acid:  Nanocomponents for 
molecular level electronics.  Carbon. 44: 1730-1739 
111. Veetil, J. and Ye, K. (2007). Development of Immunosensors Using Carbon Nanotubes. Biotechnology 
Progress. 23: 517-531 
112. Osoria, A., Silveira, I., Bueno, V. and Bergmann, C. (2008). H2SO4/HNO3/HCl-Functionalization and 
its effect on dispersion of carbon nanotubes in aqueous media. Applied Surface Science. 255: 2485-
2489 
163 
 
113. Hu, C., Su, J. and Wen, T. (2007). Modification of multi-walled carbon nanotubes for electric double-
layer capacitors: Tube opening and surface functionalisation. Journal of Physics and Chemistry of 
Solids. 68: 2353-2362 
114. Piret, J., Detriche, S., Vigneron, R., vankoningsloo, S., Rolin, S., Mejia Mendoza, J., Masereel, B., 
Lucas, S., Delhalle, J., Luizi, F., Saout, C. and Toussaint, O. (2010). Dispersion of multi-walled carbon 
nanotubes in biocompatible dispersants. Journal of Nanoparticle Research. 12: 75-82 
115. Obradović, M., Vuković, G., Stevanović, S., Panic, V., Uskoković, P., Kowal, A. and Goijović, S. 
(2009). A comparative study of the electrochemical properties of carbon nanotubes and carbon black. 
Journal of Electroanalytical Chemistry. 634: 22-30 
116. Wang, Y. , Wu, J. and Wei, F. (2003). A treatment method to give separated multi-walled carbon 
nanotubes with high purity, high crystallization and large aspect ratio.  Carbon. 41: 2939-2948. 
117. Sahoo, N., Rana, S., Cho, J., Li, L. and Chan, H. (2010). Polymer nanocomposites based on 
functionalized carbon nanotubes. Progress in Polymer Science. 35: 837-867 
118. Schierz, A. and Zanker, H. (2009). Aqueous suspensions of carbon nanotubes: Surface oxidation, 
colloidal stability and uranium sorption. Environmental Pollution. 157: 1088-1094 
119. Tune, D., Flavel, B., Quinton, J., Ellis, A. and Shapter, J. (2010). Single walled carbon nanotube 
network electrodes for dye solar cells. Solar Energy Materials & Solar Cells. 94: 1665-1672 
120. Milanovich, N., Reinot, T., Hayes, J. and Small, G.  (1998). Aluminum Phthalocyanine Tetrasulfonate 
in MCF-10, Human Breast Epithelial Cells:  A Hole Burning Story.  Biophysical Journal.  74:  2680-
2688 
121. Atilla, D., Saydan, N., Durmus, M., Gürek, A., Khan, T., Rück, A., Walt, H., Nyokong, T. and Ahsen, 
V. (2007).  Synthesis and photodynamic potential of tetra- and octa-triethyleneoxysulfonyl substituted 
zinc phthalocyanines.  Journal of Photochemistry and Photobiology A: Chemistry.  186:  298-307 
122. Ogunsipe, A., Nyokong, T. and Durmus, M.  (2007). Photophysical, photochemical and bovine serum 
albumin binding studies on water-soluble gallium (II) phthalocyanine derivatives.  Journal of 
Porphyrins and Phthalocyanines.   11:  635-644 
123. Kunz, L., Connelly, J., Woodhams, J. and MacRobert, A.  (2007). Photodynamic modification of 
disulfonated aluminium phthalocyanine fluorescence in a macrophage cell line.  Photochemical & 
Photobiological Sciences. 6:  940-948 
124. Haywood-Small, S., Vernon, D., Griffiths, J., Schofield, J. and Brown, S.  (2006).  Phthalocyanine-
mediated photodynamic therapy induces cell death and a G0/G1 cell cycle arrest in cervical cancer cells.  
Biochemical and Biophysical Research Communications. 339: 569-576 
125. Glassberg, E., Lewandowski, L., Lask, G. and Uitto, J.  (1990). Laser-Induced Photodynamic Therapy 
with Aluminum Phthalocyanine Tetrasulfonate as the Photosensitizer:  Differential Phototoxicity in 
Normal and Malignant Human Cell In Vitro.  Selective Photodynamic Toxicity.  94:  604-610 
126. Korbelik, M.  (1993). Distribution of disulfonated and tetrasulfonated aluminum phthalocyanine 
between malignant and host cell populations of murine fibrosarcoma.  Journal of Photochemistry and 
Photobiology B: Biology.  20:  173-181 
127. Schoemaker, M., Cohen, I. and Campbell, M. (2004).  Reduction of MTT by aqueous herbal extracts in 
the absence of cells. Journal of Ethnopharmachology. 93: 381 – 384 
128. Berridge, M., Tan, A., McCoy, K. and Wang, R. (1996). The Biochemical and Cellular Basis of Cell 
Proliferation Assays That Use Tetrazolium Salts.  Biochemica. 4: 14-19 
129. Labanauskiene, J., Gehl, J. and Didziapetriene, J. (2007). Evaluation of cytotoxic effect of 
photodynamic therapy in comparison with electroporation in vitro.  Bioelectrochemistry. 70: 78-82 
130. Lee, E., Cho, H., Lee, C., Lee, D., Chung, K. and Paik, S. (2004). Phthalocyanine Tetrasulfonates 
Affect the Amyloid Formation and Cytotoxicity of α-Synuclein. Biochemistry. 43: 3704-3715 
131. Cauchon, N., Tian, H., Langlois, R., Madeleine, C., Martin, S., Ali, H., Hunting, D. and van Lier, J. 
(2005). Structure-Photodynamic Activity Relationships of Substituted Zinc Trisulfophthalocyanines. 
Bioconjugate Chemistry. 16: 80-89 
132. Matthews, E. And Cui, Z.  (1990). Photodynamic action of sulphonated aluminium phthalocyanine 
(SALPC) on AR4-2J cells, a carcinoma cell line of rate exocrine pancreas.  British Journal of Cancer.  
61: 659-701 
133. Vittar, N., Prucca, C., Strassert, C., Awruch, J, Rivarola, V.  (2008). Cellular inactivation and antitumor 
efficacy of new zinc phthalocyanine with potential use in photodynamic therapy.  The international 
Journal of Biochemistry & Cell Biology.  40:  2192-2205 
134. Jin, C., Zhu, B., Wang, X. and Lu, Q.  (2008). Cytotoxicity of Titanium Dioxide Nanoparticles in 
Mouse Fibroblast Cells.  Chemical Research in Toxicology. 21: 1871-1877 
135. Alley, M., Scudiero, D., Monks, A., Hursey, M., Czerwinski, M., fine, D., Abbott, B., Mayo, J., 
Schoemaker, R. and Boyd, M.  (1988). Feasibility of Drug Screening with Panels of Human Tumor 
Cell Lines Using a Microculture Tetrazolium Assay.  Cancer Research.  45:  589-601 
164 
 
136. Edrei, R., Gottfried, V., van Lier, J. and Kimel, S.  (1998). Sulfonated phthalocyanines: photophysical 
properties, in vitro cell uptake and structure-activity relationships.  Journal of Porphyrins and 
Phthalocyanines. 2: 191-199 
137. Seotsanyana-Mokhosi, I., Kresfelder, T., Abrahamse, H. And Nyokong, T.  (2006). The effect of Ge, Si 
and Sn phthalocyanine photosensitizers on cell proliferation and viability of human oesophageal 
carcinoma cells.  Journal of Photochemistry and Photobiology B: Biology.  23: 55-62 
138. Reddi, E., Cernuschi, S., Biolo, R. and Jori, G. (1990). Liposome-or LDL-administered Zn(II)-
phthalocyanine as Photodynamic Agent for Tumours III. Effect of Cholesterol on Pharmacokinetic and 
Phototherapeutic Properties. Lasers in Medical Science. 5: 339-343 
139. Atlante, A. and Passarella, S. (1999). Detection of reactive oxygen species in primary cultures of 
cerebellar granule cells. Brain Research Protocols. 4:  266-270 
 
 
Internet References 
1. Q-Sense ® Official webpage 
Webpage:  www.qsense.org 
 
2. ThermExcel 
Webpage:  www.thermexcel.com/english/index.htm 
 
Alternative References 
1. Q-Tools Modelling Program  
3.0.7.230 
 
 
